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1.1. Introduction 
 
 
Humans are exposed to a variety of environmental stressors e.g., chemicals, solvents, 
pollutants, lifestyle factors and microorganisms, during their life span (figure 1). Over 
the past few decades, scientific research has linked exposure of environmental 
stressors to human diseases (Ziech et al., 2010b). Human exposure to environmental 
agents causes more than 13 million deaths annually, and 24% of the diseases are 
estimated to be caused by environmental stressors worldwide (Hou et al., 2012). 
Exposure to environmental stressors is linked with several multifactorial diseases e.g., 
cancer, cardiovascular, autoimmune disease etc (Miller et al., 2012, Joseph et al., 
2013). It has been estimated that 10% of about 80.000 chemicals in use today are 
recognized carcinogens (Carpenter et al., 2002). Higginson and Muir in 1977 asserted 
that 80% of all cancers were partly due to environmental exposures (Higginson and 
Muir, 1977). More recent estimations of environmental factors contributing to cancer, 
however, range from 1 to 19 % (Wild, 2009). It has thus of great interest not only to 
identify environmental stressors that can induce carcinogenesis (i.e., cellular and 
molecular events leading cancer), but also to elucidate the mechanisms by which they 
exert their carcinogenic effect. Traditional concept of chemical induced 
carcinogenesis is mainly based on mutational events leading to changes in the DNA 
sequence i.e., genetic event. Novel knowledge, however, also linked the occurrence of 
non-mutational events which regulate genes activity i.e., epigenetic events, in the 
aetiology of chemical carcinogenesis (Lund, 2011).   
 
Figure 1: Human exposure to environmental stressors.  
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Humans are exposed different environmental stressor during lifetime as shown in figure. PM: 
particulate matter; UV: ultra violet.  
 
1.2. Environmental carcinogenesis  
 
 
Early experiments in understanding the process of carcinogenesis were done in mice 
skin exposed to coal tar that lead to the formation of skin tumour.  The molecular 
changes in the mouse skins were explained by the multistage model of carcinogenesis 
(Abel and DiGiovanni, 2011). This model described that carcinogenesis initiates and 
proceeds through changes in the DNA (i.e., genetic effects) (Vogelstein and Kinzler, 
2004). Molecular events encompassing multistep model of carcinogenesis comprise 
three phases i.e., initiation phase, promotion phase and progression phase. Initiation 
phase of carcinogenesis is characterized by the induction of irreversible DNA damage 
(e.g., mutation via DNA depurination and deamination) which pre-disposes cells to 
malignancy. Initiated cells are phenotypically similar to remaining cells but they have 
accumulated genetic damage, which may lead to high proliferation rate with less time 
for DNA repair. Initiation is irreversible genetic event, which is transmitted during 
mitosis. Promotion phase contributes to carcinogenesis by increased mitogenesis and 
by fixing mutations, although additional genotoxic events are not necessary. Both 
initiation and promotion phases of carcinogenesis are dependent on the presence of 
carcinogens in cells.  Progression is the last phase of carcinogenesis during which 
cells acquire neoplastic phenotype. In this phase, cell proliferation is independent of 
the presence of carcinogens in cells, and is characterized by irreversibility, genetic 
instability, faster growth, invasion and metastasis of neoplastic cells (Oliveira et al., 
2007). 
 
1.2.1. Genetic mechanisms in carcinogenesis 
 
 
The “initiation phase” of multistage carcinogenesis in mouse skin occurred with the 
dermal application of a genotoxic chemical e.g., benzo(a)pyrene. The initiated cells 
harbouring the genetic aberrations (i.e., DNA mutation) were reported after 1 week of 
dermal exposure of genotoxic chemicals. Mutations in Hras1 gene lead to the clonal 
origin of the papillomas. In the initiation phase of carcinogenesis, chemical exposure 
 
 
10 
can induce many DNA lesions e.g., DNA adducts formation, DNA cross-links, DNA 
single or double strand breaks, gene copy number alterations. These DNA lesions 
could alter the expression and functions of genes, consequently leading to 
carcinogenesis (Abel and DiGiovanni, 2015).  
 
In contrast to tumour initiators, tumour promoters exert their effects through altering 
the cell receptors, differentiation and signalling pathways. Tumour promoters do not 
directly affect the DNA, but rather induce their effect via reversible non-genetic 
events.  In the mouse model of carcinogenesis, alterations in the signalling pathway of 
protein kinase C (PKC) were frequently implicated in the expansion of initiated cells.  
 
The progression stage of carcinogenesis in the mouse model was accompanied by the 
occurrence of additional genetic events e.g., aneuploidy. In support of genetic 
involvement in multistage carcinogenesis model, DNA aberrations in the different 
cancers have been reported. For example, mutation in adenomatous polyposis coli 
(APC) gene, K-RAS and mutations in other oncogenes and tumor suppressor genes are 
described to take place in colorectal cancer. Similarly, mutations in oncogenes and 
tumour suppressor genes are also described in the carcinogenesis of squamous-cell 
lung carcinoma, osteocarcinoma, melanoma, retinoblastoma  (Sadikovic et al., 2008).  
 
Many chemicals present in the environment are characterized for their genotoxic 
potential. Hence exposure to these environmental chemicals could potentially lead to 
the development of cancer cells. Exposure to volatile compounds (benzene, 
hydroquinone etc) is shown to induce DNA damage (Harvilchuck et al., 2009). 
Polyaromatic hydrocarbons (PAH) e.g., benzo[a]pyrene exposure induces DNA 
adduct formation with purine bases which leads to genetic damage (Phillips, 1983). 
Also, exposure to halogenated compounds e.g., tricholoroethylene, 
carbontetrachloride are shown to induce somatic mutation in lung, liver and kidneys 
(Liviac et al., 2010, Oliveira et al., 2007). Human exposure to environmental agents is 
reported to induced carcinogenesis in many tissues e.g., lungs, skin, breast, ovaries, 
brain and blood (Abel and DiGiovanni, 2015). 
 
Since genetic damage is implicated in the etiopathogenesis of environmental induced 
cancer, hence measuring the extent of genetic damage is applied in cancer screening 
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assays.  In cancer risk assessment assays e.g., ames test, comet assay and 
micronucleus assay, the extent of adduct formation, DNA cross-linking and mutations 
are investigated. Comet (single cell gel electrophoresis) assay is conducted on cells in 
order to assess whether a chemical has induced genetic damage or not, and serves to 
detect DNA breaks. Micronucleus arises from whole lagging chromosomes 
(aneugenic event) or acentric chromosomal fragment detaching from the chromosome 
after breakage (clastogenic event). These aneugenic and clastogenic events are 
assessed by the micronucleus assay. Both the comet and micronucleus assays are used 
to investigate the intensity and nature of DNA damage which might lead to 
carcinogenesis (Hussain et al., 2007, Rundle, 2006, Poirier, 2004).  
 
1.2.2. Non-genetic mechanisms in carcinogenesis 
 
 
Environmental agents-induced DNA damage is an important early event during the 
initiation phase of carcinogenesis, which reflects a permanent and irreversible change 
in the initiated cells (Pitot, 2007, Loeb and Harris, 2008). However, recent studies 
have reported that initiation per se in classical carcinogenesis model is not sufficient 
for tumor development, which results from broader alterations in the cellular 
homeostasis, mainly because of the inability of initiated cells to properly control and 
regulate the gene expression (Shiao, 2009). Exposure to environmental stressors, in 
addition to their genetic effects, also involve a variety of non-genotoxic (i.e., 
epigenetic effects) effects in cells (Tryndyak et al., 2006). These epigenetic effects 
also play key role in cancer development. Evidence suggests that epigenetic 
alterations in cells could result in the emergence of reprogrammed cells with 
characteristics similar to the cancer cells (Bombail et al., 2004) .  
 
Thus epigenetics is implicated to play critical role in different phases of multistage 
model of carcinogenesis. For example, traditionally the genetic components such 
mutations inβ-catenin and P53 were implicated in the carcinogenesis of hepatocellular 
carcinoma (HCC). With recent surge in epigenetic knowledge, however, it is now 
accepted that epigenetic factors play critical role in all stages of HCC carcinogenesis 
(Pogribny and Rusyn, 2014). Further, disruptions in epigenetic pathways are 
implicated in the carcinogenesis of prostate cancer, retinoblastoma, non-small cell 
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lung cancer, breast cancer, leukemias, renal carcinomas, colon and endometrial 
carcinomas. Cellular epigenetic pathways are susceptible to dysregulation by 
exposure to environmental agents, thus leading to the epigenetic carcinogenesis 
(Sugimura and Ushijima, 2000, Herceg and Vaissiere, 2011). In order to understand 
how environmental factors disrupt the epigenetic pathways that lead to epigenetic 
carcinogenesis, it is thus important to know the components of cellular epigenetic 
machinery. 
 
1.3. Epigenetics  
 
 
The term “epigenetics” was coined by Conard Waddington (Waddington, 1942). In 
simplest term, epigenetics is defined as cellular events, which aren’t of genetic origin. 
This means epigenetic events are not defined by the DNA sequences. Epigenetics is 
described as the cellular events that act as an interface between genes and 
environment that influence the cell functions without changing the DNA sequence.  
As an example, cellular differentiation during development could be considered as an 
epigenetic phenomenon. During development, cellular differentiation leads to the 
emergence of multicellular organisms with cells genetically similar but structurally 
and functionally heterogeneous. This cellular heterogeneity is influenced by the 
epigenetic mechanisms, which regulate and maintain different patterns of gene 
expression in cells. These differential gene expression patterns are transmitted during 
mitosis to successive generations.  Thus epigenetics can be defined as stable and 
heritable changes in gene expression occurring without changes in the DNA sequence 
(Goldberg et al., 2007).   
 
The covalent and non-covalent modifications of DNA and histone proteins and non-
coding-RNAs are the main mechanisms which are involved in the cellular epigenetic 
machinery (figure 2) (Kanwal and Gupta, 2012). Disruptions in these mechanisms are 
shown to be linked with epigenetic carcinogenesis. Histone modifications and non-
coding-RNAs and their involvement in carcinogenesis is described below briefly, 
followed by more detailed description of DNA methylation and it is implications in 
carcinogenesis.  
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Figure 2: Major categories of epigenetic mechanisms. Cells epigenetic control is mediated by 
difference mechanisms operating in the cells e.g., DNA methylation, histone modification and 
noncoding RNAs. These mechanisms confer additional control of gene regulation. Adopted from 
Sweatt et al., 2012 (Sweatt et al., 2012). 
 
1.3.1. Histone modifications  
 
 
In eukaryotes, chromatin is a highly condensed structure sequestered in nucleus.  It 
exists in two functionally distinct forms: a condensed form called heterochromatin 
which occurs during mitosis and meiosis, and decondensed or loose form called 
euchromatin. Structurally, chromatin is packed in nucleus by repeating units of 
nucleosomes. Nucleosomes consist of DNA which is wrapped around core histones. 
Within a nucleosome there are two units of each of the core histones H2A, H2B, H3, 
and H4. Nucleosomes are considered as the warehouse of epigenetically inherited 
information. Epigenetic information in this warehouse is stored in the form of 
covalent modifications of the core histones of nucleosome. Amino terminal of core 
histone proteins has flexible and highly basic tail region, which is subject to various 
post-transcriptional modification (PTMs). There are at least 60 different amino acids 
residues where PTMs has been detected, and these numbers are likely to grow. There 
are at least eight different types of histone modification: acetylation, methylation, 
phosphorylation, ubiquitination, sumoylation, ADP ribosylation, deimination, and 
proline isomerization. These PTMs regulate the epigenetic information via altering 
the nucleosome-nucleosome interactions and/or the nucleosome-DNA interactions.  
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Histone PTMs act in interdependent manner and forms so called the histone code 
which are the units of cells epigenetic programming (Zhang and Reinberg, 2001, 
Kouzarides, 2007).  
 
During epigenetic mechanism of carcinogenesis, aberrations in the histone codes arise 
which can lead to cellular transformation. With decades of research, it is now known 
that there are patterns of histones PTMs alterations that lead to epigenetic 
carcinogenesis.  For example, lymphocytes of cancer patients showed significantly 
lower levels of global histone H4 trimethylation (H4K20me3) and acetylation 
(H4K16ac) compared to the lymphocytes from healthy individuals. The progressive 
loss of histone H4 trimethylation was further confirmed in the animal model of 
carcinogenesis. Global loss of H4K20me3 represents an early event in tumorigenesis 
that arise early in carcinogenesis, and this global loss of H4K20me3 becomes more 
evident during the sequential progression of carcinogenesis moving from cell 
hyperplasia to metaplasia, dysplasia, and then to carcinoma in situ (Van Den Broeck 
et al., 2008).  
 
Histone PTMs are also susceptible to aberrations by exposure of environmental 
agents.  In systematic literature review on environmental exposure induced histone 
PTMs changes, it was shown that expression of H3Me3K4 and H3Me2K9 histone 
marks were most abundantly affected by exposure of heavy metals and ethanol (Dik 
et al., 2012). Cells exposed to these environmental stressors lead to the altered 
expression level in a number of genes via altering the histone PTMs (Martinez-
Zamudio and Ha, 2011). Since alterations in histone PTMs patterns are implicated in 
carcinogenesis, it is thus foreseen that exposure of environmental stressors can lead to 
carcinogenesis by altering the histone PTMs.  
 
1.3.2. microRNA 
 
 
The process of transcription in cells produces large numbers of RNA molecules. Not 
all of these RNAs are translated into proteins, but rather play regulatory functions in 
cells, and are called non-coding RNAs (ncRNA). (Kaikkonen et al., 2011). 
MicroRNAs (miRNA) are the most well-known of the regulatory non-coding RNA 
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classes. They are transcribed in the nucleus by polymerase II as long primary 
transcripts (pri-miRNA) up to 1000 nucleotides (nt) in length. pri-miRNA is then 
cleaved producing a pre-miRNA molecule of approximately 70-100 nt in length. pre-
miRNA is transported to the cytoplasm where it undergoes final processing step 
which produces a duplex molecule containing the single-stranded mature miRNA 
molecule and a miRNA* fragment. The miRNA:miRNA* complex is incorporated 
into the RNA-induced silencing complex (RISC). miRNAs regulate gene expression 
by silencing the target mRNA, and thus repressing expression of target genes (Hayes 
et al., 2014).  
 
MicroRNAs are involved in the regulation of gene expression at multiple levels.  Loss 
of microRNAs-controlled gene expression is implicated in carcinogenesis. A large 
number of microRNAs e.g., mir-21, miR-22, miR-200 family, miR-128, miR-193, 
miR-34a, miR-451, miR-341, miR-320, are involved in different types of cancer 
(Takahashi et al., 2014, Jansson and Lund, 2012). MicroRNAs act like tumour 
suppressor genes and proto-oncogenes, and loss of their activity is implicated in 
carcinogenesis. 
 
With their modulating effects on expression of target genes, microRNA perturbations 
in response to environmental stressors can lead to altered gene expression signature 
which could predispose cells to disease conditions. Environmental exposure has 
shown to affect the expression levels of miRNAs. For example, in a study of Wang., F 
et al 2014., they reported alterations in 69 microRNAs in response to volatile organic 
compounds exposure in vivo (Wang et al., 2014). Recently, there has been a great 
interest in profiling blood-based circulating miRNAs that are proposed to act as 
carcinogenic markers (Madhavan et al., 2013). miRNAs (e.g., miR-27a, miR-27b, 
miR-122, miR-148, miR-155, miR-192, miR-214, miR-221, miR-429, and miR-50) 
are suggested as exposure markers of aflatoxin induced hepatocellular carcinoma 
(HCC) (Valencia-Quintana et al., 2014). In one study Baccarelli, A et al 2012 
(Baccarelli et al., 2012) showed that exposure to particulate matter alters the 
expression of miR-100 which may regulate genes involved in particulate matter-
induced physiological changes. These studies have shown that miRNAs expression is 
affected by exposure to environmental stressors, which could drive cellular 
carcinogenesis.  
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1.3.3. DNA methylation 
 
 
DNA methylation is a key element among various epigenetic mechanisms. DNA 
methylation occurs when a methyl (CH3) group is attached covalently at the carbon 5 
(5C) position of the cytosine ring of CpG dinucleotides.  The cytosines (C) targeted 
for methylation are almost exclusively followed by a guanine (G), which are called 
CpG dinucleotides (Clark et al., 1995). Statistically CpG dinucleotides are 
underrepresented, and are unequally distributed in the human genome (Varriale and 
Bernardi, 2010). These CpGs are heavily methylated in the genome. Certain regions, 
however, in human genome have high density of CpG dinucleotides. These CpG rich 
regions are called CpG islands (CGIs). CGIs are, on average, 1000 base pairs (bp) 
long, and show an elevated G+C base composition. High proportions of CGIs are 
located in the gene promoter regions and first exon of the genes where they are 
largely unmethylated. Certain CpG islands are occasionally located within the body of 
the gene, or even in the 3’-region where, they are normally more prone to methylation 
(Esteller, 2002). Considerable amount of CpGs are also found in repetitive DNA 
elements such as transposons and retrotransposon-like elements. Repetitive elements 
make up a large fraction (about 40–50%) of genome, and have usually high CpG 
content, with CpGs being heavily methylated. Highly methylated CpGs in these 
regions are necessary to silence the unwanted expression of retrotransposable 
elements, and hence to maintain the genome stability (Ehrlich et al., 1982). 
 
DNA methylation (5mC) at CpG sites regulates the gene expression. Recent work has 
also shown that CGIs located remote form the transcription start sites (TSS), also 
show evidence for gene-promoter functions, which emphasize the correlation of CGIs 
with gene expression. Thus, DNA methylation plays key role in regulation of gene 
expression. Methylation poor CpGs promote more relaxed and open chromatin 
structures that favour gene expression. While, methylated CpGs promotes highly 
condense chromatin structure where gene expression is repressed. Methylated 
cytosines at CpG dinucleotides recruit methyl-DNA binding proteins. These proteins 
have both a methyl-DNA binding domain (MBD) and a transcription-regulatory 
domain (TRD). The TRD recruits other proteins which such as paired amphipathic 
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helix protein (Sin3a), and these adaptor proteins in turn recruit histone deacetylases 
(HDACs) to the site. The HDACs alter chromatin structure locally by removing acetyl 
groups from histone core proteins, leading to compaction of chromatin and 
transcriptional suppression. This cascade of events leading to gene expression 
regulation is depicted in Figure 3a.  When CpG are unmethylated (figure 3b), 
polymerase enzymes bind to DNA that leads to gene expression (Rountree et al., 
2001, Bienvenu and Chelly, 2006). 
 
 
 
Figure 3: DNA methylation dependent gene silencing. Figure gives a simplified overview of DNA 
methylation dependent gene silencing. a): Methylated CpGs (red lollipops) recruit methyl-DNA 
binding proteins which have a methyl-DNA binding domain (MDB) and a transcriptional-regulatory 
domain (TRD). TRD in turn binds with histone deacetylateses (HDACs) that alter the chromatin 
structure locally by removing acetyl groups (Ac) from core histones (green spheres). Whole process 
leads to suppression of gene expression. b): when the CpGs are not methylated (green lollipops), it 
allows binding of activator proteins which recruits polymerase enzymes that leads to gene expression 
(Bienvenu and Chelly, 2006). 
 
1.3.3.1. Regulation of DNA methylation  
 
 
Methylation of DNA is regulated by a class of enzymes known as DNA 
methyltransferases (DNMTs). Two different types of DNMTs are reported knows as: 
maintenance DNMTs and de novo DNMTs. DNMT1 is the maintenance DNMT, 
DNMTs 3a and 3b are the de novo DNMT isoforms. De novo DNMTs methylate 
previously unmethylated CpG sites in DNA; sites which have no methyl-cytosine on 
either DNA strand, and thus setting new pattern of DNA methylation. The 
maintenance DNMT isoform methylates hemimethylated DNA. Thus different 
DNMTs serve distinct roles in the cell. De novo DNMTs place new methylation 
marks on DNA, when specific genes are first silenced as part of cell fate 
determination. Maintenance DNMTs maintains the cellular methylation fidelity after 
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cell division. They regenerate the methyl-cytosine marks on the newly synthesized 
complementary DNA strand that arises from DNA replication (Robertson, 2001). 
Besides DNA methylation, other epigenetic modifications such as 5-
hydroxymethylcytosine (5hmC), have been recently discovered. 5hmC is shown to be 
intermediate of active cellular demethylation mediated by Ten-eleven translocation 
methylcytosine dioxygenase (Tet) enzymes. Significant levels of 5hmC have been 
found in DNA from embryonic stem cells, neurons and brain (Shock et al., 2011). The 
biological functions of 5hmC are not well characterized yet, but it has already showen 
to be an important pathway in the cellular demethylation machinery (Pastor et al., 
2013). 
 
1.3.3.2. DNA methylation in carcinogenesis  
 
 
Physiological distribution of tissue-specific DNA methylation marks is altered early 
during the process of carcinogenesis, which is manifested in many pathological 
conditions. In physiological state, tumour suppresser genes are kept activated by gene 
hypomethylation; whereas oncogenes and DNA reparative elements are kept silenced 
by gene hypermethylation in order to maintain genome integrity (Esteller, 2002).  In 
pathological state, tumour suppressor genes are silenced, while repetitive elements 
and oncogenes are active by aberrant region-specific DNA hypermethylation and 
genome-wide DNA hypomethylation marks respectively (figure 4). 
 
 
 
Figure 4: DNA methylation in normal and cancer cells. a) in normal cells repetitive elements are 
methylated at CpG dinucleotides (red lollipops), while CpG islands (CGI) at promoter sites are not 
methylated. b) in cancer cells, repetitive elements get aberrantly hypomethylated while and CpGs at 
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promoter sites are hypermethylated, which hinders the binding of transcription factors (TF) and leads 
to suppression of tumour suppressor genes activity (Varela-Rey et al., 2013).  
 
The occurrence of DNA methylation aberrations early during carcinogenesis suggests 
that epigenetic alterations may precede the classical transforming events, such as 
mutations of tumor-suppressor genes and amplification of oncogenes. This early 
occurrence of DNA methylation aberrations in carcinogenesis were shown by Kanai 
et al 1996. It was known that genetic aberrations are involved in hepatocellular 
carcinomas. But the involvement of DNA methylation aberrations in the pre-
cancerous liver tissue i.e., chronic hepatitis or liver cirrhosis, were largely unknown. 
Later on, aberrant DNA methylation marks were reported in the pre-cancerous (i.e., 
chronic hepatitis or liver cirrhosis) liver tissue at multiple loci, compared with normal 
liver tissue, which drives the pre-cancerous liver tissue to carcinogenesis. This  
indicated the occurrence of DNA methylation aberrations early during the multistage 
hepatic carcinogenesis (Kanai et al., 1996). In fact, aberrant DNA hypermethylation 
has been reported in the promoter regions that silence tumour suppressor genes such 
as CDKN2A (cyclin-dependent kinase inhibitor 2A), CDKN2B (cyclin-dependent 
kinase inhibitor 2B), TP73 (tumor protein p73), MLH1 (mutL homolog 1), APC 
(adenomatosis polyposis coli), BRCA1 (breast cancer 1), MGMT (O-6-methylguanine-
DNA methyltransferase), VHL (von Hippel-Lindau tumor-suppressor), GSTP1 
(glutathione S-transferase pi 1), CDH1 (cadherin 1) and DAPK1 (death-associated 
protein kinase 1) (Sharma et al., 2010). These observations highlighted the 
importance of DNA methylation patterns in functioning of tumour suppressor genes. 
Aberrations in their methylation patterns were shown to drive the process of 
carcinogenesis. Since the DNA methylation is a reversible epigenetic modification, it 
is expected that aberrant DNA methylation can be reversed in order to restore the 
physiological levels of gene expression. By characterizing the factors which trigger 
aberrant DNA methylation, it will be possible to build strategies to circumvent such 
factors, and to develop therapies to reverse the DNA methylation aberrations. 
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1.3.3.3. DNA methylation and environmental exposure 
 
 
Numbers of environmental stressors are shown to induce DNA methylation 
aberrations. Earlier studies linking effects of environmental stressors to epigenetics 
were conducted by investigating the effects of metals on DNA methylation. Nickel is 
known to be a human carcinogen, and its exposure is shown to be associated with 
nasal and lungs cancer via largely unknown mechanisms. Recent investigations 
showed the involvement of epigenetic pathways in the nickel-induced carcinogenesis. 
It is now reported that DNA methylation deregulations leading to activation and/or 
suppression of gene expression, are the early events in the nickel-induced 
carcinogenesis. Further animal studies showed that the exposure to nickel leads to 
DNA hypermethylation-induced gene inactivation (Lee et al., 1995). Exposure to 
other metals e.g., chromium, cadmium, and cobalt, is also shown to induce DNA 
methylation aberrations (Ziech et al., 2010a). All these findings corroborate the 
concept that exposure to environmental stressor induce DNA methylation 
deregulations, which might play an important role in the process of carcinogenesis. 
The presence of large number of stressors in the environment and their potential 
impact on cells epigenetic patterns lead to the foundations of relatively new scientific 
discipline called environmental epigenetics. The effect of environmental stressors i.e., 
chemicals and nanomaterial, on DNA methylation patterns are discussed further in the 
section of environmental epigenetics.  
 
So far we have mainly emphasized on epigenetic pathways involved in environmental 
exposure induced carcinogenesis. However, epigenetics factors are also shown in the 
aetiology of other disease e.g., cardiovascular, pulmonary and neurobehavioral 
diseases (Baccarelli and Ghosh, 2012, Schwartz, 2010, Conradt et al., 2013). In the 
following chapter, we will give a short introduction on the agents which will be 
studied in this thesis e.g., hydrocarbons, halocarbons, cytostatic agents and 
nanomaterial. Important findings known, thus far, about the adverse health effects 
induced by these agents are discussed below. Here, we will focus on the known 
carcinogenic effects of agents that are included in the current research.  
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1.4. Environmental epigenetics 
 
 
Environmental epigenetics encompasses studying the effects/alterations induced by 
exposure of environmental stressors to the epigenome. Humans are exposed to a wide 
variety of environmental stressors from different source e.g., exposure to chemicals, 
organic solvents, metallic dust, smoking, combustion, volcanic eruptions, particulate 
matter (PM) etc. Human exposure to environmental stressors has been changed 
dramatically with anthropogenic factors, and more recently with the advents in 
nanotechnology. In nanotechnology, materials with (nano)size-dependent properties 
called engineered nanoparticles (NPs) (one dimension <100nm) are manufactured, 
which represent entities of potential human exposure (Oberdorster et al., 2005).  The 
effect of various environmental stressors on epigenetic mechanisms i.e., histone 
PTMs and microRNAs is discussed briefly in pervious sections. Here, the effects of 
various environmental stressors on one of the most studied epigenetic modifications 
i.e., DNA methylation, are discussed. 
 
1.4.1. Exposure to environmental stressors 
 
 
It is well known that disease susceptibility is influenced by complex interplay 
between genetics and environmental factors (Tang and Ho, 2007). In vitro, animal and 
human studies have identified several environmental agents that may mediate adverse 
effects through epigenetic mechanisms. Recently, there has been a great interest on 
studying how the environmental agents lead to epigenetics alterations. Environmental 
stressors represent a broad group of agents to which humans are exposed. Chemicals 
and nanomaterial present in the environment are such group of stressors that have the 
potential to alter the epigenetic patterns. Here, we will discuss the current knowledge 
linking the exposure of chemicals and nanomaterial with the adverse health effects. 
 
1.4.1.1. Exposure to hydrocarbons, halocarbons, cytostatic agents  
 
 
Exposure to environnemental stressors i.e., PAHs, halocarbons, cytostatic agents etc., 
occurs via inhalation, skin contact, ingestion etc. PAHs are ubiquitously present in the 
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environment. Exposure to PAHs has been linked to a variety of adverse health effects, 
including cancer. Numbers of PAHs are known mutagens, carcinogens and/or 
developmental toxicants. For example, benzo[a]pyrene, a representative of PAHs, 
exerts all three types of adverse health effects. On mechanistic levels, PAHs are 
shown to induce DNA damage, which accounts for their carcinogenicity (Perera et al., 
2005). Through decades of research, a wide variety of chemicals e.g., halogenated 
hydrocarbons (carbon tetrachloride, trichloroethylene etc), cytostatic agents (e.g., 
mitomycin C), acrylamide etc, are characterized for the genotoxic potential. Recently, 
studies have reported that the carcinogenic effects induced by many chemicals e.g., 2-
acetylaminofluorene, tamoxifen, trichloroethylene, aflatoxin B1, ochratoxin, nickel 
and chromium, do not follow a classical genotoxic carcinogenesis model, but it was 
suggested that they might involve a spectrum of cellular alterations encompassing 
epigenetics. (Salnikow and Zhitkovich, 2007, Bagny ukova et al., 2008, Marin-Kuan 
et al., 2008, Shiao, 2009). Current knowledge, however, is insufficient in linking 
exposure-induced epigenetic changes that might leads to carcinogenesis in 
premalignant tissue (Carbone et al., 2004). 
 
1.4.1.2. Exposure to organic solvents  
 
Organic solvents represent a class of environmental stressors which confer risk for 
human diseases (Ziech et al., 2010b). Volatile and the lipophilic nature of organic 
solvents make them toxicologically important. Being volatile, organic solvents rapidly 
contaminate the working environment and pose a major health risk. Exposure to 
organic solvents is shown to be carcinogenic via induction of DNA damage through 
the production reactive oxygen species (ROS) (Zhang et al., 2009). Exposure to 
organic solvents is shown to induce DNA damage in cells. Organic solvent exposure 
induced DNA damage may leads cells to carcinogenesis. Some preliminary studies 
have also implicated changes in DNA methylation in organic solvents induced 
carcinogenesis (Liu et al., 2011). These findings lead us to investigate if human 
exposure to organic solvents involves DNA methylation changes, which might lead to 
carcinogenesis.   
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Owing to the lipophilic nature of organic solvents, body tissues especially the neurons 
are prone to the detrimental effects of solvents exposure. A specific syndrome, called 
chronic toxic encephalopathy (CTE) has been known for many years, clinically 
expressed as e.g., nausea, dizziness, fatigue, headache, short-term memory loss, 
attention impairment and personality changes (Arliensoborg et al., 1979, van Valen et 
al., 2009). Genetic polymorphisms in biotransformation enzymes play important role 
in modifying response towards organic solvents exposure. CYP2E1*5B, GSTPE*1C 
and EPHXI exon 4 genotypes are important in modifying the CTE risk in organic 
solvent exposed individuals (Kezic et al., 2006), yet do not fully describe the 
phenotype of acquired neurobehavioral disorders such as CTE. Recent evidence 
suggested epigenetic mechanisms might provide answers in the aetiology of CTE in 
individuals exposed to organic solvents.  
 
1.4.1.3. Exposure to nanomaterial   
 
With recent developments in the field of nanotechnology, a new class of 
environmental stressors called engineered nanoparticles has emerged (Medina et al., 
2007). NPs are defined as particles with at least one dimension less than 100 nm 
(Oberdorster et al., 2005).  Humans exposure to nanomaterial occurs by different 
route e.g., inhalation, skin contact, ingestion. Also, there are different types of 
nanomaterial to which humans are exposed (Hoet et al., 2004).  
 
Nanomaterial e.g. gold NPs (AuNPs), titanium dioxide NPs and single-walled carbon 
nanotubes (SWCNTs) and multi-walled carbon nanotubes (MWCNTs) have gained 
widespread applications. Owing to their widespread applications, humans exposure to 
nanomaterial has also changed (Yokel and Macphail, 2011). Once inside the body, the 
clearance and long-term fate of AuNPs and CNTs is not well characterized. 
Preliminary studies have reported tissue specific accumulation of nanomaterial in 
body (Choi et al., 2010, Tang et al., 2009). Apart from their small size, nanomaterial 
have other facets with associated toxicological profiles. For example, AuNPs and 
CNTs can be functionalized with different polymers to add specific physicochemical 
properties to them. This feature can also add up towards their toxicological profile 
(Love et al., 2012). 
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Number of studies has reported the cellular, immune and genotoxic deregulations 
associated with AuNPs and CNTs exposure in in vitro and in animals models (Love et 
al., 2012). In some of these reports, contradictory results regarding to the 
toxicological endpoints associated with AuNPs and CNTs exposure are reported 
(Yildirimer et al., 2011). This is understandable, since AuNPs and CNTs used across 
these studies differ in their physicochemical characteristics. Of particular interest are 
the CNTs, which are assumed to present physicochemical properties similar to 
asbestos (Pacurari et al., 2010). One study reported the carcinogenic potential of 
CNTs, but results of that study were not replicated in further studies (Pacurari et al., 
2010, Lohcharoenkal et al., 2014). Studies conducted on assessing toxicological 
properties of nanomaterial are mainly focused on classical cellular endpoints i.e., 
cytotoxicity, immunetoxicity and genotoxicity assays (Yildirimer et al., 2011). 
Nanomaterial effects on cells epigenetic status have not been investigated. Since cells 
epigenetic machinery is susceptible to alterations in response to exposure of 
environmental agents (Szyf, 2011), it is expected that cells exposure to AuNPs and 
CNTs could also lead to the altered patterns of DNA methylation. AuNPs and CNTs 
induced DNA methylations have not been investigated previously. It is, hence, 
proposed that DNA methylation could be an important epigenetic factor that regulates 
the gene expression on cellular exposure to AuNPs and CNTs.  Since the larger 
counterpart of nanomaterial, i.e., particulate matter (PM) is shown to induce DNA 
methylation deregulations (Hou et al., 2011), nanomaterial exposure could also lead 
to similar epigenetic changes in cells.  
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2.1. Study objectives 
 
Humans are chronically exposed to different chemicals in the environment, such as 
organic solvents, hydrocarbons and halocarbons and cytostatic agents.  With recent 
advancements in the field of nanotechnology, there has emerged new category of 
environmental stressors called nanomaterial. Exposure to these environmental 
stressors is shown to induce adverse cellular effects under different experimental 
settings. For example, exposure to number of chemicals and nanomaterial has shown 
to induced cytotoxic and genotoxic effects. Recently, there has been great interest in 
understanding the epigenetic effects associated with exposure to these environmental 
agents. Cells epigenetic changes after exposure to environmental stressor does not 
necessarily means that cells are undergoing to disease process. But rather, epigenetic 
changes induced by environmental agents could be a part of cells normal 
physiological response.  Hence, it is important to understand cells epigenetic response 
to environmental agents, and to differentiate the epigenetic changes associated with 
cells normal physiological response, from epigenetic changes leading to pathological 
response. Thus characterizing epigenetic changes in response to exposure of 
environmental agents are important in understanding aetiology of environmentally 
induced diseases.  Current project is set-up to fill this knowledge gap; that to 
characterize the epigenetic changes associated with exposure to the environmental 
stressors. The aims of the project are summarized below. 
 
2.1.1. To investigate the epigenetic effects of environmental stressors  
 
Epigenetic effects of chemicals exposure were investigated in two phase i.e., a 
laboratory phase and a human phase. The epigenetic effects of exposure to 
nanomaterial were investigated in rodent model.  
 
2.1.1.1. Exposure to organic solvents, hydrocarbons, halocarbons, 
cytostatic agents in vitro 
 
 
 
34 
In the laboratory phase, epigenetic alterations were investigated in vitro induced by 
exposure to different classes of chemicals e.g., organic solvents, polyaromatic 
hydrocarbons, halocarbons, and cytostatic agents. It was hypothesized that exposure 
of these carcinogens in vitro would induce global DNA methylation alterations 
similar to ones observed in cancer cells. Study was conducted in TK6 cells exposed to 
different chemicals at three dose levels for 24 hours. Preliminary cell viability assays 
were performed in order to select the exposure dose, and global DNA methylation 
was quantified by LC-MS/MS method.   
 
2.1.1.2. Exposure to organic solvents in humans  
 
In vitro findings, of DNA methylation changes in response to organic solvents 
exposure, were further translated in human population exposed to solvents. In the 
human phase, hypothesis was investigated whether solvent exposure in humans would 
alter their blood cells DNA methylation patterns. Also, gene-environment interactions 
were investigated by analysing the association between global DNA methylation and 
genotypic difference in drug metabolizing enzymes.  
 
2.1.2. Exposure to nanomaterial  
 
Epigenetic effects induced by exposure of nanomaterial were investigated in mice 
exposed to gold nanoparticles and carbon nanotubes.  
 
2.1.2.1. Exposure to gold nanoparticles and carbon nanotubes 
 
Mice were exposed to gold nanoparticles of three primary sizes of 5 nm, 60 nm, and 
250 nm, and were also exposed to two types of carbon nanotubes; single walled 
carbon nanotubes and multi walled carbon nanotubes. Hypothesis was tested whether 
exposure of gold nanoparticles and carbon nanotubes to rodents would induce global 
DNA methylation and hydroxymethylation changes similar to ones observed in 
cancer cells. Gene promoter methylation changes were also investigated in rodents in 
response to nanoparticles and carbon nanotubes exposure, and it was hypothesized 
 
 
35 
that gold nanoparticles and carbon nanotubes exposure in rodents would lead to 
alterations in their gene promoter methylation as well. Cellular pathways often 
responsive to environmental exposure e.g., oxidative stress pathway, immune 
pathway, cell cycle regulation pathways, DNA methylation pathways; were selected 
based on the literature search. Within these pathways, we selected nineteen candidate 
genes with reported gene promoter alterations in response to xenobiotic exposure. 
PCR-pyrosequencing based gene promoter methylation assays were developed for the 
selected genes to investigate changes in their promoter methylation in mice lung and 
blood DNA samples exposed to nanomaterial. List of selected genes with their 
respective PCR-pyrosequencing assays is given in chapter 5. 
 
The aims and objectives of current research were investigated and results are 
presented in three manuscripts. Each manuscript is represented by a chapter (chapter 
3, 4 and 5) in this thesis. In order to overcome the technical issues in testing 
hypothesis, techniques and methods were developed where required. Methods 
development and validations are published in two research articles, which are 
represented in this thesis as two chapters (chapter 6 and 7).   
 
In chapter 3, global DNA methylation patterns associated with exposure to a wide 
range of chemical stressors were investigated in lymphoblastic (TK6) cells. TK6 cells 
have wild type P53, grow in suspension and have short doubling time. These 
characteristics make TK6 cells suitable for toxicological screening of environmental 
stressors (Brehwens et al., 2010).  In chapter 4, epigenetic effects induced by 
exposure to organic solvents in human blood were investigated. Blood comprises 
epigenetically different subpopulations of cells, and since epigenetic patterns are 
tissue specific, use of blood as surrogate tissue in epigenetic toxicology is greatly 
discussed (Horvath et al., 2012, Terry et al., 2011). In chapter 5, epigenetics effects 
induced by exposure to nanomaterials in BALB/c mice were investigated. BALB/c 
mice are inbred strain which offers homogenous response to xenobiotic exposure. 
Balb/c mice are commonly used in studies investigating the effects of environmental 
stressors (Rosenfeld, 2010).  
 
Several techniques are made available which can be used to analyse the epigenetic 
variations associated with environmental exposure. Use of techniques, to some extent, 
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is based on the expected magnitude in epigenetic variations under investigations.  For 
example, if the magnitude of variations is expected to be low, the choice of analytical 
methods is limited to those with high sensitivity to quantify these variations. Also, 
some techniques allow the quantification of DNA methylation at global level and 
other quantify at single base resolution (Zuo et al., 2009). In current research, 
quantification of global DNA methylation and hydroxymethylation was performed 
with liquid chromatography – tandem mass spectrometry (LC-MS/MS). LC-MS/MS 
methods for global DNA methylation and hydroxylmethylation quantification was 
developed and optimized. Development and validation of method is described in 
chapter 6. For gene promoter methylation, highly quantitative bisulfite-PCR 
pyrosequencing assays were developed and optimized for rodent genome. Details of 
bisulfite-PCR pyrosequencing method are described in chapter 7. 
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Abstract 
 
In the current study, we assessed the global DNA methylation changes in human 
lymphoblastoid (TK6) cells in vitro in response to 5 direct and 10 indirect-acting 
genotoxic agents. TK6 cells were exposed to the selected agents for 24 h in the 
presence and/or absence of S9 metabolic mix. Liquid chromatography-mass 
spectrometry was used for quantitative profiling of 5-methyl-2’-deoxycytidine. The 
effect of exposure on 5-methyl-2’-deoxycytidine between control and exposed 
cultures was assessed by applying the marginal model with correlated residuals on % 
global DNA methylation data. We reported the induction of global DNA 
hypomethylation in TK6 cells in response to S9 metabolic mix, under the current 
experimental settings. Benzene, hydroquinone, styrene, carbon tetrachloride and 
trichloroethylene induced global DNA hypomethylation in TK6 cells. Furthermore, 
we showed that dose did not have an effect on global DNA methylation in TK6 cells. 
In conclusion we report changes in global DNA methylation as an early event in 
response to agents traditionally considered as genotoxic.   
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3.1. Introduction 
 
 
Environmental carcinogens are a known risk factor of human cancer (Ziech et al., 
2010). In its classical model, carcinogenesis initiates and proceeds through changes in 
the genome (i.e., genetic effects) (Vogelstein and Kinzler, 2004). Thus, measuring 
carcinogen-induced DNA damage i.e., DNA adducts formation and cross-linking, and 
DNA mutations have been employed in classic cancer risk assessment approaches, 
e.g., Ames test, comet assay and micronucleus assay (Hussain et al., 2007, Rundle, 
2006, Poirier, 2004). Carcinogen-induced DNA damage is an important early event 
during the initiation phase of carcinogenesis, which reflects a permanent and 
irreversible change in the initiated cells (Pitot, 2007, Loeb and Harris, 2008). 
However, initiation per se in a classical carcinogenesis model is not sufficient for 
tumor development, which results from broader alterations in the cellular 
homeostasis, mainly because of the inability of initiated cells to properly control and 
regulate the gene expression (Shiao, 2009).  
 
Exposure to genotoxic carcinogens, in addition to their genetic effects, might involve 
a variety of non-genotoxic effects in cells (Tryndyak et al., 2006). Non-genotoxic 
effects in cells may play an important role in cancer development (Nakayama et al., 
2006). Evidence suggest that non-genotoxic alterations in cells, e.g., alterations in 
cellular epigenome, could result in the emergence of epigenetically reprogrammed 
cells (Bombail et al., 2004). These epigenetically reprogrammed cells show an 
epigenetic profile similar to that frequently observed in cancer cells, such as altered 
histone modification patterns, hypomethylation of DNA repetitive elements and 
proto-oncogenes and hypermethylation of tumor suppressor genes. Altered epigenetic 
status confers genome instability and loss of controlled growth signals, typically 
observed in cancer cells (Karpinets and Foy, 2005). Epigenetic alterations rather than 
specific genetic mutations per se are reported for the clonal expansion of altered 
hepatic preneoplastic foci and tumor development (Pogribny et al., 2010).  
 
Recently, a number of studies reported that the carcinogenic effects induced by 2-
acetylaminofluorene, tamoxifen, trichloroethylene, aflatoxin B1, ochratoxin, nickel 
and chromium do not follow a classical carcinogenesis model, but rather involve a 
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spectrum of cellular alterations encompassing the epigenetics. (Salnikow and 
Zhitkovich, 2007, Bagnyukova et al., 2008, Marin-Kuan et al., 2008, Shiao, 2009). 
Epigenetic factors play an important role in cancer etiology; however, there is 
insufficient knowledge in linking epigenetic factors to environmental carcinogenesis 
in premalignant tissue (Carbone et al., 2004). Based on increasingly documented 
epigenetic changes in cancer etiology, the goal of this study is to assess if alterations 
in global DNA methylation are an early cellular event in response to genotoxic 
carcinogens with a well-known mode of action (adducts forming and cross-linking 
agents). In this study, we used 5 direct and 10 indirect- acting genotoxic carcinogens 
to expose human lymphoblastoid cells (TK6) for 24 h. TK6 cells were exposed to 
carcinogens at 3 dose levels (low, medium and high) in duplicates. S9 metabolic mix 
was added in cultures in half of the experiments because indirect- acting carcinogens 
require S9 metabolic mix to become functional carcinogens. We used human thymidine 
kinase heterozygote TK6 cells in this study because they express wild-type p53, grow 
rapidly in suspension (population doubling time of 12–14 h), and are routinely used in 
genetic toxicology studies.  After exposure, cells were harvested, DNA was extracted, 
hydrolyzed, and global DNA methylation levels were quantified in TK6 cells. 
 
3.2. Materials and methods 
3.2.1. Cell culture  
 
 
TK6 cells were purchased from the European Collection of Cell Cultures (ECACC, 
Wiltshire, UK). Cells were divided into 15 treatment groups and 2 control groups 
(control S9-, control S9+), and cultured in RPMI 1640 medium containing 10% heat-
inactivated horse serum, 100 U/ml penicillin, 100 μg/ml streptomycin and 2 mM l-
glutamine at 5% CO2 and 37° C. Cells were maintained at a density of 10
6
 cells/ml and 
exposed for 24 h to carcinogens. We set up two biological replicates per chemical dose, 
10 control S9- replicates, and 5 control S9+ replicates. 
 
Due to the requirement of enzymatic biotransformation of procarcinogens to become 
active carcinogens, a mixture of S9 (1% v/v) from human liver was added to the culture 
in half of the experiments (van Leeuwen et al., 2005, González Borroto et al., 2001). 
Liver S9 fractions were obtained from Celsis (Neuss, Germany), and contained drug-
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metabolizing enzymes including the cytochromes P450, flavin monooxygenases, and 
UDP glucuronyl transferases. An exogenous NADPH-regenerating system (1.3 mM 
NADP+, 3.3 mM glucose-6-phosphate, 0.4 U/ml glucose-6-phosphate dehydrogenase, 
and 3.3 mM magnesium chloride; BD Biosciences, Erembodegem, Belgium) required 
by liver S9 for phase I oxidation was included in the experiments. Cells were exposed to 
carcinogen in duplicates with or without S9 metabolic mix. 
 
3.2.2. Chemicals, viability assays and dose  selection 
 
We selected chemicals with well-described genotoxic characteristics (Tsuda et al., 
2000). A list of the selected agents, their classification and exposure dose is given in 
Table S1. All chemicals were purchased from Sigma Aldrich, and dissolved and 
diluted in dimethylsulfoxide (DMSO). Viability assays were used to select doses per 
agent. We used 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) 
viability assay (Mosmann, 1983), and also counted the proportions of living and dead 
cells using a Countess
TM
 Automated Cell Counter (Invitrogen, Carlsbad, CA). Based on 
the viability assays, we selected three doses per chemical, i.e. a dose with 95% cellular 
viability (high dose), 1/10 of high dose (medium dose) and 1/100 of high dose (low 
dose). 
  
3.2.3. DNA extraction, concentration and purity  
 
After 24 h of treatment, cells were immediately processed for DNA extraction. DNA 
was extracted using Trizol® reagent with the PureLinkTM Micro-to-Midi System® 
according to the manufacturer’s protocol (Invitrogen, Carlsbad, CA). DNA quantity and 
quality was measured by NanoDrop Spectrophotometry and Agilent 2100 bioanalyzer.  
 
3.2.4. Enzymatic hydrolysis of DNA  
 
Extracted DNA was hydrolyzed to individual deoxyribonucleosides in a simplified one-
step procedure (Quinlivan and Gregory, 2008). In short, DNA digest mix was prepared 
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by adding 250 U Benzonase (Sigma Aldrich), 300 mU Phosphodiesterase I (Sigma 
Aldrich), and 200 U alkaline phosphatase (Sigma Aldrich) to 5 ml Tris-HCl buffer (pH 
7.9, 20mM) containing 100mM NaCl and 20 mM MgCl2. 1 µg of extracted DNA from 
exposed and control samples was hydrolyzed in 100 µl of reaction by adding 50 µl of 
digest mix, and samples were incubated at 37° C for 6 h. Hydrolyzed samples were 
brought to 1 ml by adding HPLC-grade H2O.  
 
3.2.5. Calibration standards  
 
Calibration standards for 5’methyl- deoxycytidine ((5Me)dC) and deoxycytidine (dC) 
were purchased from Sigma, and dissolved in LC-MS grade water (stock solutions). A 
calibration series was prepared for 5(Me)dc and dC in a range of 0.1-10 ppb and 10-100 
ppb respectively from the stock solutions. The same calibration standards were used in 
all of the experiments. 
 
3.2.6. LC-ESI-MS/MS instrumental analysis  
 
Global DNA methylation was obtained by quantifying (5Me)dC and dC using ultra-
pressure liquid chromatography (UPLC) for fraction separation and tandem mass 
spectrometry (MS-MS) for quantification. Analyses were carried out on Waters 
Acquity UPLC equipped with autosampler and Micromass MS Technologies Quattro 
Premier mass spectrometer. A 10 µl sample was introduced on an Acquity UPLC 
BEH C18, 50 mm x 2.1 mm, 1.7 µm column, held at 40°C. Mobile phase used for 
chromatographic separation was a mixture of 0.1 % formic acid in water (A) and 0.1 
% formic acid in acetonitrile (B) using the following gradient: 0 min: 90% A and 10% 
B, 2 – 2.5 min: 100% B, 3.9 – 4.0 min: 90 % A and 10 % B at a flow rate of 0.35 
ml/min. All mobile phase constituents were LC-MS grade and were purchased from 
Biosolve (Valkenswaard, the Netherlands). 
 
First, we performed full-scan spectrum under electrospray ionization (ESI) conditions. In 
full scan spectrum, sodium adducts 5(Me)dC/dC [M+Na]+ and 5(Me)dC-dC dimers 
were also observed, which is a common phenomenon in an ESI-MS full scan (Song et 
al., 2004). Analyses were performed in ESI+ mode and a multiple reaction monitoring 
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(MRM) method was used with argon as the collision gas at a pressure of 2.88 10
-3
 
mbar. Transitions monitored were m/z 242.00 → 125.85 for 5(Me)dC (cone voltage 
14 V, collision energy 10 eV) and m/z 228.10 → 112.00 for dC (cone voltage 14 V, 
collision energy 17 eV). Dwell time per transition was 100 ms. 
 
3.2.7. Calibration curve   
 
We observed linear response of standards over a range of concentrations (0.1-10 ppb and 
10-100 ppb) for 5(Me)dC and dC with correlation coefficients of 0.9991 and 0.9970 
respectively. 
 
3.3. Statistics 
 
The percentage of global DNA methylation was calculated per chemical dose and is 
expressed as (5Me)dC / [(5Me)dC+dC] %. We used marginal model to explore 
factors accounted for in the observed variation in global DNA methylation in TK6 
cells, i.e., chemicals, dose and S9. Residuals were plotted to verify the assumptions of 
normality in the marginal model. The Shapiro-Wilk test for residuals was shown to be 
non-significant, which implied that approximating a response to a normal distribution 
was appropriate. The SAS 9.2 statistical package was used to fit the marginal model. 
Box plots were generated for chemicals with a significant effect on global DNA 
methylation in TK6 cells using SPSS v.18. 
 
3.4. Results 
 
Global DNA methylation in control and exposed cultures per chemical dose without and 
with S9 metabolic mix is given in Table 1 and 2 respectively. Our results show induction 
of global DNA hypomethylation in response to S9 metabolic mix as shown in Figure 1. 
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Table 1: Global DNA methylation in TK6 cells per chemical dose in the absence of S9 metabolic mix. 
 
 
Table 2: Global DNA methylation in TK6 cells per chemical dose in the presence of S9 metabolic mix. 
 
 
 
Variation in global DNA methylation of control and exposed cultures demonstrated 
normal distribution (Figure S1). Assuming global DNA methylation to be normally 
distributed, and considering each chemical exposure to be independent but replication 
within exposure to be correlated, a marginal model, which captures this dependency, 
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was applied. Covariance between model residuals, which corresponds to uniform 
correlation within repeated samples, was estimated to be 0.54. Ignoring the 
correlation within replicated exposures could result in an in accurate estimate of the 
significance of global DNA methylation.  
 
 
Figure 1: Global DNA methylation in TK6 cells cultured without S9 (control S9−) and with S9 
(control S9+) is shown in the box plot. 
Global DNA methylation is expressed as a percentage of 5-methylcytosine versus the total number of 
cytosines present in the genome. The box plot describes the median (line across the box), inter-quartile 
range and maximum and minimum values (whiskers). Outliers are shown as open circles outside the 
ends of whiskers. 
 
In our results, we observed chemicals and S9 accounting for the observed variability 
in global DNA methylation in TK6 cells (Table S2). Dose was found to be non-
significant even in the absence of S9 in the marginal model. The model was refitted 
excluding the dose and the results are given in Table 3.  
 
Table 3: The effect of S9 metabolic mix and carcinogens on global DNA methylation in TK6 cells in 
vitro. 
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Furthermore, we show that benzene and its metabolite hydroquinone, and styrene, 
carbon tetrachloride and trichloroethylene significantly affected the global DNA 
methylation in TK6 cells (Table 3).  Global DNA methylation profiles observed with 
exposure to these chemicals in TK6 cells without and with S9 are shown in Figure 2 
and 3 respectively. 
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Figure 2: Box plot representation of global DNA methylation in control TK6 cells and TK6 cells 
exposed with benzene, hydroquinone, styrene, carbon tetrachloride and trichloroethylene without S9 
metabolic mix.  
 
Global DNA methylation is expressed as percentage of 5-methylcytosine versus the total number of 
cytosines present in the genome. The box plot describes the median (line across the box), inter-quartile 
range and maximum and minimum values (whiskers). Outliers are shown as open circles outside the 
ends of whiskers. 
 
 
 
Figure 3: Box plot representation of global DNA methylation in control TK6 cells and TK6 cells 
exposed with benzene, hydroquinone, styrene, carbon tetrachloride and trichloroethylene with S9 
metabolic mix.  
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Global DNA methylation is expressed as percentage of 5-methylcytosine versus the total number of 
cytosines present in the genome. The box plot describes the median (line across the box), inter-quartile 
range and maximum and minimum values (whiskers). Outliers are shown as open circles outside the 
ends of whiskers. 
 
3.5. Discussion 
 
The classical theory of carcinogenesis is driven by genetic mutations and chromosomal 
abnormalities conferring genome instability (Yamasaki et al., 1992, Parodi et al., 1992). 
However, the current study highlights the importance of global DNA methylation as an 
early epigenetic factor in response to genotoxic exposure.  
 
Indirect- acting carcinogens require metabolic activation to become reactive 
carcinogens. Due to the required metabolic activation, a mixture of S9 liver extract (1% 
v/v) was added to half of the cultures. S9 mixture contains enzymes required for phase-I 
metabolic activation of xenobiotics. Expression of metabolic enzymes is linked to 
reactive oxidative stress pathways (Paolini et al., 2004). Oxidative stress affects DNA 
methylation by altering the S-adenosylmethionine (SAM) and S-
adenosylhomocysteine (SAH) ratio (Panayiotidis et al., 2009, Hitchler and Domann, 
2007, Lertratanangkoon et al., 1997). In this study, the addition of S9 metabolic mix 
in TK6 cell cultures resulted in global DNA hypomethylation (β = -0.9082, p < 
0.0001) (Table 3, Figure 1). S9-induced global DNA hypomethylation in these 
cultures could be mechanistically linked to the induction of oxidative stress pathways. 
Oxidative stress activates cellular and nuclear signaling pathways, which have 
intrinsic histone acetyltransferase (HAT) and histone deacetylase (HADC) activities. 
In turn, these proteins are linked to DNA methyltransferases (DNMTs) in the nuclear 
pathways leading to the conformational changes in histones and chromatin structure, 
and thus they alter the cellular transcription level (Ziech et al., 2011, Rahman, 2003).  
 
A number of chemicals used in this study affected global DNA methylation changes 
in TK6 cells (Table 3, Figure 2 and 3). We observed interesting global DNA 
methylation patterns. Benzene (β = -1.5289, p < 0.0295) and it metabolite 
hydroquinone (β = -1.8029, p < 0.0108) exposure induced global DNA 
hypomethylation in TK6 cells, while styrene exposure (β = -1.7332, p < 0.0115) 
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induced global DNA hypomethylation but its metabolite styrene oxide exposure did 
not affect the global DNA methylation in TK6 cells (β = -0.2999, p < 0.6547).  
Benzene exposure has shown to be linked to reduced methylation levels of DNA 
repetitive elements (Bollati et al., 2007). Benzene and hydroquinone exposure activates 
the oxidative stress pathways in cells which affects the cellular DNA methylation pattern 
(Badham et al., 2010). Styrene exposure induces DNA adduct formation and oxidative 
stress in cells (Harvilchuck et al., 2009). Besides these effects, we report the induction 
of global DNA hypomethylation by styrene as a potential non-genotoxic mechanism, 
which could account for its toxicity. We also exposed TK6 cells to carbon 
tetrachloride and trichloroethylene. These chemicals mainly act through the formation 
of reactive intermediates after the metabolic activation. In the current study, we 
observed global DNA hypomethylation induced by carbon tetrachloride (β = -1.3879, 
p < 0.0475) and trichloroethylene (β = -1.5302, p < 0.0294) exposure in TK6 cells 
(Table 3, Figure 2 and 3). Previous studies also reported similar findings about carbon 
tetrachloride and trichloroethylene (TCE) induced global DNA hypomethylation. 
Carbon tetrachloride induced global DNA hypomethylation was rescued by 
supplementation with S-adenosylmethionine (SAM) in rat liver (Varelamoreiras et al., 
1995, Tao et al., 1999). These observations suggested that carbon tetrachloride 
induced DNA hypomethylation involved methionine metabolic pathways. In addition, 
these chemicals induce oxidative stress, which could affect the cellular methylome. 
 
In contrast to other studies, we did not observe global DNA methylation changes in TK6 
cells by exposure to poly-aromatic hydrocarbons (PAHs). Chronic exposure of 
benzo[a]pyrene to mouse embryonic fibroblasts in vitro induced global DNA 
hypermethylation (Yauk et al., 2008). Also, differences in DNA methylation levels 
have been reported in peripheral blood lymphocytes of workers chronically exposed 
to PAH compared to their matched controls (Pavanello et al., 2009). Different 
experimental settings used in these studies compared to the current study could 
explain the heterogeneity observed in PAHs induced DNA methylation changes. 
Furthermore, no global DNA methylation changes in TK6 cells were observed for 
mitomycin C, formalin, cyclophosphamide, ethylenedibromide, epichlorohydrin and 
acrylamide. Global DNA methylation changes in response to these chemicals have 
not been reported elsewhere. Subtle epigenetic effects, such as histone modifications 
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and gene specific DNA methylation, in response to these chemicals could not be 
ignored and will be explored further.  
Global DNA hypomethylation in TK6 cells induced by direct and indirect- acting 
genotoxic carcinogens investigated in this study could imply that cells are under pre-
neoplastic conditions. If sustained global DNA hypomethylation persists, this could 
drive these cells to neoplastic phenotype. However, the duration and extent of 
exposure required for sustained global DNA hypomethylation to confer neoplastic 
phenotype needs to be fully understood.  
 
Conclusion 
 
In conclusion, we report the non-genotoxic effect, i.e., alteration in global DNA 
methylation, in response to a number of carcinogens, which are traditionally 
considered to act through genotoxic mechanisms. We also describe that S9 metabolic 
mix alters the global DNA methylation pattern in TK6 cells. Future work will address 
the dose-dependent effects of S9 metabolic mix in vitro and the pathways involved in 
carcinogen-induced DNA methylation changes.  Our results suggest the use of 
different cell lines and more varied assays to validate the above findings, and to 
explore the mechanistic links. 
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Supporting information  
 
Figure S1: Histogram and density plot of residuals to assess normality. Normality assumption of 
response (global DNA methylation) was assessed by plotting the residuals (x-axis). The plot appears to 
indicate that this assumption is plausible. Shapiro-Wilk test was also performed to confirm normality 
and residuals were shown to be non-significant. 
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Table S1: Overview of agents, their classification and administered doses used in the treatment of TK6 
cells. 
Agents IARC
§
 Category Concentration (µM) 
   High Medium Low 
Formaldehyde
*,1,2
 1 Aldehyde 100 10 1 
Styrene
**,1
 2B 
a
AH 5000 500 50 
Styrene 7,8-oxide
*,1
 2A 
a
AH 500 50 5 
Benzene
**,1
 1 
a
AH 100 10 1 
Hydroquinone
*,1
 3 
a
AH 0.5 0.05 0.005 
Mitomycin C
*,2
 2B Cytostaticum 0.5 0.05 0.005 
Ethylenedibromide
**,1,2
 2A Organobromide 1000 100 10 
Epichlorohydrin
*,1
 2A Organochloride 500 50 5 
Acrylamide
**,1
 2A Amide 500 50 5 
Trichloroethylene
**,1
 2A 
b
CH 5000 500 50 
Carbontetrachloride
**,1
 2B 
b
CH 1000 100 10 
Cyclophosphamide
**,1
 1 Cytostaticum 50 5 0.5 
Benzo[a]fluoranthene
**,1
 2B 
c
PAH 500 50 5 
Benzo[a]pyrene
**,1
 1 
c
PAH 500 50 5 
Benz[a]anthracene
**,1
 2B 
c
PAH 500 50 5 
a
AH: aromatic hydrocarbons; 
b
CH: Chlorinated hydrocarbon; 
c
PAH: polyaromatic hydrocarbons; 
§
International agency for research on cancer; *Direct acting agent; **Indirect acting agent, 1: DNA 
adduct forming agent; 2: DNA Cross linking agent 
 
Table S2: Results of the marginal model describing the effect of exposure, i.e., chemicals, dose, and 
S9, on global DNA methylation in TK6 cells in vitro.  
Effect 
Num 
DF** 
Den 
DF*** 
F 
Value 
p-
Value 
Chemicals 15 67 3.72 <.0001* 
S9 1 67 21.41 <.0001* 
Dose 1 67 2.74 0.1024 
*Significant at α level of 0.05, **Num DF: Numerator Degree of Freedom, ***Den DF: Denominator 
Degree of Freedom 
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Abstract 
 
Aims: we investigated global DNA methylation alterations in lymphocytes of solvent 
workers and chronic toxic encephalopathy (CTE) patients and explored potential 
gene-environment interactions for glutathione S-transferases. 
Study Population: Cross sectional study was setup in 41 referents, 128 solvent 
workers, and 23 CTE patients. 
Results and Discussion: We found a global DNA hypermethylation in solvent-
exposed population compared to the referents (p = 0.001, r = -0.544). Global DNA 
methylation was negatively associated with exposure. Further, GSTP1 genotypic 
polymorphism was found to be significantly associated (p = 0.033) with global DNA 
hypomethylation, which describes the potential gene-environment interaction in the 
etiology of solvent-induced phenotypes.  
Conclusion: This study indicates that solvent-induced DNA methylation alterations 
have an impact on neurotoxicity and development of CTE.  
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4.1. Introduction 
 
 
Chronic organic solvent(s) exposure confers risk for human disease (Ziech et al., 
2010). Organic solvents comprise chemically heterogeneous compounds, capable of 
dissolving oils, fats, resins, cellulose acetate and cellulose nitrate, with a widespread 
application in a range of industries and occupational settings. The volatility and the 
lipophilicity make organic solvents toxicologically important. Being volatile, organic 
solvents rapidly contaminate the working environment and pose a major health risk at 
occupational settings [2]. Exposure to organic solvents mainly occurs through 
inhalation and skin contact. Organic solvents can damage different tissues e.g., 
hematopoietic tissue, nervous system and tissues rich in fat content. Due to their 
lipophilic and hydrophilic properties, solvent exposure affects central nervous system. 
A specific syndrome, called chronic toxic encephalopathy (CTE) has been known for 
many years, which results in neurotoxic effects e.g., nausea, dizziness, fatigue, 
headache, short-term memory loss, attention impairment and personality changes 
(Arliensoborg et al., 1979, van Valen et al., 2009).  
 
It has been suggested that solvents or reactive metabolites generated after 
biotransformation of solvents result in long-term health effects. Genetic 
polymorphisms of enzymes involved in biotransformation might thus play an 
important role in modifying the response to occupational toxicants. The conversion of 
solvents to reactive intermediates mainly occurs by oxidation through cytochrome 
(CYP) P450 family of enzymes. Reactive metabolites are detoxified by conjugation 
with glutathione, catalysed by glutathione-S-transferase (GST), or by hydrolysis 
catalysed by microsomal epoxide hydrolase (EPHX1). Kezic et al. (2006) reported an 
increased risk for the development of CTE in individuals with CYP2E1*5B and a 
decreased risk with the GSTPE*1C and EPHXI exon 4 genotypes (Kezic et al., 2006). 
CTE subjects exhibit signs of mild Parkinsonism (Hageman et al., 1999). Genetic 
polymorphism in dopamine receptor genes was also suggested to have an effect in 
response to solvent exposure (Noble, 2000). We previously reported that exposure 
itself increases the risk of CTE, and that genetic polymorphisms in GST i.e., GSTT1 
and GSTM1 modulates the effect of exposure on neurobehavioral effects. These 
genetic factors were suggested to have no effect on CTE in the absence of relevant 
exposure (Godderis et al., 2010). However, it is important to note that genetic factors 
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alone do not fully describe the phenotype of acquired neurobehavioral disorders. 
Evidence suggests the dynamic framework of epigenetic regulation may provide 
answers in the etiologic of phenotypically complex disorder such as CTE.  
 
These findings lead us to investigate the cellular response to solvents exposure 
through epigenetic pathways. Epigenetics comprises all kinds of structural landmarks 
on DNA and histones, which code for heritable changes in gene expression without 
affecting the DNA sequence. Epigenetic information are maintained through post-
replication DNA cytosine methylation, post-transcriptional modification of histones 
and RNA-mediated gene silencing. DNA cytosine methylation is the most studied 
epigenetic modification. In DNA cytosine methylation, a methyl group is selectively 
added to the 5’ position of the cytosine bases in the DNA sequences rich in CpG 
islands. In general, CpG methylation is associated with gene silencing (Iacobuzio-
Donahue, 2009). 
 
Recently, DNA cytosine methylation is said to provide the missing link between 
neurodegenerative phenotype and the environment (Iraola-Guzman et al., 2011). A 
number of environmental and occupational agents, e.g., arsenic, cobalt, dietary 
factors, alcohol, have been identified to affect the DNA methylation (Fragou et al., 
2011). We also reported the global loss of DNA methylation in TK6 (human 
lymphoblastoid) cells in response to environmental and occupational toxicants 
(Tabish et al., manuscript submitted). The list of neurobehavioral disorders in which 
epigenetic factors play an etiopathogenic role is increasing, e.g. Prader-Willi and 
Angelman syndrome, fragile X (A and E) mental retardation syndrome, autism 
(Mehler, 2010), schizophrenia (Akbarian, 2010), alcoholism (Ishii et al., 2008), 
Alzheimer's disease, Parkinson's disease, and Huntington's disease (Urdinguio et al., 
2009, Kwok, 2010). Epigenetic deregulation of genome may represent the functional 
mechanism in neurobehavioral disorders. Based on these observations, we 
hypothesize the involvement of DNA methylation in the etiopathogenesis of solvent 
induced neurobehavioral phenotypes such as CTE. In this report, we assessed the 
global DNA methylation profile of lymphocytes of solvent-exposed workers and CTE 
patients to investigate the impact of solvent exposure on global DNA methylation. We 
also looked at the type 2 gene-environment interaction in the context of global DNA 
methylation. 
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4.2. Population and methods  
 
The study population, exposure assessment and genotyping methods used in this 
study have been described in detail elsewhere (Godderis et al., 2010). Study 
(reference number: B32220072332) was approved by the Commission for Medical 
Ethics of University Hospital of Leuven (Belgium) and samples were obtained 
following the informed consent. 
 
4.2.1. Subjects 
 
A cross sectional study was setup with an original population of referents (n = 41; non 
solvent-exposed workers e.g., packagers, drivers, catering staff etc.) from small and 
medium sized enterprises who were invited to participate voluntarily during their 
yearly medical examination. Solvent-exposed workers (n = 128) with a minimum 
exposure period of 2 years were selected from a pharmaceutical production plant. 
They were exposed to mixtures of organic solvents e.g., exposed to chloroform during 
cleaning of surfaces. CTE patients (n = 23) were selected out of a group of 91 CTE 
patients from the Neuropsychotoxicological Centre of Expertise (Geel, Belgium). 
CTE patients were included on the condition that the diagnosis for CTE was 
confirmed in a second independent clinical reference centre of the Belgian fund for 
occupational diseases.  
 
4.2.2. Exposure assessment 
 
Solvent exposure was assessed by a comprehensive interview to identify the exposure 
parameters i.e., duration of exposure, and degree of exposure and % work time. For 
pharmaceutical plant workers, more detailed information was available from 
historical and current data of air sampling and biomonitoring. Since every participant 
was not exposed to the same agent, we reported the degree of exposure as a 
percentage compared to the Belgian threshold limit value (TLV) (e.g., TLV of 
chloroform = 10 mg/m³). For each exposure period, the ‘degree of exposure * 
exposure duration * %work time’ was determined, which was used to calculate the 
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cumulative exposure index (CEI). Further details regarding to the exposure 
assessment are provided elsewhere (Godderis et al., 2010). 
 
4.2.3. Questionnaires 
 
A set of questionnaires regarding to the influencing factors, such as: schooling, 
lifestyle, medical and occupational histories, possible leisure-time neurotoxic 
exposures, alcohol consumption, smoking habits, and use of psychotropic medication 
(anti-psychotics, anti-depressants, mood stabilizers, anti-anxiety agents, etc.) was 
completed by all participants.  
 
4.2.4. Genotyping 
 
From each participant, a total of 5 ml blood in EDTA tubes was obtained in order to 
perform genotyping analysis. The GSTM1 and GSTT1 polymorphisms were analysed 
by the method described by Arand et al. (1996), which detects individuals with 
homozygous deleted genes (Kubota et al., 2012). The GSTP1 polymorphism in codon 
105 was assayed with a PCR-RFLP-based method. For the statistical analysis, each 
genotype was coded with a binary variable e.g., 1: absent (GSTM1, GSTT1) or at least 
one variant allele (GSTP1) and 2: present (GSTM1, GSTT1) or wild type (GSTP1). 
 
4.2.5. Global DNA methylation analysis  
 
 
Details of DNA extraction, DNA hydrolysis and global DNA methylation analysis 
using ultra-pressure liquid chromatography-electrospray ionization-tandem mass 
spectrometry (UPLC-ESI-MS/MS) have been described elsewhere (Tabish et al., 
manuscript submitted). In brief, 1µg of extracted DNA per sample was hydrolysed 
into individual deoxynucleotides and was subjected to LC-ESI-MS/MS to quantify 5-
methyl-2’- deoxycytidine (5Me)dC and deoxycytidine (dC). We calculated % global 
DNA methylation as (5Me)dC/[(5Me)dC+dC] %. The analyses were carried out on a 
Waters Acquity UPLC equipped with autosampler and a Micromass MS 
Technologies Quattro Premier mass spectrometer.  
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4.3. Statistics 
 
Statistical analysis was performed with SPSS v.19.0 (Chicago, USA). Mann-Whitney 
–U (MW-U) test and Kruskal-Wallis statistics were used to compare age, vocabulary 
and education level, exposure measures, use of alcohol and tobacco and global DNA 
methylation between groups. Spearman correlations and multivariate linear regression 
was used to assess the association between global DNA methylation and exposure 
parameters. Global DNA methylation was determined while correcting for the 
confounders.  Further, we used linear regression models incorporating an interaction 
term for each GST genotype and exposure parameter to assess the type 2 gene-
environment interaction. Relevant population parameters i.e., age, education level, 
alcohol, and smoking were included in the multiple regression model as independent 
variables. Significance level (α) was set at 0.05 in all statistical analysis. 
 
4.4. Results 
4.4.1. Study population characteristics 
 
Relevant study population characteristics are listed in Table 1, and discussed in detail 
elsewhere (Godderis et al., 2010). CTE-patients had higher age and longer exposure 
to solvents than solvent-workers (Table 1). The median CEI was also higher in CTE 
patients compared to solvent-workers (Table 1).  
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Table 1: Characteristics of study population. 
 
 
4.4.2. Global DNA methylation in solvent exposed and CTE patients  
 
 
We observed global DNA hypermethylation (M-W U, p < 0.001) in the lymphocytes 
of solvent exposed-workers (median global DNA methylation 6.3%, IQR 5.9-6.8%) 
compared to the referents (median global DNA methylation 4.4%, IQR 4.1-5.2%). 
CTE patients had a global DNA methylation profile (median global DNA methylation 
4.3%, IQR 3.7-4.6%) similar to the referents (M-W U, p = 0.233) but significantly 
lower than solvent-workers (M-W U, p < 0.001). 
The association of the global DNA methylation with the different exposure 
parameters is given in Table 2.  
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Table 2: Correlations between global DNA methylation and exposure parameters. 
 
 
After correcting for age, total exposure time and CEI were significantly correlated 
with global DNA methylation (solvent-workers: r = -0.198, CTE patients r = -0.441; 
and solvent-workers: r = -0.244 respectively). Strong association between the 
exposure and global DNA methylation (all p < 0.012) was observed in the 
multivariate regression models. The association of CEI and global DNA methylation, 
in the lymphocytes of solvent-exposed and CTE patients, is shown in Figure 1.  
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Figure 1: Association of global DNA methylation with cumulative exposure index (years) of total 
exposed group (n=151). Global DNA methylation is expressed as a percentage of 5-methylcytosine 
versus the total number of cytosines present in the genome. 
Age (r = -0.371, p = 0.001), smoking (r = -0.275, p = 0.001) and use of psychiatric 
drugs (r = -0.425, p = 0.001) were negatively associated with global DNA 
methylation, while alcohol consumption had positive association with global DNA 
methylation (r = 0.241, p = 0.001).  
 
4.4.3. Gene-environment paradigm 
 
 
First, we assessed the global DNA methylation distribution per GST genotypes in 
referents, solvent-workers, and CTE patients group (Table 3). As expected, there was 
no statistical difference in the global DNA methylation between the 3 genotypes 
considered (MW-U: p>0.05), nor in the total population, or in the respective 
subpopulations.  
 
Table 3:Global DNA methylation per GST genotypes in referents, solvent workers and chronic toxic 
encephalopathy patient group. 
 
 
 
Further, we assessed the association of type 2 gene-environment interaction with 
global DNA methylation. We included an interaction term for each GST genotype and 
relevant exposure parameter in the regression models. Degree of exposure was 
excluded from further analysis because it was not significantly associated with global 
DNA methylation. Out of the three GST polymorphisms included in this study, only 
GSTP1 polymorphism was found to be significantly associated with global DNA 
hypomethylation (p = 0.033) in response to total exposure time in the entire study 
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population (Figure 2 and Table 4). We found a borderline GSTM1–exposure time 
interaction with global DNA hypermethylation (p = 0.053) in solvent-workers (Table 
4). 
 
 
 
Figure 2: Effect of GSTP1 genotypic variation on global DNA methylation profile in the lymphocytes 
of total study population (n=192) with total exposure time. Global DNA methylation is expressed as a 
percentage of 5-methylcytosine versus the total number of cytosines present in the genome. R
2
 linear of 
homozygous and heterozygous mutant individuals = 0.006; R
2
 linear of wild-type individuals = 0.161. 
 
Table 4: Genotypic influence on global DNA methylation with total exposure time as an independent 
variable in the solvent exposed and total population. 
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4.5. Discussion 
 
 
Workers chronically exposed to solvents are at risk of developing CTE. Epigenetic 
mechanisms, such as DNA methylation, might play a role in the development and 
progression of CTE. In this study, we investigated whether chronic solvent exposure 
results in altered epigenetic status, which could lead to a long term reprogramming of 
genetic information with subsequent development of CTE. Duration of solvent 
exposure was negatively associated with global DNA methylation while intensity of 
exposure was only significantly associated with global DNA hypomethylation when 
considering all exposed individuals. These finding could be suggestive for an age-
dependent effect, known to lead to a gradual demethylation of DNA (Christensen et 
al., 2009). Nevertheless, even after controlling for age we could confirm these results, 
observing a strong association between global DNA methylation and CEI (Figure 1, 
Table 2). Our results suggest that epigenetic changes may have an impact on the 
development of CTE. This is in line with findings in other neurodegenerative and 
neuropsychiatric diseases and in neurotoxicity induced by ethanol and drugs (Fragou 
et al., 2011). DNA hypermethylation has been proposed to play a part in the 
pathogenesis of schizophrenia (Mill et al., 2008, Zhubi et al., 2009). 
DNMT1expression alterations in GABAergic neurons are also reported to contribute 
in the occurrence of schizophrenia symptoms (Mill et al., 2008, Zhubi et al., 2009).  
 
Studies have described the induction of both DNA hypo- and hypermethylation in 
response to solvents, and environmental and occupational carcinogens (Zhong and 
Mass, 2001). The outcome seems to depend on the type of agent studied and the 
exposure characteristics. For example, low level exposure to benzene has shown to 
induce DNA hypomethylation of repetitive DNA elements as well as hypo- and 
hypermethylation of specific genes in peripheral blood DNA (Bollati et al., 2007). In 
a recent human cohort based study, the PAH exposure has been linked with global 
DNA hypermethylation (LINE-1 and Alu repetitive elements). Conversely, DNA 
hypomethylation of specific promoter sequences (p15 and HIC1) was suggested in 
PAH-exposed workers (Herbstman et al., 2009, Pavanello et al., 2009). Global loss of 
DNA methylation in vitro in response to solvent exposure (chronic formaldehyde) has 
also been suggested in a recent report (Liu et al., 2011).  The mechanisms by which 
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solvents exposure induces DNA methylation alterations are still unclear. Solvents 
have been shown to induce higher levels of oxidative stress (Dreiem et al., 2005). 
Oxidative stress affects DNA methylation by changing the S-adenosylmethionine 
(SAM) and S-adenosylhomocysteine (SAH) ratio through regulating the methionine 
metabolic pathway in human lung epithelial-like (A549) cells (Ziech et al., 2011, 
Panayiotidis et al., 2009). Decreased level of methyl donor SAM and DNA 
methyltransferase 3B (DNMT3B) expression due to alcohol exposure affected the 
DNA methylation in hepatic tissue (Szyf, 2011). Oxidative stress, DNA 
methyltransferases expression and DNA cross-links and strand breaks in response to 
benzene and formaldehyde exposure are suggested underlying mechanisms which 
disrupt genomic methylation signatures (Liu et al., 2011, Bollati et al., 2007, Szyf, 
2011).  
 
Induction of global DNA hypermethylation was observed in solvent exposed workers 
compared to the CTE patients. A number of factors could explain the observed 
difference in global DNA methylation profiles in these groups. Solvent-exposed 
workers were still exposed to solvents while CTE patients were no longer exposed but 
rather had a past history of chronic solvent exposure. Alcohol consumption was 
positively associated with global DNA hypermethylation in this study. Alcohol 
consumption was higher in the solvent-exposed workers than in the CTE group. These 
factors could explain the dynamics of DNA methylation differences observed in the 
lymphocytes of solvent-exposed workers and CTE patients. On the other hand, 
sometimes results are contradictive. For example, both the induction of hypo- and 
hypermethylation of specific genomic regions have been described in response to 
alcohol exposure (Ishii et al., 2008, Liu et al., 2009). 
 
In this study we used peripheral blood lymphocytes, which are heterogeneous 
population of cells with a short life span compared to the neurons that represent the 
target tissue in CTE, to profile the methylome. The question remains whether 
lymphocytes can be used as surrogate tissue. Lymphocytes of solvent-workers show 
DNA methylation stress because they are currently exposed to the solvents, whereas 
absence of current solvent exposure in CTE patients could result in the alleviation of 
sustained DNA methylation stress in lymphocytes, leading to a DNA methylation 
pattern similar to the controls. Since neurons are terminally divided cells, and it is to 
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be expected that epigenetic changes in the neuronal cells be maintained in CTE 
individuals with previous history of chronic solvent exposure. Studies have reported 
similar DNMT1 and DNMT3a expression profiles in peripheral blood lymphocytes 
and telencephalic GABAergic neurons of schizophrenia patients, which supports the 
popular concept that readily available blood lymphocytes can express epigenetic 
markers relevant to schizophrenia (Zhubi et al., 2009). This suggests that lymphocytes 
could be used as reporter cells to assess the risk factors of developing neurobehavioral 
disorders. Additionally, lymphocytes provide a live cell model to examine the 
functional consequence of epigenomic alteration in solvent-exposed population and 
CTE patients, as opposed to post-mortem brain where mRNA and DNA could get 
degraded. Epidemiological studies have also reported the association between global 
DNA methylation in white blood cells and demographic, environmental, behavioural 
risk factors and cancer (Terry et al., 2011). Studies investigating the association 
between DNA methylation in white blood cells and different disease endpoints are 
intriguing but need to be replicated in larger and prospective studies.  
 
Although the genetic vulnerability towards neurobehavioral disorder has been 
described in many reports, there exists an ample room for epigenetic explanations for 
risk factors in developing neurobehavioral disorders. Genetic polymorphisms in 
metabolizing enzymes and dopamine receptor genes, have been described as 
conferring advantageous and disadvantageous towards the development of CTE 
(Godderis et al., 2010). However, phenotypic plasticity is more than a simple property 
of genetic variation in a number of genes.  Genetic differences could affect the 
cellular epigenetic status in response to environmental factors. The current study also 
highlights the involvement of a gene-environment interaction that defines the 
individual’s susceptibility towards solvent exposure. There was no statistical 
difference in the global DNA methylation between the 3 genotypes considered (MW-
U: p>0.05), nor in the total population, or in the respective subpopulations. This is to 
be expected since we focused on genes involved in the metabolism. Our results 
suggest significant GSTP1–total exposure time interaction with global DNA 
hypomethylation for the entire study group. This implies the involvement of type 2 
gene-environment interaction. GSTP1 polymorphism does not predetermine for 
neurotoxic effects in absence of solvent exposure. However, in case of exposure, 
GSTP1–exposure time interaction modulates the epigenetic response, and may 
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confers individual’s susceptibility towards neurotoxic effects. Epigenetic processes 
themselves increases individual’s susceptibility towards solvent exposure as discussed 
previously. The GSTM1 genotype showed a borderline association with global DNA 
methylation in solvent workers. This is in line with our previous study, indicating that 
the GSTM1 polymorphism affects an individual’s susceptibility towards CTE 
(Godderis et al., 2010). 
 
Certain methodological limitation specific to this study should be considered. The 
blood samples, to obtain the genome DNA, were collected over a period of six 
months. The time-laps in sample collection among participants could have an effect 
on DNA methylation process. After sample collection, DNA was extracted and store 
at -80°C until further analysis. Also the gene-specific DNA methylation status was 
not assessed in this study. In this regard, it is possible that genetic factors, which are 
important in aetiology CTE, are differentially methylated in response to solvent 
exposure. Another limitation of this study is the selection bias, which could effect the 
exposure assessment, and could also have an affect the global DNA methylation 
measurement. Since it is a cross-sectional study, it is not possible to address the issue 
of reverse causality in the current study design. 
In conclusion, we described the global DNA methylation alterations in solvent-
exposed workers and CTE patients with a history of chronic solvent exposure. We 
also delineate the potential association of genetic difference in drug metabolizing 
enzyme i.e., GST with global DNA methylation in these groups. In future studies, we 
will focus on the effects of solvent exposure on gene specific promoter methylation 
e.g., dopamine receptor genes, promoter sequences of drug metabolizing enzymes, in 
solvent-exposed and CTE patients. We will also characterize the role of epigenetics in 
gene-environment-interaction model towards the development of CTE-related 
phenotypes. 
 
Future Prospective 
Epigenetics is an emerging area of the genome in disease research. Molecular and 
cellular networks regulating the tissue specific epigenetic information could help 
understanding the basis of neurobehavioral disorder such as CTE. Since the first 
application of epigenetic information in clinical setting to diagnose two imprinted 
disorders (Parader-Willi and Angelman Syndrome) based on gene-specific differential 
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methylation, several methodological advancements e.g., genome-wide methylation 
analysis based on next-generation DNA sequencing, have been made in the field of 
epigenetic (Kubota et al., 2012). These genome-wide assays will help scientific 
community to dissect both genetic and epigenetic factors in the aetiology of acquired 
neurobehavioral disorders. Environmental exposure induces DNA methylation 
alteration in the cells. However, the extent and duration of the methylation alterations 
to confer disease phenotype remains to be understood fully. 
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Abstract 
 
DNA methylation effects, including global DNA methylation/hydroxymethylation 
and gene specific methylation, associated with exposure to nanomaterial (NM) are 
largely unknown. In this study, we investigated the effects of NM exposure on DNA 
methylation. We exposed BALB/c mice to gold NPs (AuNPs) of 5nm, 60nm and 
250nm diameter; single-walled carbon nanotubes (SWCNTs) and multi-walled carbon 
nanotubes (MWCNTs) at high dose of 2.5 mg/kg and low dose of 0.25 mg/kg for 48 
hrs. Cytotoxicity assays revealed AuNPs induced macrophage-dominant while CNTs 
induced macrophage and neutrophil-dominant immune response. In exposed mice, no 
effects of AuNPs and CNTs exposure were observed on oxidative stress and DNA 
damage, global DNA methylation and hydroxymethylation. In mice lung tissue, 
following DNA methylation effects were observed; AuNPs 60nm exposure induced 
promoter CpGs hypermethylation in Atm, Cdk and Gsr genes, while promoter CpGs 
hypomethylation in Gpx gene; changes in promoter methylation of Gsr and Trp53 
was also observed between low and high dose of AuNPs 60 nm and AuNPs 250 nm 
respectively; AuNPs size effects on promoter methylation was observed for Trp53 
gene; and CNTs exposure affected the promoter methylation of Atm gene. In mice 
blood DNA, the only effect observed was the induction of promoter hypermethylation 
in Pparg gene by exposure of AuNPs 60 nm high dose compared to the AuNPs 60 nm 
low dose. Epigenetically altered genes were involved DNA apoptotic process, 
immune system process, metabolic process and response to stimulus pathways. In 
conclusion our results showed that exposure to NM lead to gene specific methylation 
changes in vivo.  
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5.1. Introduction 
 
 
Humans are exposed to airborne ultra-fine particles (UFP) from different sources 
(Terzano et al., 2010). This exposure has changed because of the anthropogenic 
factors, and more recently with the rapid developments in nanotechnology, which is 
engineering nanomaterial (NM) with size-dependent properties called nanoparticles 
(NPs). NPs are defined as particles with at least one dimension less than 100 nm 
(Oberdorster et al., 2005).  Nanomaterial e.g., gold nanoparticle (AuNPs), titanium 
dioxide NPs, zinc oxide NPs, and single-walled carbon nanotubes (SWCNTs) and 
multi-walled carbon nanotubes (MWCTs) are currently used in many applications. 
For example, some of them are used chemotherapy, targeted drug delivery systems 
(TDDS), intracellular gene regulation, as well as in aerospace, automobiles, electronic 
and optical applications (Allhoff et al., 2009). Their widespread presence, small size 
and unique physicochemical properties also pose public health concerns (Luyts et al., 
2013). Human exposure to NPs mainly occurs via inhalation, skin contact and 
ingestion. NPs exposure via inhalation is particular important as NPs can penetrate 
deep into the pulmonary interstitium, and can translocate from lungs into systemic 
circulation (Choi et al., 2010). In line with this, it is important to investigate the 
effects of nanomaterial in lungs and in blood cells. Also, in TDDS, AuNPs and CNTs 
are introduced into the body, which raises question on the fate and effects of these 
nanomaterials in the body.  
 
Gold (Au) is considered relatively inert and biocompatible; however, recent studies 
raised concern of the biocompatibility of Au in nano-size range (Alkilany and 
Murphy, 2010). Also, physicochemical properties of CNTs pose health concerns 
similar to that observed with asbestos, such as development of mesothelioma 
(Boczkowski and Lanone, 2012). Different mechanisms have been proposed for the 
observed toxicity of AuNPs and CNTs e.g., induction of oxidative stress, DNA 
damage, immune deregulation etc (Manke et al., 2013). In line with these 
observations, it is shown that exposure to some NPs alters the expression of genes 
implicated in exposure-induced pathways (Rahman et al., 2009, Kim et al., 2009). 
AuNPs exposure has shown to alter the expression IL-6, TNF-α, CDK genes (Khan et 
al., 2013). Carbon nanotubes exposure has also been associated with changes in 
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expression of genes such as C-MYC, GSR, IL6, Gpx3 and many other genes regulating 
diverse cellular pathways (Alazzam et al., 2010, Pacurari et al., 2011). This indicates 
that NM exposure alters cell signaling pathways that regulate gene expression.  
 
Epigenetic modifications are involved in regulating gene expression. Epigenetic 
modifications i.e., DNA methylation, histone modification, microRNAs, alter gene 
activity without altering the DNA sequence. DNA methylation (5-Methylcytosine: 
5mC) is one of the most studied epigenetic modifications (Jones and Baylin, 2002) 
occurs almost exclusively on cytosine followed by guanine base (i.e., CpG 
dinucleotides) in humans. Within genome, regions of high density of CpG 
dinucleotides are present called CpG islands (CGIs). CGIs are preferentially 
distributed within the gene promoter regions where they regulate gene expression 
(Esteller, 2002). Several classes of environmental chemicals, including metals, 
particulate matter, and endocrine/reproductive disrupters are shown to modify gene 
promoter methylation marks (Baccarelli and Bollati, 2009).  Moreover, xenobiotic 
exposure is also shown to affect global DNA methylation (total number of methylated 
cytosines in the genome), and global DNA hydroxymethylation (5-
hydroxymethylcytosine: 5hmC) (total number of hydroxymethylated cytosines in the 
genome) (Dao et al., 2014, Tabish et al., 2012). 5hmC is a DNA cytosine 
modification (hydroxymethylation of cytosines), which recently gained interest 
because it represents the DNA demethylation pathway (Tabish et al., 2012). In this 
study, we investigated the DNA methylation effects, including global 5mC, 5hmC 
and gene specific methylation, induced by exposure of NM in BALB/c mice.  
 
5.2. Methods  
5.2.1. Gold nanoparticles and carbon nanotubes  
 
 
Citrate coated colloidal AuNPs of three primary sizes (small sized AuNPs: 5nm; 
medium sized AuNPs: 60 nm, and large sized AuNPs: 250 nm) were obtained from 
BBInternational (Cardiff, UK). SWCNTs (Raw Soot) were purchased from National 
Institute of Standards and Technology (NIST) (SRM: standard reference materials; 
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2483) (Gaithersburg, US). AuNPs were thoroughly characterized for their primary 
particle diameter, hydrodynamic diameter and zeta-potential in baxter water (B.Braun 
Medical Inc, Irvine, US) and in 2% serum by dynamic light scatting (DLS) method. 
MWCNTs (NM-400) were obtained from European Commission, Joint Research 
Centre, Institute for Reference Materials and Measurements (Milan, Italy). CNTs 
were characterized for their size distribution in H2O by electron microscopy (Powers 
et al., 2007). 
 
5.2.2. Preparation of nanomaterial  
 
Stock suspensions (2 mg/ml) of powder samples (SWCNTs & MWCNTs) were 
prepared in pure H2O with 2% mouse serum by ultra-sonication (PTS Technics, 
Huddinge, Sweden) for 16 minutes. NPs stock suspensions were used within an hour 
of preparation. Working concentration (high dose: 1mg/ml; low dose: 100 μg/ml) of 
CNTs and AuNPs were prepared prior to instillation in saline solution with 0.2% 
mouse serum in lipopolysaccharide (LPS) free vials. 
 
5.2.3. Animals  
 
Male BALB/c mice (~20g, 7 weeks old) were obtained from Harlan (Horst, The 
Netherlands), and housed in filter cages in a conventional animal house at controlled 
temperature (21 ± 1°C) and humidity (50 ± 10%) with 12-h dark/light cycles. Mice 
were fed on lightly acidified water and pelleted food (Trouw Nutrition, Ghent, 
Belgium) ad libitum. All experimental procedures were approved by the Local Ethical 
Committee (Katholieke Universiteit Leuven, Leuven, Belgium) with the project 
number ML8557.  
 
5.2.4. Experimental design  
 
Mice were divided into five experimental groups designated as; 1) shame-control (n = 
8), 2) vehicle-control (n = 8), 3) decitabine group (n = 5) which was used as a positive 
control, 4) AuNPs (n = 5/group): 5nm AuNPs low dose (0.25 mg/kg ) and high dose 
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(2.5 mg/kg), 60 nm AuNPs low dose (0.25 mg/kg) and high dose (2.5 mg/kg), and 
250 nm AuNPs low dose (0.25 mg/kg) and high dose (2.5 mg/kg), 5) carbon 
nanotubes (n = 5/group); SWCNT low dose (0.25 mg/kg) and high dose (2.5 mg/kg) 
and MWCNTs low dose (0.25 mg/kg) and high dose (2.5 mg/kg).  
 
Mice were anesthetized in the chamber using isoflurane (3-5%) (Abbott Laboratories, 
SA Abbott NV, Ottignies, Belgium) for 2 minutes. Each mouse received 50 μl of 
working NPs solution or decitabine,  (1mg/kg prepared in saline with 0.2% mouse 
serum) or vehicle (saline with 0.2% serum) by single intra-tracheal instillation by 1 
ml syringes (BD, Erembodegem, Belgium) followed by 200 μl of air. Sham-control 
mice were also anesthetized and instilled with 250 μl of air. Mice were weighted 
before instillation and examined after instillation till fully recovered from the 
anesthesia or any adverse effects e.g., anxiety etc.  After instillation mice were 
transferred to the animal facility for 48h. After 48h of exposure, mice were weighed; 
sacrificed using an overdose of pentobarbital (90 mg/kg i.p.), blood was sampled from 
the retro-orbital plexus in K3EDTA coated vials and flash-frozen in liquid nitrogen. 
Mice lungs were perfused with saline solution to clear them from blood cells. Mice 
lungs were dissected into each lobe, transferred into sterile vials, weighed and 
samples were flash-frozen. Samples were transferred to -80 °C till further analysis. 
 
5.2.5. Bronchoalveolar lavage and bronchoalveolar lavage fluid 
processing  
 
Bronchoalveolar lavage (BAL) fluid was sampled and cytospin slides were prepared 
as described previously (De Vooght et al., 2009). BAL cells were stained with trypan 
blue dye (Invitrogen, Belgium) and total cell count (TCC) BAL cells was performed 
under the light microscope. BAL cells were fixed on slides, stained with hematoxylin 
and eosin and differential counts of BAL cells were performed. Images of BAL cells 
were taken with a zeiss axiovert 220M microscope equipped with axiovision rel. 4.8.2 
imaging software at a 100x oil lens with a 10x ocular lens. 
 
5.2.6. Lung cytokine measurements by cytometric bead array  
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Cytokines (Il-1, Il-4, Il-5, Il-6, Il17a, KC) expression in mice lung tissue was 
analyzed by cytometric bead array kits (CAB, BD biosciences, Belgium) as per 
manufacturers protocol on LSR Fortessa flow cytometry platform equipped with 
FCAP array v3.0 software  (BD biosciences, Belgium). Briefly, lung tissue was 
homogenized in lysis buffer and protein concentration of the lysates was measured. 
Cytokine concentrations were calculated based on standard curve data using FCAP 
Array software (BD Biosciences). 
 
5.2.7. DNA damage measurement by comet assay  
 
The comet assay was conducted in accordance with the standard protocol “European 
Network on the Health and Environmental Impact of Nanomaterials” issued by the 
ENPRA(risk assessment of engineered nanoparticles) project. All experimental 
processing for the comet assay was done at 4 ºC in dark. Comet assay consumables 
were purchased from (Trevigen Inc, Gaithersburg, US). BAL fluid was centrifuged at 
2000xg for 10 minutes. Cell pellet was resuspended in 250 μl of saline solution, and 5 
μl of this solution mixed with LM agarose were applied on the comet slides. LM 
agarose was allowed to set for 10 minutes and slides were immersed in the cell lysis 
solution for 1h. Further, slides were immersed in alkaline unwinding solution (30 
minutes) prior to electrophoresis at alkaline condition (pH > 13) for 30 minutes at 
constant voltages. Slides were washed in H2O, dehydrated in 70% ethanol for 5 
minutes, dried, stained with cyber green in TE buffer, and slides were imaged on 
fluorescence microscope (Olympus Corporation, Tokyo, Japan). Images were 
analyzed using autocomet software (TriTek Corp, Sumerduck, US).  
 
5.2.8. Oxidative stress measurement by Liquid chromatography-mass 
spectrometry  
 
Lung samples were minced immersed in 1 mM N-ethylmaleimide (NEM); a blocking 
thiol agent to prevent rapid oxidation of GSH. The measurements of the reduced 
(GSH) and oxidized (glutathione disulfide, GSSG) forms of glutathione were 
performed by liquid chromatography-mass spectrometry (LC-MS) in-house 
developed method, partially based on the method of Guan et al., 2003 (Napierska et 
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al., 2012). The LC-MS analysis was conducted on a Waters Acquity UPLC coupled to 
a Micromass MS Technologies Quattro Premier mass spectrometer using electron 
spray ionization (ESI). The LC separation was done on a Waters Acquity UPLC BEH 
C18, 50 mm × 2.1 mm, 1.7 μm column, held at a temperature of 40 °C. 
 
5.2.9. Global DNA methylation measurement by LC-MS/MS 
 
5-methylcytosine (5mC) and hydroxymethylation (5hmC) in mice lung DNA samples 
(DNA isolated using Qiagen Blood and Tissue kits, Qiagen; Venlo, Netherlands) were 
performed as described previously (Tabish et al., 2012, Lode Godderis, 2014). One μg 
of DNA was hydrolyzed into individual nucleosides, and samples were subject to LC-
MS analysis to quantify the absolute amount of 5mC and 5hmC in control and 
exposed lung DNA samples. Global 5mC and 5hmC analysis was performed in mouse 
lung DNA samples only because not enough DNA was obtained from mouse blood 
samples to carry out global 5mC and 5hmC analysis. 5mC is expressed as a 
percentage of 5-methylcytosine versus the total number of cytosines present in the 
genome. 5hmC is expressed as percentage of 5-hydroxymethylcytosine versus the 
total number of cytosines present in the genome. 
 
5.2.10. Gene specific DNA methylation measurements by bisulfite 
pyrosequencing 
 
Based on literature, we selected cellular pathways often responsive to environmental 
exposure e.g., oxidative stress pathway, immune pathway, cell cycle regulation 
pathways, DNA methylation pathway etc. Within these pathways, we selected 
nineteen (n=19; supplementary table T1) candidate genes with reported gene 
promoter alterations in response to xenobiotic exposure. For the selected genes, we 
designed bisulfite-PCR pyrosequencing assays (n=17) in order to investigate if the 
NPs exposure alters their gene promoter methylation (supplementary table T1). 
Genomic DNA was treated with the EZ DNA methylation Gold kit (Zymo Research, 
Orange, CA, USA) according to the manufacturer’s instructions. Final elution volume 
was 40 μl with M-elution buffer. PCR was carried in 30 μl using 15 μl of GoTaq 
Green Master mix (Promega), 10 pmol forward and 10 pmol reverse primers, 50 ng of 
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bisulfite-treated DNA, and water to reach 30 μl final volume. Amplicons were 
analyzed in 2% agarose gel. Pyrosequencing was performed as previously described 
using 0.3 μm sequencing primer (Ali M. Tabish, 2014). PCR and sequencing assays 
information are given in supplementary table T2. We designed control oligo for 100% 
DNA methylation (PSQ-C oligo), 0% DNA methylation (PSQ-T oligo) and the 
sequencing primer for control oligo. We mixed PSQ-C oligo (or PSQ-T oligo) with 
sequencing oligo in PyroMark Annealing Buffer (QIAGEN Inc., Valencia, CA) and 
performed pyrosequencing (sequencing entry C/TGTAT) (supplementary table T2). 
The methylation level is expressed using % 5mC. 
 
5.3. Statistical analysis 
 
Effects of NM exposure on immune endpoints (BAL total cell and differential cell 
count, cytokine measurements), DNA damage, global DNA methylation and 
hydroxymethylation were assessed using Wilcoxon test with dunn all pairs post-hoc 
analysis using JMP v. 10 (SAS institute, NC, USA) .  
 
In order to perform statistical analysis on the results of gene promoter methylation, 
we took a three-step approach. In the first step, we took an average of methylation of 
all CpGs analyzed for a given gene. Wilcoxon test was performed taking average 
methylation of all CpGs per gene as dependent variable and exposure groups as 
independent variables. Wilcoxon test returned p-value of test statistics. In the second 
step, we performed statistical analysis per CpG methylation.  In this analysis, 
Wicoxon test was performed taking each CpG methylation within a gene (e.g., Atm 
CpG#1) as dependent variable and exposure groups as independent variables.  P-
values of test statistics were returned by Wicoxon test. In the third step, we performed 
dunn all pair post hoc analysis on methylation values of exposure groups where 
Wilcoxon statistics returned significant exposure effects. Dunn all pair post-hoc 
analysis was performed in order to investigate exposure parameters i.e., AuNPs size 
and exposure dose (Figure 3, Table 3), CNTs shape and exposure dose (Figure 4, 
Table 3), responsible for the observed variance in methylation in lung and blood 
DNA. α level of 0.05 defined as significant. Graphs were made using SPSS software 
(SPSS Inc., Chicago, IL). 
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5.4. Results  
5.4.1. Nanomaterial characteristics 
 
Physicochemical characteristics of NM used in this study where thoroughly 
characterized for their size and charge distribution (supplementary table T3 and T4). 
AuNPs average diameter Average diameter of AuNPs measured with DLS was 
greater in 2 % serum than their average diameter in H2O. Distribution curves 
(supplementary figure F1) for AuNPs show the aggregation of each NP. Curves show 
the particle aggregation decreases with increase in particles size in 2 % serum 
compared to their aggregation in H2O. AuNPs showed negative zeta potential in H2O 
and in 2 % serum. In H2O, AuNPs showed size dependent increase in negative zeta 
potential, while in serum this dependency was not observed. These charges stabilize 
the suspension via repulsive forces.  
 
5.4.2. Cytotoxicity of nanomaterial 
 
In order to examine the cytotoxicity of NM exposure, we examined total and 
differential changes in BAL cells count. We observed significantly higher total cell 
count in response to AuNPs and CNTs exposure compared to the non-exposed mice 
(Figure 1a). BAL differential cell count revealed macrophage and neutrophils 
dominant influx into lung interstices after AuNPs and CNTs exposure respectively 
compared to control mice (Figure 1b). Percent BAL cells that had taken up/or were 
associated with the AuNPs and CNTs are shown in figure 1c. In sham- and vehicle 
control groups no macrophages were observed that had taken up NPs; therefore, they 
are not visible in figure 1c. Images of BAL macrophages in AuNPs and CNTs 
exposed and control mice showed that AuNPs and CNTs were taken up/ or associated 
with the BAL cells in a dose response manner (Figure 1d-i). We did not observe 
changes in selected cytokines in mice lung in AuNPs and CNTs exposed mice 
compared to the controls (supplementary Figure F2). 
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Figure 1 a-i: Bronchoalveolar lavage (BAL) analysis. a): total cell count; b): differential cell count.; 
c): uptake/association by/with BAL macrophages. For clarity of presentation in panel b, significant 
groups are not annotated. In panel b, macrophages count was significant in following exposure groups: 
AuNPs 5nm 50µg and AuNPs 60nm 50µg compared to the vehicle; AuNP 5nm 50µg compared to 
AuNP 250nm 5µg; and AuNPs 60 nm 50µg compared to the AuNP 250nm 5µg dose categories. 
Neutrophils count was significant in following exposure groups: SWCNT 50µg and MWCNTs 50µg 
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compared to vehicle. Lymphocytes count was significant in following exposure groups: SWCNT 50µg 
and MWCNTs 50µg compared to vehicle. Representative images of macrophage d): vehicle; e): 
AuNPs 5nm; f): AuNPs 60nm; g): AuNPs 250 nm; h): SWCNTs; i): MWCNTs., In panel a and c; the 
box plot describes the median (line across the box), inter-quartile range and maximum and minimum 
values (whiskers). Outliers are shown as colored circles outside the ends of whiskers. Data in panel b is 
represented as median ±SD. Asterisk sign (*) shows significance levels at p=0.05. Gold nanoparticles: 
AuNPs;  single-walled- and multi-walled carbon nanotubes: SWCNTs and MWCNTs. 
 
5.4.3. Oxidative stress and DNA damage effects 
 
NPs exposed mice did not show induction of oxidative stress, or DNA damage 
compared to the control mice (supplementary figure F3 and F4 respectively). 
5.4.4. Global DNA methylation and hydroxymethylation in lungs  
 
Wilcoxon statistics showed no significant effects of AuNPs exposure on 5mC and 
5hmC levels. Also no effects of CNTs exposure were observed on 5mC and 5hmC 
levels compared to the controls (Figure 2a-b). 
 
 
Figure 2: Global DNA methylation (5mC) and hydroxymethylation (5hmC) in lungs. a): no significant 
effects (Wilcoxon test) of gold nanoparticle (AuNPs) and single-walled and multi-walled carbon 
nanotubes (SWCNTs and MWCNTs) were observed on 5mC (p=0.667 and 0.284 respectively). b): also 
no significant effect of AuNPs exposure on lung 5hmC were observed (p=0.107). However, CNTs 
exposure showed significant effect on 5hmC (p=0.024) levels by Wilcoxon statistics, while no group 
remained significant after multiple comparisons (Dunn all pairs post-hoc). In panel a and b; box plot 
describes the median (line across the box), inter-quartile range and maximum and minimum values 
(whiskers). Outliers are shown as colored circles outside the ends of whiskers.  
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5.4.5. Gene promoter methylation in lungs and blood  
 
 Effects of NMs exposure on average gene promoter methylation and promoter CpG 
methylation were investigated: in lung tissue of mice exposed to AuNPs 
(supplementary table T5-a); in lung tissue exposed to carbon nanotubes 
(supplementary table T5-b). The effects of NMs exposure on average gene promoter 
methylation and promoter CpG methylation were also profiled: in blood tissue of 
mice exposed to AuNPs (supplementary table T6-a); in blood tissue exposed to 
carbon nanotubes (supplementary table T6-b). P-values significant at preset alpha 
level of 0.05 are highlighted in red, while p-values with borderline significance 
compared to the preset alpha level of 0.05 are highlighted in yellow (supplementary 
tables 5 a-b and 6 a-b).  
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Figure 3: Effect of gold nanoparticles (AuNPs) exposure on gene promoter methylation. Bars connect 
exposure groups with significant methylation difference a-g): effects of AuNPs exposure on promoter 
methylation levels of Atm(a), Cdk(b), Gpx(c), Gsr(d-f), and Trp53(g) genes in lungs; h): effect of 
AuNPs exposure on gene promoter methylation levels of Pparg gene in blood. In panels, box plot 
describes the median (line across the box), inter-quartile range and maximum and minimum values 
(whiskers). Outliers are shown as colored circles outside the ends of whiskers. Asterisk sign (*) shows 
significance levels at p=0.5. Atm: ataxia telangiectasia mutated; Cdk; cyclin-dependent kinase; Gsr: 
glutathione reductase; Gpx: glutathione peroxidase; Trp53: tumor protein P53; Ppar: peroxisome 
proliferator-activated receptor gamma gene. 
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For exposure groups with significant/or borderline significant effects on average gene 
methylation and on CpG methylation, dunn all pair test was performed to determine 
the effects of exposure parameters (i.e., NPs size, CNTs shape and dose). Table 1 
gives the results of dunn all pair test with associated p-values. Compared to the 
vehicle group, AuNPs 60 nm exposure in mice lung tissue induced promoter 
hypermethylation in ataxia telangiectasia mutated (CpG#10), cyclin-dependent kinase 
(CpG#6) and glutathione reductase (CpG#1) genes, while promoter hypomethylation 
in glutathione peroxidase (CpG#3) gene (figure 3, table 3). Alterations in promoter 
methylation were observed for glutathione reductase (CpG#4, CpG#6) and tumor 
protein P53  (CpG#1) genes between low and high dose (i.e., dose effect) of AuNPs 
60 nm and AuNPs 250 nm respectively (figure 3, table 1). AuNPs size effects on 
promoter methylation was observed for tumor protein P53  (CpG#1) gene (figure 3, 
table 1). CNTs exposure affected the promoter methylation of ataxia telangiectasia 
mutated gene (figure 4, table 1).  
 
 
Figure 4: Effect of nanomaterial exposure on gene promoter methylation. Bars connect exposure 
groups with significant methylation difference. a-b): effect of single-walled and multi-walled carbon 
nanotubes (SWCNTs and MWCNTs) exposure on promoter methylation levels of Atm gene in lung 
tissue. In panels, box plot describes the median (line across the box), inter-quartile range and maximum 
and minimum values (whiskers). Outliers are shown as colored circles outside the ends of whiskers. 
Asterisk sign (*) shows significance levels at p=0.5. Atm: ataxia telangiectasia mutated. 
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Table 1: Effect of exposure i.e., AuNPs size, CNTs shape and dose on CpGs methylation level 
within promoter region(s) of gene(s). Dunn all pairs post-hoc test was used to observe factors 
accounted for the observed variability (p- value of 0.05 set to be significant).  
 
 AuNPs exposed lung DNA methylation  CNTs exposed lung DNA methylation 
Gene 
Symbol 
Per 
Position 
and/or 
per 
gene 
Variable 1 
Mean DNA 
methylation 
(95%CI) 
Variable 2 
Mean DNA 
methylation 
(95%CI) 
p-
value 
Gene 
Symbol 
Per 
Position 
and/or 
per gene 
Variable 1 
Mean 
methylation 
(95%CI) 
Variable 2 
Mean 
methylation 
(95%CI) 
 p-
value 
Atm CpG#10 Vehicle 
0.912 
(0.763-
1.061) 
AuNP 60 
nm 50 µg 
1.62 
(1.36-1.89) 
0.002 Atm CpG#2 Vehicle 
1.842 
(1.588-
2.096) 
SWCNTs 5 
µg 
1.356 
(1.197-1.514) 
0.038 
Cdk CpG#6 Vehicle 
0.726 
(-0.113-
1.565) 
AuNP 60 
nm 50 µg 
2.638 
(0.732-
4.544) 
0.031 Atm average 
(CpG#1-
6) 
SWCNTs 5 
µg 
1.187 
(1.046-
1.329) 
MWCNTs 5 
µg 
1.843 
(1.464-2.221) 
0.0316 
Gpx CpG#3 Vehicle 
0.640 
(0.455-
0.826) 
AuNP 60 
nm 5 µg 
0.101 
(-0.071-
0.273) 
0.041      
Gsr CpG#1 Vehicle 
0.063 
(-0.01-
0.136) 
AuNP 60 
nm 50 µg 
0.771 
(-0.082-
1.624) 
0.034      
Gsr CpG#4 AuNP 60 
nm 5 µg 
0.484 
(-0.125-
1.092) 
AuNP 60 
nm 50 µg 
1.765 
(1.361-
2.169) 
0.018      
Gsr CpG#6 AuNP 60 
nm 5 µg 
0.042 
(-0.074-
1.158) 
AuNP 60 
nm 50 µg 
1.11 
(0.519-1.7) 
0.012      
Trp53 CpG#1 AuNP 60 
nm 5 µg 
0.051 
(-0.09-
0.192) 
AuNP 250 
nm 5 µg 
1.198 
(0.458-
1.937) 
0.034      
Trp53 CpG#1 AuNP 250 
nm 5 µg 
1.198 
(0.458-
1.937) 
AuNP 250 
nm 50 µg 
0.045 
(-0.079-
0.169) 
0.028      
AuNPs exposed blood DNA methylation CNTs exposed blood DNA methylation 
Pparg CpG#3 AuNP 60 
nm 5 µg 
1.18 
(0.502-
1.858) 
AuNP 60 
nm 50 µg 
4.813 
(-0.95-
10.576) 
0.031      
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In mice blood DNA, the only effect observed was the induction of promoter 
hypermethylation in peroxisome proliferator-activated receptor gamma gene (CpG#3) 
gene by exposure of AuNPs 60 nm high dose compared to the AuNPs 60 nm low dose 
(figure 3, table 1). AuNPs of 5nm did not significantly impacted CpG methylation 
compared to controls. Genes with significant/and or borderline significant 
methylation levels in response to NM exposure were involved in apoptotic process, 
immune system process, metabolic process and response to stimulus pathways. 
 
5.5. Discussion 
 
In current study, we investigated the epigenetic alterations in response to NM 
exposure in BALB/c mice. NM doses used to observe the epigenetic response in mice 
were based on the initial cytotoxicity experiments. In order to examine the 
cytotoxicity of NM, we examined the BAL cells. BAL cells analysis showed 
induction of immune response to AuNPs and CNTs exposure in BALB/c mice. NM 
exposure induced alterations in BAL total cell count in exposed mice. Deferential cell 
count revealed macrophage dominant immune response by AuNPs exposure, while 
CNTs exposure lead to macrophage and neutrophils driven immune response in mice. 
After 48 hrs of exposure, NPs were associated with pulmonary macrophages. Our 
findings are in agreement with previous studies, where NPs were shown to be 
engulfed by the pulmonary macrophages after the intra-tracheal instillation in vivo 
(Sadauskas et al., 2009). Previous studies in BALB/c mice exposed to AuNPs also 
demonstrated immune response dominated by macrophage; whereas SWCNTs and 
MWCNTs exposure in BALB/c were shown to induce macrophages as well as 
neutrophils influx in lung interstices (Ravichandran et al., 2011, Hussain et al., 2011). 
Pulmonary inflammation plays key role in various pathologies. Macrophage influx 
into lung interstices after AuNPs and CNTs exposure carry out cleaning function in 
lungs. These macrophages can take different phenotypes based environmental signals, 
and can enhance the oncogenic growth leading to pulmonary pathologies (Yang et al., 
2012). For the selected cytokines under the current settings, we did not observe 
alterations in their concentrations in lung interstices after AuNPs and CNTs exposure 
compared to the controls. Contrary to our observation, studies have reported that 
exposure of certain nanomaterial to BALB/c mice is associated with changes in 
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cytokines concentrations in the lung tissue (Meng et al., 2011). Further, some studies 
also showed contradictory effects of nanomaterial exposure on inflammatory 
endpoints under different experiment settings (Alkilany and Murphy, 2010). These 
observations highlight need for the use of standardized nanomaterial applied under 
similar experimental settings in order to draw conclusion across studies. 
 
To measure the induction of oxidative stress in NM exposed mice lung samples, we 
measured GSSG/GSH ratio. Our results showed that AuNPs and CNTs at selected 
doses do not induce significant alterations neither for GSSG/GSH ratio nor for 
mitochondrial copy member compared to the controls. Similarly, our results also did 
not show the induction of DNA damage in BAL cells in exposed mice compared to 
the controls. Comparing with the published data, our findings supports the concept 
that AuNPs exhibit low toxicity, as described by Chen et al (Chen et al., 2009), and 
that AuNPs are not genotoxic. Contrarily, some studies also have reported DNA 
damage and oxidative stress induction by AuNPs (Sabella et al., 2011). Use of 
different dose, exposure methods, in vitro and in vivo models, and even the AuNPs 
and CNTs purchased/manufactured from different sources/methods make it difficult 
to compare our findings with the published ones. Contradictory reports are published 
on the cellular and genotoxic effects of SWCNTs and MWCNTs (Singh et al., 2009). 
Some of these studies are criticized owing to high doses applied. In current study we 
applied low subcytoxic CNTs doses and relatively short exposure period (48 hrs), 
which could partly explain the contradiction on the observed effects. Previous reports 
have shown that the size of NPs could have strong effect on cellular activates in 
exposed cells (Shang et al., 2014).  Chen et al., 2009 exposed BALB/c mice to AuNPs 
of 3nm, 5nm, 50nm, and 100 nm, and reported that AuNPs of 37nm were more 
harmful than other AuNPs sizes (Chen et al., 2009). Although it is difficult to 
compare above studies with the current one, but under the current experimental 
settings, we did not observe the effect of size and shape of nanomaterial on the 
induction of oxidative stress and DNA damage in vivo.  
 
Important part of current study was to investigate the epigenetic alterations induced 
by NPs. Epigenetic alterations i.e., DNA methylation, histone modifications, 
microRNAs, are described in response to particulate matter (PM) and UFP (Bellavia 
et al., 2013). This encouraged us to investigate if NM also induce epigenetic changes 
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similar to their larger counterparts. To investigate the epigenetic effects, we analyzed 
the DNA methylation/hydroxymethylation at global and at gene promoter levels in 
NM exposed mice. Gene specific methylation was analyzed in mice lung and blood 
DNA by bisulfite-PCR pyrosequencing, while global 5mC and 5hmC was analyzed 
by LC-MS method only in mice lung DNA, owing to insufficient yield of DNA from 
mice blood. For global 5mC and 5hmC, we did not observe significant effects in 
exposed compared to the control mice. DNA repetitive elements constitutes ~ 50% of 
genome, and are highly methylated thus contributing significantly towards global 
DNA methylation. Also within repetitive elements, different subfamilies show 
differential sensitivity to environmental stressors (Byun et al., 2013). Our results 
indicate that BALB/c lungs are insensitive to global DNA methylation changes by 
AuNP of 5 nm, 60 nm and 250 nm, and SWCNTs and MWCNTs at selected doses 
and time. Although cells are insensitive to methylation changes globally in response 
to AuNPs and CNTs exposure, it is possible that the exposure leads subtle 
methylation changes at gene levels. Thus, we further investigated the gene specific 
methylation changes in exposed mice lung and blood DNA. 
 
For gene specific methylation, we observed AuNPs size and CNTs shape, and dose 
specific significant alterations in gene promoter methylation in exposed mice 
compared to the controls. In general, we observed more genes with methylation 
changes in lung DNA than in the blood DNA in exposed mice compared to the 
controls. This is expected since lung cells were directly exposed, while the blood cells 
did not have direct exposure to NPs and CNTs. Interestingly, we observed more genes 
with promoter methylation perturbations in AuNPs exposed mice compared to the 
CNTs exposed mice (Table 1). This is in contrast to the current paradigm that 
exposure to AuNPs do not induce adverse biological response. Based on the current 
findings; we can report that AuNPs are potent to induce epigenetic changes compared 
to CNTs. It is difficult to compare current findings with previous data, especially on 
gene specific methylation endpoints. Currently, one study investigated the effect of 
nano-silicon dioxide (nano-SiO2) on PARP-1 gene methylation in vitro, and reported 
hypermethylation of PARP-1 gene (Gong et al., 2012). No other studies investigated 
the effects of NM exposure on gene methylation. We are first to report that genes are 
sensitive to methylation changes by the nature, size, shape and dose of NM applied in 
vivo. Our statistical analysis included the assessment of DNA methylation changes at 
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each CpG level, within the selected region of gene promoter sites, in response to NM 
exposure. Our results indicated the induction of CpG specific methylation changes in 
NM exposed mice. This highlighted the differential sensitivity of individual CpGs 
within gene promoter to NM exposure. Some previous reports described alterations in 
histone posttranscriptional modifications and microRNA in response to NM exposure 
in vitro (Gong et al., 2010, Li et al., 2011). Cells epigenetic marks i.e., DNA 
methylation, histone posttranscriptional modifications and microRNAs are described 
to work in concert. In line with this, current findings complement previous reports (on 
NM induced alterations in histone posttranscriptional modifications and in 
microRNAs) that NM exposure leads to epigenetics changes. 
 
Genes with significant/and or borderline significant methylation levels in response to 
NM exposure were mapped to their biological processes (Table 4). Epigenetic 
induction of apoptotic, immune, metabolic, and response to stimulus processes, in 
NM exposed mice highlighted the importance of these cellular processes in NM 
induced stress response.  
 
In current study, we included 17 genes for the promoter methylation analysis. These 
genes were selected because they are commonly affected by xenobiotic exposure. It is 
possible that NM exposure also induce promoter methylation changes in other genes 
as well, which further needs to be explored. Investigations remain in order to 
understand the functional importance of these epigenetic changes in nanotoxicology. 
Recently, cellular epigenetic stress rather than genetic events are suggested to be 
culprit in driving disease process. Our findings also corroborate this fact; since we 
observed significant gene promoter methylation alterations in NM exposed mice lung 
and blood DNA without significant genotoxic effects. However, the extent and 
duration of epigenetic stress leading to diseases needs to be fully understood.  
 
 
Conclusion 
 
We conclude AuNPs and CNTs exposure induce size, shape and dose specific DNA 
methylation changes in vivo. Although methylation changes were not observed at 
global scale, but gene specific methylation changes were observed in response to 
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AuNPs and CNTs potentially leading to adverse health consequences, and warrants 
further investigations. Also, our data highlights the bronchial inflammation in 
response to NPs and CNTs exposure. Reverse causality between observed DNA 
methylation changes in lung DNA and bronchial inflammation needs further 
investigations.  
 
Acknowledgements  
 
We would like to thank Vanessa De Vooght for her contribution in ordering BALB/c 
mice and Steffen Fieuws for his help in statistical analysis. We also grateful to Fonds 
voor Wetenschappelijk Onderzoek (FWO) for their generous grant to support current 
research (KU Leuven project number 3M090531).  
 
Conflict of interest  
 
The authors declare that there are no conflicts of interest. 
 
 
 
 
 
 
 
 
 
 
 
 
 
101 
5.6. Chapter references 
 
 
Alazzam, A., Mfoumou, E., Stiharu, I., Kassab, A., Darnel, A., Yasmeen, A., 
Sivakumar, N., Bhat, R. & Al Moustafa, A. E. 2010. Identification of 
deregulated genes by single wall carbon-nanotubes in human normal bronchial 
epithelial cells. Nanomedicine, 6, 563-9. 
Ali M. Tabish, A. A. B., Lode Godderis, Timothy M. Barrow, and Hyang-Min Byun 
2014. Assessment of repetitive elements DNA methylation by 
pyrosequencing. Pyrosequencing Protocols (Methods in Molecular Biology),  
Alkilany, A. M. & Murphy, C. J. 2010. Toxicity and cellular uptake of gold 
nanoparticles: What we have learned so far? Journal of Nanoparticle 
Research, 12, 2313-2333. 
Baccarelli, A. & Bollati, V. 2009. Epigenetics and environmental chemicals. Current 
Opinion in Pediatrics, 21, 243-251. 
Bellavia, A., Urch, B., Speck, M., Brook, R. D., Scott, J. A., Albetti, B., Behbod, B., 
North, M., Valeri, L., Bertazzi, P. A., Silverman, F., Gold, D. & Baccarelli, A. 
A. 2013. DNA hypomethylation, ambient particulate matter, and increased 
blood pressure: Findings from controlled human exposure experiments. J Am 
Heart Assoc, 2, e000212. 
Boczkowski, J. & Lanone, S. 2012. Respiratory toxicities of nanomaterials — a focus 
on carbon nanotubes. Advanced Drug Delivery Reviews, 64, 1694-1699. 
Byun, H. M., Motta, V., Panni, T., Bertazzi, P. A., Apostoli, P., Hou, L. & Baccarelli, 
A. A. 2013. Evolutionary age of repetitive element subfamilies and sensitivity 
of DNA methylation to airborne pollutants. Part Fibre Toxicol, 10, 28. 
Chen, Y. S., Hung, Y. C., Liau, I. & Huang, G. S. 2009. Assessment of the in vivo 
toxicity of gold nanoparticles. Nanoscale Res Lett, 4, 858-864. 
Choi, H. S., Ashitate, Y., Lee, J. H., Kim, S. H., Matsui, A., Insin, N., Bawendi, M. 
G., Semmler-Behnke, M., Frangioni, J. V. & Tsuda, A. 2010. Rapid 
translocation of nanoparticles from the lung airspaces to the body. Nature 
Biotechnology, 28, 1300-U113. 
Dao, T., Cheng, R., Revelo, M., Mitzner, W. & Tang, W. 2014. Hydroxymethylation 
as a novel environmental biosensor. Current environmental health reports, 1, 
1-10. 
De Vooght, V., Vanoirbeek, J. A. J., Haenen, S., Verbeken, E., Nemery, B. & Hoet, P. 
H. M. 2009. Oropharyngeal aspiration: An alternative route for challenging in 
a mouse model of chemical-induced asthma. Toxicology, 259, 84-89. 
 
 
102 
Esteller, M. 2002. Cpg island hypermethylation and tumor suppressor genes: A 
booming present, a brighter future. Oncogene, 21, 5427-40. 
Gong, C., Tao, G., Yang, L., Liu, J., Liu, Q., Li, W. & Zhuang, Z. 2012. Methylation 
of parp-1 promoter involved in the regulation of nano-sio2-induced decrease 
of parp-1 mrna expression. Toxicol Lett, 209, 264-9. 
Gong, C., Tao, G., Yang, L., Liu, J., Liu, Q. & Zhuang, Z. 2010. Sio(2) nanoparticles 
induce global genomic hypomethylation in hacat cells. Biochem Biophys Res 
Commun, 397, 397-400. 
Hussain, S., Vanoirbeek, J. A., Luyts, K., De Vooght, V., Verbeken, E., Thomassen, 
L. C., Martens, J. A., Dinsdale, D., Boland, S., Marano, F., Nemery, B. & 
Hoet, P. H. 2011. Lung exposure to nanoparticles modulates an asthmatic 
response in a mouse model. Eur Respir J, 37, 299-309. 
Jones, P. A. & Baylin, S. B. 2002. The fundamental role of epigenetic events in 
cancer. Nat Rev Genet, 3, 415-28. 
Khan, H. A., Abdelhalim, M. A., Alhomida, A. S. & Al-Ayed, M. S. 2013. Effects of 
naked gold nanoparticles on proinflammatory cytokines mrna expression in rat 
liver and kidney. Biomed Res Int, 2013, 590730. 
Kim, S., Choi, J. E., Choi, J., Chung, K. H., Park, K., Yi, J. & Ryu, D. Y. 2009. 
Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma 
cells. Toxicol In Vitro, 23, 1076-84. 
Li, S., Wang, H., Qi, Y., Tu, J., Bai, Y., Tian, T., Huang, N., Wang, Y., Xiong, F., Lu, 
Z. & Xiao, Z. 2011. Assessment of nanomaterial cytotoxicity with solid 
sequencing-based microrna expression profiling. Biomaterials, 32, 9021-30. 
Lode Godderis, C. S., Ali Tabish, Katrien Poels, Peter Hoet, Andrea Baccarelli, and 
Kirsten Van Landuyt 2014. Global methylation and hydroxymethylation in 
DNA from blood and saliva in healthy volunteers. Biomed Res Int,  
Luyts, K., Napierska, D., Nemery, B. & Hoet, P. H. M. 2013. How physico-chemical 
characteristics of nanoparticles cause their toxicity: Complex and unresolved 
interrelations. Environmental Science-Processes & Impacts, 15, 23-38. 
Manke, A., Wang, L. & Rojanasakul, Y. 2013. Mechanisms of nanoparticle-induced 
oxidative stress and toxicity. Biomed Res Int, 2013, 942916. 
Meng, J., Yang, M., Jia, F., Xu, Z., Kong, H. & Xu, H. 2011. Immune responses of 
balb/c mice to subcutaneously injected multi-walled carbon nanotubes. 
Nanotoxicology, 5, 583-91. 
 
 
103 
Napierska, D., Rabolli, V., Thomassen, L. C., Dinsdale, D., Princen, C., Gonzalez, L., 
Poels, K. L., Kirsch-Volders, M., Lison, D., Martens, J. A. & Hoet, P. H. 
2012. Oxidative stress induced by pure and iron-doped amorphous silica 
nanoparticles in subtoxic conditions. Chem Res Toxicol, 25, 828-37. 
Oberdorster, G., Oberdorster, E. & Oberdorster, J. 2005. Nanotoxicology: An 
emerging discipline evolving from studies of ultrafine particles. 
Environmental Health Perspectives, 113, 823-839. 
Pacurari, M., Qian, Y., Porter, D. W., Wolfarth, M., Wan, Y., Luo, D., Ding, M., 
Castranova, V. & Guo, N. L. 2011. Multi-walled carbon nanotube-induced 
gene expression in the mouse lung: Association with lung pathology. Toxicol 
Appl Pharmacol, 255, 18-31. 
Powers, K. W., Palazuelos, M., Moudgil, B. M. & Roberts, S. M. 2007. 
Characterization of the size, shape, and state of dispersion of nanoparticles for 
toxicological studies. Nanotoxicology, 1, 42-51. 
Rahman, M. F., Wang, J., Patterson, T. A., Saini, U. T., Robinson, B. L., Newport, G. 
D., Murdock, R. C., Schlager, J. J., Hussain, S. M. & Ali, S. F. 2009. 
Expression of genes related to oxidative stress in the mouse brain after 
exposure to silver-25 nanoparticles. Toxicol Lett, 187, 15-21. 
Ravichandran, P., Baluchamy, S., Gopikrishnan, R., Biradar, S., Ramesh, V., 
Goornavar, V., Thomas, R., Wilson, B. L., Jeffers, R., Hall, J. C. & Ramesh, 
G. T. 2011. Pulmonary biocompatibility assessment of inhaled single-wall and 
multiwall carbon nanotubes in balb/c mice. J Biol Chem, 286, 29725-33. 
Sabella, S., Brunetti, V., Vecchio, G., Galeone, A., Maiorano, G., Cingolani, R. & 
Pompa, P. P. 2011. Toxicity of citrate-capped aunps: An in vitro and in vivo 
assessment. Journal of Nanoparticle Research, 13, 6821-6835. 
Sadauskas, E., Jacobsen, N. R., Danscher, G., Stoltenberg, M., Vogel, U., Larsen, A., 
Kreyling, W. & Wallin, H. 2009. Biodistribution of gold nanoparticles in 
mouse lung following intratracheal instillation. Chemistry Central Journal, 3 
Shang, L., Nienhaus, K. & Nienhaus, G. U. 2014. Engineered nanoparticles 
interacting with cells: Size matters. J Nanobiotechnology, 12, 5. 
Singh, N., Manshian, B., Jenkins, G. J., Griffiths, S. M., Williams, P. M., Maffeis, T. 
G., Wright, C. J. & Doak, S. H. 2009. Nanogenotoxicology: The DNA 
damaging potential of engineered nanomaterials. Biomaterials, 30, 3891-914. 
Tabish, A. M., Poels, K., Hoet, P. & Godderis, L. 2012. Epigenetic factors in cancer 
risk: Effect of chemical carcinogens on global DNA methylation pattern in 
human tk6 cells. PLoS One, 7, e34674. 
 
 
104 
Terzano, C., Di Stefano, F., Conti, V., Graziani, E. & Petroianni, A. 2010. Air 
pollution ultrafine particles: Toxicity beyond the lung. Eur Rev Med 
Pharmacol Sci, 14, 809-21. 
Yang, M., Meng, J., Cheng, X., Lei, J., Guo, H., Zhang, W., Kong, H. & Xu, H. 2012. 
Multiwalled carbon nanotubes interact with macrophages and influence tumor 
progression and metastasis. Theranostics, 2, 258-70. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
105 
Supplementary material 
Supplementary table T1: gene specific methylation assay sequences for rodent bisulfite-PCR 
pyrosequencing.  
 
Gene 
symb
ol 
Forward primer Reverse primer (biotinylated) Sequencing 
primer 
Anneali
ng 
temper
ature 
(
o
C) 
Atm GGGTGTTTTAAAGGAA
GAAGT 
TATAACCAAAAAAAACCT
AATAACC 
TTTAAAGGA
AGAAGT 
52 
Cdk TTGTTTTTGGTTTTGTAT
ATTATTT 
TTATCAAAAACTAAACTCT
CCTTAC 
AAGTTTTTTA
TGGAG 
52 
Dnmt
1 
GTTGGTATTTTGTAGGT
TGTAGA 
ACATAATCTTCCCCCACTC
TCTTA 
TAGAATAGT
TTTGAA 
58.3 
Gadd
45a 
TTTAGTAGATTTTGGGT
TGTAGTTT 
TAACTCTACAAATCCATTT
CACCCT 
TATATAGTGT
AGGTT 
53.9 
Gpx1 TTAAAAGGAGGTGTAG
GGTTTTGT 
CAAAAAACCCAAACTCAC
AAACT 
AGTATGTGT
GTTGTT 
58.3 
Gsr GGAGAGTTATAAGTTG
GGTGGTATTT 
TTTTTAACTTCAACATTAC
ACCTATACAAA 
GTTGGGTGG
TATTTG 
53.9 
Gss TTTTTTTTAAGGAAATT
TGATTTT 
ATCACTACTCATATAATAC
CCCTTCC 
AGGAAATTT
GATTTT 
50 
Myc TTAAGAAGGTAGTTTTG
GAGTGAGAG 
AACAAAAAACACTATCCC
CAAATAA 
GTAAGAGTT
TTTTTT 
53.9 
Nfkb
2 
GTAGAATTGGAGTTGG
GTGATATTT 
TTACTCCTCTCCAACCAAA
AAACT 
AGTTGGGTG
ATATTT 
59.4 
Oxsr
1 
GGGAATTTGATTTTTAG
TTTTTAT 
AAACCTTTTATCCTAATTA
ACCTTC 
AAAATTTTTT
AGGAT 
50.7 
Trp5
3 
GAATTTAAAGTAATTAT
TAGGGAA 
AAAACCCAAAATTCAAAC
TACAACT 
GTGTTTAAA
GTTAAG 
50.7 
Trp7
3 
TTGTAATTTAGGGGTTT
AGGAGTGTT 
AACTATAATCTCTACCAAA
CAAATC 
GAATATTGA
AAGTTT 
53.9 
Ppar
g 
GGAGTTTGTGAGATTA
ATAGTTTGA 
ATCACCTAACCAATCAAAT
CCAA 
AGATTAATA
GTTTGA 
53.9 
Tet1 ATTAATTTTTGGATAAA
TTTTTTAG 
AATCATATACCTCTACCTA
CCTCTTCTAC 
GGATAAATT
TTTTAG 
52 
Tet2 GTTTATTTTTTGTTTATT
TTGGTTA 
CATTAAAAACTACTAACTT
AATTCTTTC 
TGTTTATTTT
GGTTA 
50.7 
Tnf-a TTTTTTTGGTGGAGAAA
ATTATGAT 
CTAATTAACCCCAAATTAC
CACAAA 
TTTATATTTT
TGTTT 
53.9 
Xrcc
1 
GGTTTAATGATTAGGGT
AAATTATA 
AATTCCCTTAACAACAAAC
ATTCC 
AGGTTTTTAG
GAAGT 
52 
Nfkb
1 
AGGGGTTTGGGTATATT
TTTTTAAA 
AAAAAACCCCAAACAAAA
ATC 
GTAAGAGTT
TTTTTT* 
53.9 
Tdg GGTTTTAAGTTTTTTTG
AAGGTTT 
ATTAACCTAACCAACATCA
C 
TTTTTTTGAA
GGTTT* 
52.1 
 *  Sequencing primers did not pass the validation step for these assays. 
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Supplementary table T2: sequences for pyrosequencing control run.  
 
Assay name Assay sequence  
PSQ-C TTGCGATACGACGGGAACAAACGTTGAATTC 
PSQ-T TTGCGATACAACGGGAACAAACGTTGAATTC 
Sequencing 
primer 
AACGTTTGTTCCCGT 
 
 
Supplementary table T3: Physicochemical characteristic of Au NPs used in this study. 
 
Nanoparticle 
Average 
diameter  
(nm) [TEM]* 
H2O  
[DLS]** 
 2% serum  
[DLS]** 
 
 Average 
hydrodynamic 
diameter (nm) 
Zeta 
potential 
Average 
hydrodynamic 
diameter (nm) 
Zeta 
potential 
Au NP 5 nm 5 9.6 -3.99 121.6 -18.42 
Au NP 60 nm 60 69.3 -11.49 98.1 -0.54 
Au NP 250 nm 250 226.5 -21.17 225.8 -7.15 
*TEM: transmission electron microscopy, ** DLS: dynamic light scattering, Au NP: gold nanoparticle 
 
Supplementary table T4: Size distribution of CNTs used in this study. 
 
Nanoparticle Average diameter (nm)  Average length (μm)  
SWCNT* 0.8 10 
MWCNT** 9.5 105 
*SWCNT: single-walled carbon nanotubes, **MWCNT: multi-walled carbon nanotubes 
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Supplementary table T5: Effect on gene promoter methylation changes in mice lung DNA induced by 
exposure to gold nanoparticles (AuNPs) (table T5 a) and CNTs (table T5 b). P-values of Wilcoxon test 
statistics conducted on average methylation per gene and methylation per CpG within each gene are 
reported. Number of CpGs analysed are variable e.g., 10 CpGs were analysed in the promoter region of 
Atm gene while 6 CpGs were analysed in the promoter region of Cdk gene. Cells highlighted in red 
indicated the significant effects of exposure on gene promoter methylation, whereas cells highlighted in 
orange indicate the effect of exposure close to pre-set cut-off value of significance (borderline 
significant effect) (Wilcoxon test, p-value of 0.05 set to be significant).  
Table T5-a 
 
Gene 
name 
% promoter methylation per CpG analyzed Average 
methylatio
n  
 CpG#
1 
CpG#
2 
CpG#
3 
CpG#
4 
CpG#
5 
CpG#
6 
CpG#
7 
CpG#
8 
CpG#
9 
CpG#1
0 
Average 
Atm 0.3257 0.8046 0.8746 0.2089 0.803 0.6207 0.5829 0.848 0.7524 0.0047 0.3813 
Cdk 0.9899 0.2353 0.993 0.4541 0.2772 0.0128     0.1244 
Dnmt1 0.0541 0.9241 0.6743 0.0757 0.4352 0.5077     0.086 
Gad45
a 
0.623 0.1968 0.4785 0.1458 0.4374      0.7185 
Gpx 0.5123 0.6818 0.0524 0.5604 0.0906 0.6996 0.2329    0.2795 
Gsr 0.0074 0.5716 0.2056 0.0209 0.6202 0.0046 0.2957    0.0247 
Gss 0.491 0.8148 0.8558 0.3835 0.0543 0.0975     0.1156 
Myc 0.9589 0.0382 0.4463 0.594 0.8079      0.6047 
Nfkb2 0.9589 0.0382 0.4463 0.594 0.8079      0.6047 
Oxsr1 0.439 0.3600 0.1164 0.7459 0.6121 0.5029     0.671 
Trp53 0.0054 0.4646 0.9752 0.316 0.7373      0.195 
Trp73 0.5096 0.4696 0.8897 0.4248 0.4973 0.0687 0.4644    0.4962 
Pparg 0.1857 0.2319 0.3317        0.1494 
Tet1 0.1432 0.1899 0.6474 0.2344       0.4266 
Tet2 0.0515 0.2236 0.4958 0.2144       0.1474 
Tnf-a 0.9205 0.5134 0.563        0.9662 
Xrcc1 0.2505 0.6725 0.0201 0.0463       0.0428 
 
 
Table T5-b 
Gene 
name 
% promoter methylation per CpG analyzed Average 
methylation  
 CpG#1 CpG#2 CpG#3 CpG#4 CpG#5 CpG#6 CpG#7 CpG#8 CpG#9 CpG#10  
Atm 0.4138 0.0386 0.2837 0.2381 0.0591 0.1695 0.1116 0.0787 0.1521 0.2134 0.0341 
Cdk 0.4791 0.2092 0.9904 1.0000 0.9205 0.27073     0.8049 
Dnmt1 0.4913 0.4413 0.6225 0.1473 0.2981 0.554     0.123 
Gad45a 0.9297 0.1789 0.0233 0.0677 0.076      0.0208 
Gpx 0.9445 0.4656 0.2049 0.2537 0.6287 0.3983 0.1002    0.7854 
Gsr 0.8397 0.8851 0.2114 0.8429 0.9521 0.4091 0.6959    0.5762 
Gss 0.3545 0.0588 0.7796 0.5792 0.5271 0.9308     0.6912 
Myc 0.8819 0.6977 0.5416 0.3552 0.3511      0.5943 
Nfkb2 0.8819 0.6977 0.5416 0.3552 0.3511      0.5943 
Oxsr1 0.4995 0.3883 0.8502 0.6006 0.4781 0.3776     0.4406 
Trp53 0.4249 0.6457 0.3662 0.3851 0.177      0.506 
Trp73 0.9571 0.5316 0.7191 0.7224 0.8648 0.5531 0.4787    0.9518 
Pparg 0.5558 0.1755 0.8536        0.5589 
Tet1 0.1935 0.9631 0.283 0.87       0.7665 
Tet2 0.8484 0.1528 0.7587 0.5324       0.3193 
Tnf-a 0.7754 0.6052 0.4227        0.7282 
Xrcc1 0.8234 0.6512 0.4549 0.4296       0.664 
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Supplementary table T6: Effect on gene promoter methylation changes in mice blood DNA induced 
by exposure to gold nanoparticles (AuNPs) (table T6 a) and single and multi-walled carbon nanotubes 
(table T6 b). P-values of Wilcoxon test statistics conducted on average methylation per gene and 
methylation per CpG within each gene are reported. Number of CpGs analysed are variable e.g., 8 
CpGs were analysed in the promoter region of Atm gene while 4 CpGs were analysed in the promoter 
region of Cdk gene. Cells highlighted in red indicate the significant effects of exposure on gene 
promoter methylation, whereas cells highlighted in orange indicate the effect of exposure close to pre-
set cut-off value of significance (borderline significant effect) (Wilcoxon test, p-value of 0.05 set to be 
significant).  
DNA coordinates of CpGs analysed in each bisulfite-PCR pyrosequencing promoter assay were same 
between nanomaterial (AuNPs and CNTs) exposed lung and blood DNA samples (table T5 a-b and 
table T6 a-b). However, CpGs in blood DNA (table T6 a-b) that did not pass the quality control were 
discarded from the analysis (e.g., Atm: CpG#9, CpG#10 were discarded).  
 
Table T6-a 
Gene 
name 
% promoter methylation per CpG analyzed  Average 
methylation 
 CpG#1 CpG#2 CpG#3 CpG#4 CpG#5 CpG#6 CpG#7 CpG#8 Average 
Atm 0.5516 0.1097 0.2099 0.1476 0.4140 0.9800 0.2440 0.0518 0.0937 
Cdk 0.6546 0.8591 0.2216 0.7286     0.9245 
Dnmt1 0.6771 0.7706 0.4168 0.4367     0.0492 
Gad45a 0.5658 0.7372 0.1964 0.8110 0.2403 0.4333   0.1250 
Gpx 0.7089 0.3167 0.1554 0.4168     0.8460 
Gsr 0.0289 0.3296 0.9747 0.5951 0.6961    0.7558 
Gss 0.1712 0.6327 0.8110 0.8298 0.1849    0.5645 
Myc 0.5179 0.6050 0.0725 0.2900 0.0648    0.2296 
Nfkb2 0.7646 0.8653 0.7866 0.0284     0.4722 
Oxsr1 0.6496 0.0421 0.2984 0.0836 0.2387 0.2637 0.2219  0.1410 
Trp53 0.4593 0.5987 0.5980 0.1730 0.9058    0.9147 
Trp73 0.9528 0.4376 0.3356 0.6810 0.6781 0.2334   0.4677 
Pparg 0.2731 0.4694 0.0266      0.1774 
Tet1 0.1200 0.6402 0.2331      0.6766 
Tet2 0.6085 0.3630 0.7674 0.8278 0.0632 0.1547   0.4022 
Tnf-a 0.2409 0.5941 0.0618      0.3339 
Xrcc1 0.1310 0.7489 0.5490 0.4880     0.2913 
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Table T6-b 
 
Gene 
name 
% promoter methylation per CpG analyzed  Average 
methylation 
 CpG#1 CpG#2 CpG#3 CpG#4 CpG#5 CpG#6 CpG#7 CpG#8 Average 
Atm 0.5197 0.3225 0.7894 0.3572 0.2222 0.0735 0.3668 0.3698 0.3438 
Cdk 0.5753 0.8984 0.4204 0.0843     0.4719 
Dnmt1 0.3472 0.4760 0.3502 0.8024     0.3053 
Gad45a 0.4004 0.6074 0.6911 0.3233 0.8528 0.9192   0.6850 
Gpx 0.0314 0.2887 0.2532 0.3526     0.5776 
Gsr 0.6608 0.8585 0.8389 0.7721 0.2066    0.9513 
Gss 0.4128 0.5522 0.7695 0.9210 0.1153    0.5591 
Myc 0.2901 0.5256 0.5641 0.7266 0.7149    0.4488 
Nfkb2 0.1004 0.7606 0.7383 0.5800     0.7004 
Oxsr1 0.1943 0.2633 0.5936 0.3783 0.7116 0.1427 0.1254  0.1136 
Trp53 0.8158 0.2784 0.7899 0.3486 0.7920    0.3903 
Trp73 0.8472 0.1694 0.1500 0.9733 0.7635 0.9052   0.5599 
Pparg 0.3358 0.5994 0.5078      0.9370 
Tet1 0.5861 0.6663 0.1443      0.9303 
Tet2 0.2455 0.3804 0.9849 0.1545 0.5037 0.5114   0.4169 
Tnf-a 0.5134 0.5823 0.8623      0.5642 
Xrcc1 0.5945 6242.0000 6545.0000 0.6420     0.8234 
 
 
 
Supplementary figure F1: Dynamic light scattering (DLS) size distribution of AuNPs 5nm (a), 
AuNPs 60nm (b) and AuNPs 250nm (c) in H2O (blue curve) and in 2 % serum (red curve). Au: gold. 
 
 
 
 
 
 
 
 
 
 
a) b) c) 
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Supplementary figure F2: Cytokine levels were measured using flow cytometry. For the selected 
cytokines, we did not observe significant difference (KC: p-value=0.663; IL1: p-vaue=0.66; IL4: p-
value=0.66; IL5: p-value=0.663; IL6: p-value=0.663; IL17: p-value=0.661) between AuNPs and CNTs 
exposed and control groups. Data represented as mean ±SD. Significant level was set at 0.05. 
 
 
 
 
 
 
Supplementary figure F3: Oxidative stress in mice lung samples in response to AuNPs and CNTs 
exposure. GSSG/GSH (Wilcoxon test; p=0.173) ratio was measured in mice lung samples in order to 
quantify the levels of oxidative stress. GSSG: oxidized form of glutathione disulfide; GSH: reduced 
glutathione. In the panel, box plot describes the median (line across the box), inter-quartile range and 
maximum and minimum values (whiskers). Outliers are shown as colored circles (panel a) outside the 
ends of whiskers. 
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Supplementary figure F4: DNA damage profile of AuNPs and CNTs in exposed and control mice. 
DNA damage was assessed by comet assay. Comet tail is a marker of DNA damage, that was not 
significant (Wilcoxon test; p=0.486) between exposed and control samples. In figure, box plot 
describes the median (line across the box), inter-quartile range and maximum and minimum values 
(whiskers). Outliers are shown as colored circles outside the ends of whiskers. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
112 
 
 
 
 
 
 
6. Chapter 6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
113 
Adopted from:  
Global methylation and hydroxymethylation in DNA from blood and 
saliva in healthy volunteers 
 
Lode Godderis
1,2
 , Caroline Schouteden
1
, Ali Tabish
1
, Katrien Poels
1
, Peter 
Hoet
1
, Andrea A. Baccarelli
3
, Kirsten Van Landuyt
4
 
 
1
KU Leuven, Department of Public Health and Primary Care, Centre Environment & 
Health, B-3000 Leuven, Belgium; 
2
Idewe, External Service for Prevention and 
Protection at Work, B-3001 Heverlee, Belgium; 
3
Department of Environmental 
Health, Landmark Center, Suite 415 West, P.O. Box 15677, 401 Park Dr, Boston, MA 
02215, USA; 
4
KU Leuven BIOMAT, Department of Oral Health Sciences, B-3000 
Leuven, Belgium. 
 
Contact information: Lode Godderis, Department of Public Health and Primary Care, 
Centre Environment & Health, Kapucijnenvoer 35/5, B-3000 Leuven, Belgium; 
lode.godderis@med.kuleuven.be 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
114 
Abstract 
 
Aims: We describe a liquid chromatography-tandem mass spectrometry (LC-MS/MS) 
method to quantify and compare simultaneously global methylation and 
hydroxymethylation in human DNA of different tissues. Materials and Methods: 
Blood and saliva DNA from fourteen volunteers was processed for epigenetic 
endpoints using LC-MS/MS and PCR-pyrosequencing technology. Results: Global 
DNA methylation was significantly lower in saliva (mean 4.61%+/-0.80%), compared 
to blood samples (5.70%+/-0.22%). In contrast, saliva (0.036%+/-0.011%) revealed 
significantly higher hydroxymethylation compared to blood samples (mean 
0.027%+/-0.004%). Whereas we did not find significant correlations for both 
epigenetic measures between the tissues, a significant association was observed 
between global methylation and global hydroxymethylation in saliva DNA. Neither 
LINE-1 nor Alu elements of blood and saliva correlated, nor were they correlated 
with the DNA hydroxymethylation of blood or saliva respectively. Conclusion: 
Global DNA methylation and hydroxymethylation of cytosine can be quantified 
simultaneously by LC-MS/MS. Saliva-DNA cannot be considered as a surrogate for 
blood-DNA to study epigenetic endpoints.  
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6.1. Introduction 
 
Epigenetics refers to the study of changes in gene function that are mitotically and/or 
meiotically heritable and that do not entail a change in DNA sequence (Wu and 
Morris, 2001). Epigenetic mechanisms are essential for development (genome 
imprinting, X chromosome inactivation, etc.) and differentiation (transcriptional 
regulation), but can be disrupted by exogenous agents (Bird, 2007). Epigenetic 
changes have been described in relation to environmental exposure similar to changes 
observed in chronic diseases, such as cancer or Alzheimer disease. The most 
investigated epigenetic mechanisms include DNA methylation, histone modifications 
and RNA-mediated silencing (Jaenisch and Bird, 2003, Feinberg et al., 2006). 
 
DNA cytosine methylation (5mC) is chemically relatively stable, but still, dynamic 
epigenetic modifications regulated by DNA methyltransferases (DNMTs) often occur. 
These alterations involve the covalent addition of a methyl group to the 5-position of 
cytosine with S-adenosyl methionine (SAM) as the methyl donor (Webster et al., 
2013, Barros and Offenbacher, 2009).
 
DNA methylation is almost exclusively 
restricted to CpG dinucleotides clustered within the gene promoter and in repeated 
elements such as long (LINE-1) and short (Alu) interspersed elements (Webster et al., 
2013, Kile et al., 2010). Paradoxically, 90% of the methylated CpG lies outside the 
coding regions such as CpA, CpT, and CpNpG sites, possibly to serve as repressors of 
transposons or viral-like transcripts (Baccarelli and Ghosh, 2012). In general, 
hypermethylation of the DNA promoter regions inactivates the gene expression and 
hypomethylation activates the expression (Klein and Costa, 1997). Aberrant 5mC 
levels, i.e., global hypomethylation and/or gene-specific hypermethylation or 
hypomethylation, are observed in diseases like leukemia and cancer, but have also 
been observed in cells exposed to carcinogenic agents (Baccarelli and Bollati, 2009, 
Godderis et al., 2012, Bollati et al., 2007). 
 
Besides 5mC, other epigenetic modifications such as 5-hydroxymethylcytosine 
(5hmC), have been recently discovered in this rapidly evolving field. Significant 
levels of 5hmC have been found in DNA from embryonic stem cells, neurons and 
brain (Shock et al., 2011). Even though the biological function is not yet completely 
clarified, 5hmC is of special interest in order to understand the regulation of gene 
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expression and chromatin structure since it acts as an oxidized intermediate in the 
active demethylation of 5mC or even may be the final product of genome-wide 
demethylation (Shock et al., 2011, Wang et al., 2012). 
 
The conversion of 5mC to 5hmC is catalysed by ten eleven translocation (TET) 
family of proteins (TET1, TET2 and TET3) which are 2-oxoglutarate (2OG)- and 
Fe(II)-dependent dioxygenases. TET1 and TET2 are involved in the maintenance of 
embryonic stem cells pluripotency and cell lineage commitment. TET1 is a fusion 
partner of the MLL gene in rare cases of acute myeloid and lymphoid leukemias. 
TET2 modulates the balance between self-renewal and differentiation in 
hematopoietic stem cells, making them critical for normal myelopoiesis. Loss-of-
function of TET2 is associated with acute myeloid leukemia, myelodysplastic and 
myeloproliferative disorders. TET3 contributes to the global DNA demethylation 
during the zygotic stage of embryonic development (Wang et al., 2012). These studies 
highlight the role of TET-mediated 5-hmC in the developmental processes, and the 
possibility that altered DNA 5hmC levels can lead to malignancy (Webster et al., 
2013, Wang et al., 2012). 
 
Beside the TET pathway, 5hmC can also be formed by other mechanisms, e.g. UV 
irradiation of 5mC in aerated aqueous solution and DNA methyltransferase reaction 
of cytosine with formaldehyde. The process of active DNA demethylation via 5hmC 
also seems to be mediated by activation-induced deaminase and DNA glycosylase, 
which are involved in deaminating and excision repair (Webster et al., 2013). This 
indicates that environmental factors might modify the DNA methylation and 
hydroxymethylation status, and that assays are needed to measure both total DNA 
methylation and hydroxymethylation (Lewandowska and Bartoszek, 2011).  
 
In-vivo studies on the epigenetic effects of environmental carcinogens are scarce, and 
have mainly been performed on human lymphocytes (Bollati et al., 2007, Godderis et 
al., 2012). Blood samples are often the preferred source of genetic material because 
they provide large amounts of cells and in the same sample a wide range of 
environmental agents can be determined (Hansen et al., 2007). The desire for large-
scale epidemiological studies involving thousands of participants necessitates less 
invasive and more cost-efficient procedures for collecting DNA that would facilitate 
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the trial recruitment (Rogers et al., 2007). Saliva and buccal swab samples are 
described as a non-invasive alternative to collect human DNA for epigenetic 
epidemiological studies (Philibert et al., 2008, Sapienza et al., 2011). Previous 
research showed that sufficient amounts of high-quality DNA could be collected from 
saliva (Quinque et al., 2006). The potential advantages of saliva sample collection 
compared with blood sample collection include lower overall cost, lower infection 
risk, increased patient convenience, acceptability and compliance (Abraham et al., 
2012). However, a potential drawback is the presence of exogenous DNA (e.g. from 
bacteria) commonly present in human saliva and buccal swab samples (Herraez and 
Stoneking, 2008). 
 
In this paper we report on the application of a fast and sensitive liquid 
chromatography-tandem mass spectrometry (LC-MS/MS) method for the 
simultaneous quantification of 5mC and 5hmC in human DNA from different tissues. 
We investigated the association between both epigenetic marks and compared the 
results with LINE-1 and Alu methylation, often used as surrogates for global DNA 
methylation in monitoring studies, determined with PCR-pyrosequencing. In addition, 
we also investigated for the first time whether these epigenetic endpoints in DNA of 
saliva are comparable with DNA from blood of human volunteers in order to serve as 
a non-invasive alternative for biomonitoring purposes.  
 
6.2. Material and methods 
6.2.1. Study design and Population  
 
 
Fourteen healthy volunteers (n=4 male, n=10 female) aged less than 45 years were 
enrolled in this study. Most of the volunteers (n=12) were Caucasian. The participants 
were recruited among the scientific staff of the department of Oral Health Sciences 
and the department of Public Health and Primary Care and among KU Leuven 
pregraduate medical students. All participants received information about the purpose 
and objectives of the study and gave written informed consent to the proposed 
processing of the data. Participants were asked to fill out a small questionnaire on 
general health and lifestyle. The study was approved by the Commission for Medical 
Ethics of UZ Leuven (reference number: S53445). 
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6.2.2. Sample Collection 
 
Donors were refrained from eating and drinking for at least 8 hours prior to sample 
collection and were asked to rinse their mouth prior to sample taking. Subjects were 
asked to produce 2 mL unstimulated saliva using the self-collection kit OG-500 from 
Oragene (DNA GenoTek, Ottawa, OT, Canada). Next, blood was drawn from each 
participant (three EDTA tubes of 4,5 mL).  
 
6.2.3. DNA extraction 
 
DNA extraction was performed with GeneCatcher™ gDNA Blood Kit for blood 
samples and Oragene OG-500 kit (DNA GenoTek) for saliva samples. The quantity 
and purity of DNA was determined by a NanoDrop spectrophotometer. 
 
6.2.4. DNA methylation and DNA hydroxymethylation analysis 
 
DNA was analyzed by LC-MS/MS as described previously (Song et al., 2005). 
Briefly, isolated genomic DNA samples (1 µg) were enzymatically hydrolyzed to 
individual deoxyribonucleosides by a simple one-step DNA hydrolysis procedure. A 
digest mix was prepared by adding phosphodiesterase I, alkaline phosphatase and 
benzonase
®
 Nuclease to Tris-HCl buffer. Extracted DNA was hydrolyzed by adding 
50 µl digest mix and incubating at 37°C for at least 8 h. After hydrolysis, 900 µL of 
HPLC-grade water was added to each sample. Exposure to daylight was avoided over 
the entire sample preparation procedure in order to minimize potential deamination of 
the target compounds. 
 
Stock solutions of 5-methyl-2’-deoxycytidine (5mdC), 5-hydroxymethyl-2’-
deoxycytidine (5hmdC) and 2’-deoxycytidine (dC) were prepared by dissolving 
commercial solid reference standards in HPLC-grade water. Stock solutions were 
used to prepare calibration standards. Global DNA methylation and 
hydroxymethylation was obtained by quantifying 5mdC, 5hmdC and dC using ultra-
pressure liquid chromatography (UPLC), in combination with tandem mass 
spectrometry (MS-MS). LC/MS-MS analysis of the samples was conducted on a 
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Waters
®
 Acquity UPLC
TM
, coupled to a Waters
®
 Micromass Quattro Premier
TM
 Mass 
Spectrometer using electro spray ionization (ESI). A 15 µL aliquot of the sample was 
introduced on an Acquity UPLC BEH C18, 50 mm x 2.1 mm, 1.7 µm column, held at 
a temperature of 40°C. The mobile phase used for the chromatographic separation 
was a mixture of 0.1 % formic acid in water (A) and 0.1 % formic acid in acetonitrile 
(B) using the following gradient: the program was starting at 10%B, increasing linearly 
to 100%B for 2 min, then hold from 2 to 2.1 min at 100%B and finally brought back to the 
initial status from 2.1 to 3.0 min. A flow rate of 0,35 mL/min was applied. The analyses 
were performed in the positive ESI mode and a multiple reaction monitoring (MRM) 
method was used with argon as the collision gas.  
 
All DNA samples isolated from blood and saliva were hydrolysed in triplicate. Each 
sample was then analysed twice using the LC-MS/MS method. By interpolation from 
the established calibration curves, the absolute concentrations, expressed in ng/mL, 
for 5mdC, dC and 5hmdC, present in the samples (1 µg DNA / mL), could be derived. 
Together with every set of 14 volunteer DNA samples, also 3 quality control (QC) 
DNA samples have been prepared and analysed, in order to uncover any potential 
errors upon sample preparation and analysis. Global DNA methylation is expressed as 
a percentage of 5mdC versus the sum of 5mdC, 5hmdC and dC [%Methylation = 
5mdC / (5mdC + 5hmdC+ dC)], while global DNA hydroxymethylation is expressed 
as a percentage of 5hmdC versus the sum of 5mdC, 5hmdC and dC 
[%Hydroxymethylation = 5hmdC / (5mdC + 5hmdC + dC)].  
 
6.2.5. Pyrosequencing of LINE-1 and Alu elements 
 
Long interspersed nucleotide elements (LINE-1) and the AluSX (Alu) methylation 
levels were assessed using PCR-pyrosequencing of bisulfite-treated DNA. Details of 
the PCR-pyrosequencing assays used in the current study are described by Kile. M, 
2010 (Kile et al., 2010). 
6.3. Statistical analysis 
 
Differences between groups were analysed by Mann Whitney U test for unrelated 
data and Wilcoxon signed rank test for related data. Within tissue and between tissue 
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DNA association of methylation and hydroxymethylation levels was investigated by 
spearman correlation.  
 
6.4. Results 
6.4.1. Characteristics of participants and method 
 
A total of 14 healthy subjects (4 male, 10 females) enrolled in the study. Mean age 
was 29 years (range 22-43) and BMI ranged between 20 and 29 (mean 24). 6 subjects 
reported a history of allergy of dust mites, hay fever, asthma, eczema, penicillin or 
nickel allergy.  
 
The OrageneTM saliva collection kit yielded sufficient DNA out of 2 mL saliva for 
all participants with a mean yield of 20.1 µg DNA (range 6.8-135.4 µg DNA). To 
perform LC-MS analysis, a minimum concentration of 20 ng DNA/µL is required. 
We extracted on average 42.4 µg DNA (range 1.8-97.4 µg) out of 4.5 mL blood. The 
minimum 260/280 ratio was > 1.6 for DNA of both tissues. 
 
In order to perform the DNA (hydroxy)methylation analysis of the samples, a 
calibration series in HPLC-grade water was prepared for 5mdC, dC and 5hmdC and 
run by the analytical method. Calibration standards were prepared, starting from 
purchased reference standards, in a range of respectively 0.01 – 5 ng/mL for 5mdC, 
0.2 – 50 ng/mL for dC and 0.005 – 0.07 ng/mL for 5hmdC. The same calibration 
standards were used in all experiments. Upon LC/MS-MS analysis, independent 
quantification of 5mdC, dC and 5hmdC was possible since different, unique 
transitions from precursor ion to product ion were monitored in MRM mode : m/z 
242.2 → 125.95 for 5mdC (cone voltage 20 V, collision energy 14 eV), m/z 228.1 → 
111.9 for dC (cone voltage 18 V, collision energy 12 eV) and m/z 258.0 → 141.9 for 
5hmdC (cone voltage 15 V, collision energy 10 eV) . The dwell time per transition 
was 90 ms. Calibrations solutions were analysed in MRM mode and data processing 
was based on absolute peak areas of the different unique product ions. In Figure 1, the 
UPLC chromatograms are shown for dC, 5mdC and 5hmdC, for a volunteer’s blood 
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and saliva sample, as well as for a calibration standard. For the three different 
compounds, calibration curves were constructed, as presented in Figure 2.  
 
 
 
Figure 1: UPLC-chromatograms of the monitored ion transitions for 2’-deoxycytidine (dC), 5-methyl-
2’-deoxycytidine (5mdC), and 5-hydroxymethyl-2´-deoxycytidine (5hmdC):  
A) blood sample from a volunteer, B) saliva sample from the same volunteer and C) calibration 
standard, containing dC (30.7 ng/mL), 5mdC (1.5 ng/mL) and 5hmdC (0.07 ng/mL). 
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Figure 2: Calibration curves for A) 2’-deoxycytidine (dC), B) 5-methyl-2’-deoxycytidine (5mdC), and 
C) 5-hydroxymethyl-2´-deoxycytidine (5hmdC). 
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DNA, the method’s limits of detection (LODs) for 5 mdC, dC and 5hmdC were 
respectively 0.01 ng/mL, 0.01 ng/mL and 0.005 ng/mL. As a sample aliquot of 15 µL 
is injected, these LODs correspond to amounts of 0.62 fmol 5mdC, 0.66 fmol dC and 
0.29 fmol 5hmdC injected on-column. These LODs are comparable to previously 
LC/MS-MS sensitivity data, reported by Thuc et al. (2011) (0.5 fmol for 5mdC and 
5hmdC) (Thuc et al., 2011).  
 
6.4.2. Results of %methylation and %hydroxymethylation 
 
In table 1 the results of % DNA methylation and % DNA hydroxymethylation are 
presented. The mean value of global DNA methylation was significantly (p=0.001) 
lower in saliva samples (mean 4.61%), compared to blood samples (mean 5.70%). 
This is in contrast with global hydroxymethylation, which was significantly higher 
(p=0.001) in saliva samples (mean 0.036%), compared to blood samples (mean 
0.027%). 
 
We did not observe significant differences in global DNA methylation and 
hydroxymethylation levels between males and females. In contrast, 6 individuals with 
allergy (0.029% +/- 0.002%, 0.027% - 0.032%) showed a small but significant 
increase (p=0.042) in %hydroxymethylation in DNA from blood compared to 8 non-
allergic participants (0.025% +/- 0.004%; 0.021% - 0.031%). Neither age, nor BMI 
seemed to influence the epigenetic endpoints, however only subjects under 45 were 
allowed to participate. 
 
Table 1: %methylation and %hydroxymethylation in blood and saliva  
 Mean Standard  
deviation 
Minimum Maximum 
Saliva DNA % hydroxymethylation  0.036 0.011 0.019 0.053 
Blood DNA % hydroxymethylation 0.027 0.004 0.021 0.032 
Saliva DNA % methylation 4.61 0.80 2.36 5.75 
Blood DNA % methylation 5.70 0.22 5.25 6.12 
 
Next, we compared %DNA methylation in blood and saliva; and %DNA 
hydroxymethylation in blood and saliva. No significant association could be observed 
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(spearman rho=0.141, p=0.631 and -0.021, p=0.943) for both epigenetic endpoints 
between the two tissues.  
 
We also performed the correlation between %DNA methylation and % DNA 
hydroxymethylation in the same tissue. A significant association was found between 
% methylation and %hydroxymethylation in saliva DNA (spearman rho=0.716; 
p=0.004) (Figure 3A). In blood, no such significant correlations could be revealed 
(spearman rho=0.056; p=0.850) (Figure 3B). 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Association between % DNA methylation and % DNA hydroxymethylation in A) saliva 
samples and B) blood samples. 
 
Figure 3: Correlation between %DNA methylation and % DNA hydroxymethylation in the same tissue 
 
6.4.3. LINE1 and Alu methylation  
 
It is suggested that analyzing the methylation of DNA repetitive elements can serve as 
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methylation levels of LINE-1 and Alu elements of blood and saliva DNA 
(supplementary table1). No significant correlation was observed between the 
methylation levels of blood and saliva Alu elements (spearman rho=0.297, p=0.303). 
Methylation levels of blood and saliva LINE1 elements were also not significantly 
correlated (spearman rho=-0.196, p=0.503). Although in general lower methylation 
levels were observed for LINE1 and Alu elements in saliva DNA compared to their 
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methylation levels in blood DNA (supplementary table 1). Also, no significant 
correlations were observed in the methylation levels of Alu (spearman rho=-0.117, 
p=0.690) and LINE elements (spearman rho=0.155, p=0.598) of saliva with the DNA 
hydroxymethylation in saliva, and in the methylation levels of Alu (spearman 
rho=0.139, p= 0.635) and LINE1 elements (spearman rho=0.099, p=0.737) of blood 
with the DNA hydroxymethylation level of blood. 
 
6.5. Discussion 
 
We described the method for simultaneous quantification of global DNA methylation 
and hydroxymethylation by LC-MS/MS with a high sensitivity and accuracy. The 
DNA methylation pattern is in line with a previously published study (Thompson et 
al., 2013). By applying the calibrated assay we showed that 5hmC is present in DNA 
of different human tissues. Little is known about the global 5hmC levels in different 
species. We report lower global 5hmC contents compared to the other studies 
reporting global DNA 5hmC contents in different non-human tissues. Different 
detection and expression methods for 5hmC used in small number of studies 
investigating the global DNA 5hmC contents make it difficult to compare them with 
our findings of global DNA 5hmC levels in blood and saliva. 
 
Global DNA methylation levels in males and females were comparable, which is in 
line with published data (Weber et al., 2005). Gender also does not seem to affect 
global hydroxymethylation levels in DNA from blood or saliva. Since we limited the 
age at participation, we cannot draw conclusion on the absence of an age-effect on 
global DNA hydroxymethylation. The effect of age on global DNA methylation has 
been widely discussed (Zhu et al., 2012). Several studies based on relatively small 
study samples (between 76 and 237 subjects) reported an inverse association between 
age and genomic 5mC content from blood of healthy subjects (Zhu et al., 2012). In 
contrast, other studies of similar size or larger (between 32 and 526 samples) reported 
no association of age with genomic 5mC content (Moore et al., 2008). 
 
One of the objectives was to determine whether saliva could be a reliable source of 
DNA and serve as a non-invasive alternative of blood DNA in biomonitoring studies. 
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Sufficient good quality DNA could be extracted from saliva and both quality and 
quantity were in line with previously published data (Hansen et al., 2007, Rylander-
Rudqvist et al., 2006, Rogers et al., 2007). We did not observe any association 
between the two tissues for both epigenetic endpoints (global DNA methylation and 
DNA hydroxymethylation), and also no correlation was observed between the LINE1 
and Alu elements of both tissues. On one hand, this could be due to the lack of power 
due to the small sample size or due to differences DNA extraction methods 
(Rylander-Rudqvist et al., 2006).  
 
On the other hand, it is known that saliva samples are contaminated with DNA from 
oral bacteria and/or food, which can overestimate the amount of DNA in these 
samples (Hansen et al., 2007, Rogers et al., 2007, Abraham et al., 2012). In our study, 
participants were refrained from eating and drinking 8 hours prior to the sample 
collection and mouth was rinsed prior to sampling. In addition, the Oragene sample 
kit contains an antibacterial agent, which also prevents the growth of bacteria between 
the time of collection and the time of DNA purification. Immediately after collection, 
the samples were stored at -80°C to avoid bacterial growth. Previous studies have 
shown that buccal swabs contain around 11% human DNA, whereas saliva samples 
yield on average 68% human DNA (Garcia-Closas et al., 2001, Rylander-Rudqvist et 
al., 2006). 
 
Both blood and saliva contain a variety of cell types, with different function and half-
life, and presumably different susceptibility to external factors. DNA extracted from 
blood samples typically originates from leucocytes (granulocytes, lymphocytes and 
monocytes), whereas human DNA from buccal swabs mainly stems from exfoliated 
epithelial cells. Human DNA from saliva on the other hand is derived both from 
leucocytes (granulocytes, lymphocytes and monocytes) and exfoliated epithelial cells 
(Vidovic et al., 2012). Blood, saliva and buccal swabs not only differ in types of the 
cells they contain, but also in the viability of the cells. DNA from blood mostly stems 
from viable cells, whereas many cells in buccal swabs are dead (exfoliated cells). 
These differences might explain the differences in methylation pattern between the 
different tissues. 
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Our results indicated positive association for global DNA methylation and 
hydroxymethylation within the same tissue; i.e. saliva. Interestingly, the direction of 
difference between global DNA methylation and hydroxymethylation levels in saliva 
and blood is opposite to each other; i.e. low global DNA methylation and high global 
DNA hydroxymethylation in saliva compared to blood. This supports the hypothesis 
that 5hmC is involved as an intermediate in the active demethylation of 5mC. No 
association in methylation levels of blood and saliva LINE1 and Alu elements was 
observed with the DNA hydroxymethylation levels in blood and saliva DNA 
respectively. Since LINE1 and Alu elements methylation does not represent the 
complete cellular pool of global DNA methylation, this might explain the lack of this 
association along with other factors e.g., small sample size. DNA methylation and 
hydroxymethylation are tightly regulated in live cells. Saliva comprises mainly dead 
cells, which can explain the low levels of global DNA methylation but high levels of 
global DNA hydroxymethylation (i.e., dead cells lose control in methylating the 
repetitive elements which would increase the global DNA hydroxymethylation) as 
compared to the blood, which contains the live cells tightly regulating their genome. 
The mechanisms explaining how this process is controlled and mediated in different 
cell types is still unclear (Severin et al., 2013). 
 
Conclusion 
 
In conclusion: both global DNA methylation and hydroxymethylation of cytosine can 
be quantified simultaneously by LC/MS-MS. Global DNA methylation and 
hydroxymethylation in saliva and blood DNA do not seem to be comparable and 
consequently saliva cannot be considered as a surrogate for blood for epigenetic 
endpoints. There are indications of a positive association between global DNA 
methylation and hydroxymethylation within the same tissue; i.e. saliva. 
 
Future perspectives 
 
Epigenomics is an active research field driven by the massive amount of new 
information. New cellular pathways are emerging as knowledge of epigenomics is 
growing. Recently, the identification and tissue-specific distribution of DNA 
hydroxymethylation lead to speculation that DNA hydroxymethylation is not just a 
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passive mark but could play an important cellular function. Further research in tissue-
specific correlation of different epigenetic factors will help understanding how 
epigenetic factors play a role in regulating the activity of genes. 
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Executive Summary 
 
Introduction 
 Saliva samples are described as a non-invasive option to collect human DNA 
for epigenetic epidemiological studies.  
 We describe a sensitive liquid chromatography-tandem mass spectrometry 
(LC-MS/MS) method for the simultaneous quantification of global DNA 
methylation and global DNA hydroxymethylation at cytosine in blood and 
saliva. 
 
Population & Methods 
 Blood and saliva DNA from fourteen healthy volunteers was processed for 
epigenetic measures. 
Results 
 Global DNA methylation at cytosine was significantly lower in saliva samples 
compared to blood samples. 
 Saliva samples revealed higher global hydroxymethylation compared to blood 
samples.  
 Saliva DNA showed significant association between global methylation and 
global hydroxymethylation. 
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Discussion & Conclusion 
 Sensitive quantification of global DNA methylation and global DNA 
hydroxymethylation can be performed from the same samples using LC-
MS/MS method. 
 Saliva DNA cannot be considered as a surrogate for blood-DNA to study 
epigenetic endpoints. 
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Abstract 
 
Transposable elements (TE) comprise half of the human genome. LINE-1 and Alu are 
the most common TE, and they have been used to assess changes in the DNA 
methylation of repetitive elements in response to intrinsic and extrinsic cellular 
events. Pyrosequencing is a real-time sequencing technology that enables quantitative 
assessment of TE methylation at single-base resolution. In pyrosequencing, a region 
of interest is first amplified from bisulfite-converted DNA by polymerase chain 
reaction (PCR), before PCR amplicons are rendered single stranded and annealed 
with the pyrosequencing primer prior to sequencing. In this chapter, we will provide 
an overview of the analysis of repetitive element DNA methylation by bisulfite 
pyrosequencing, and we will describe such a protocol that is routinely used in our 
laboratory. 
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7.1. Introduction 
 
Transposable elements (TEs) comprise approximately half of the human genome 
(Lander, Linton et al. 2001). Among TEs, the long interspersed elements (LINEs) and 
short interspersed elements (SINEs) are most common and well-studied. The most 
common SINEs in mammals are the Alu elements. LINE-1 and Alu methylation can 
be altered in response to stress, infection, diseases (Byun, Motta et al. 2013), and they 
are linked with the genomic instability that is implicated in genetic disorders such as 
gastrointestinal stromal tumors, myeloma, ependymomas and lung cancer (Su, Shao et 
al. 2012). The methylation of these elements reduces genomic instability by 
controlling LINE-1 and Alu induced retrotransposition. Different classes of TEs, such 
as retrotransposons and DNA transposons, display different susceptibility to changes 
in DNA methylation in response to environmental exposures or disease (Choi, 
Worswick et al. 2009, Guo, Byun et al. 2014). Furthermore, different subfamilies of 
LINE-1 and Alu elements, generated through mutations over the evolutionary history 
of the elements, show differential sensitivity to exposome (Byun, Motta et al. 2013). 
 
Bisulfite pyrosequencing is a technique based upon the “sequencing by synthesis” 
approach. It provides quantitative and highly reproducible methylation data at single-
base resolution, and it requires relatively low quantities of DNA (Florea 2013). 
Pyrosequencing assays for the analysis of TE (LINE or Alu) DNA methylation 
interrogate several thousand copies of elements across the genome, as opposed to one 
unique locus. CpG sites are particularly enriched at TEs, accounting for >65% of 
those found throughout the human genome (Lai, Chen et al. 2014), and therefore the 
methylation of these elements has been suggested as an indicator of global DNA 
methylation (Yang, Estecio et al. 2004, Baccarelli, Wright et al. 2010, Zhu, Hou et al. 
2012). However, several investigations have reported poor correlations in normal 
tissues between the DNA methylation of TEs and global genomic DNA methylation, 
as determined by the ‘gold standard’ of high performance liquid chromatography 
(HPLC) (Wagner and Capesius 1981, Feinberg and Vogelstein 1983). Nonetheless, 
LINE-1 and Alu methylation can serve as a robust surrogate marker of global DNA 
methylation for some purposes, such as in cancer cells, where profound TE 
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demethylation contributes to a global loss of nuclear DNA methylation (Baba, 
Huttenhower et al. 2010, Lisanti, Omar et al. 2013).  
Here, we describe a protocol routinely used in our lab for the analysis of DNA 
methylation of TE.  
 
7.2. Materials 
 
 Human genomic DNA: up to 1.0 µg of DNA is required.  
 Bisulfite-converted DNA: this should be prepared using 0.5 - 1.0 µg of 
isolated genomic DNA in conjunction with a commercially available bisulfite 
conversion kit. The eluted bisulfite-converted DNA (20 - 40 μl) can be 
aliquoted and stored at −80 °C until required for use.  
 LINE-1 PCR primer sets (100 μM): for the PCR-based amplification of LINE-
1 subfamilies from bisulfite-converted DNA and the performance of bisulfite 
pyrosequencing (See Note 1 and Table 1). 
 Pyrosequencer and Vacuum Workstation: e.g. PyroMark Q96 MD system 
(QIAGEN, Valencia, CA).  
 PyroMark Gold Q96 Reagents: enzymes, substrate and nucleotides required to 
perform the pyrosequencing reaction (QIAGEN, Valencia, CA). 
 PyroMark Binding Buffer, Annealing Buffer, Denaturation Solution and Wash 
buffer (QIAGEN, Valencia, CA). 
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Table 1: Bisulfite pyrosequencing assays for LINE-1 subfamilies.  
LINE-1 
subfamilie
s 
Forward 
primer 
Reverse 
biotinylated 
primer 
Sequencing 
primer 
Sequence to 
analyze 
Annealin
g 
temperat
ure (
o
C) 
L1
P
A5 
TTAGTTAA
GGGAAGA
GGGGATA
AA 
ATAAACAT
AAAACCCT
CTAAACCA
AACA 
TTAGTTA
AGGAAG
A 
GGGGATAAA
C/TGGTATTT
GGAAAATC 
40 
L1
P
A2 
TTAGATAG
TGGGYGT
AGGTTAGT
GGGT 
CCTCCRAA
CCAAATAT
AAAATAT
AATCT 
GAGTTAA
AGAAAGG
G 
GTGAC/TGG
AC/TGTATTT
GGAAAATC/
TGGGTTATT
TTTATT 
55 
L
1
H
s 
TTTTGAGT
TAGGTGT
GGGATAT
A 
AAAATCA
AAAAATTC
C CTTTC 
AGTTAG
GTGTGG
ATATAG
T 
TTC/TGTGG
TGC/TGTC/T
GTTTTTTAA
GTC/TGGTT
TGAAAAGC/
TGTA 
56.3 
L1Ta 
GGGTTAG
GGAGTTTT
TTTTT 
CTCTAAAC
CAAATATA 
AAATATA 
GGGTTAG
GGAGTTT
TT TTTT 
C/TGAGTTA
AAGAAAGG
GGTGAC/TG
GAC/TGTATT
TGGAAAATC
/TGGGTTATT
TTTAT 
55 
 
 
7.3. Method 
7.3.1. PCR amplification of bisulfite-converted DNA 
 
PCR amplification can be performed using 10 - 20 ng of bisulfite-converted DNA, 
and the following thermocycling conditions: 15 minutes at 95 °C; 45 cycles of (94 °C 
for 30 seconds; annealing temperature (Table 1) for 30 seconds; 72 °C for 30 
seconds); 72 °C for 5 minutes. The specificity and yield of PCR products should be 
checked for each reaction by visualization on an agarose gel. 
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7.3.2. Bisulfite pyrosequencing 
7.3.2.1. Sample preparation 
 
 Prepare the PyroMark Binding Buffer mixture as follows; PyroMark Binding 
Buffer: 38 μl, streptavidin-sepharose beads: 2μl, dH2O: 30 μl. 
 Dispense 70 μl of Binding Buffer mixture into each well of a 96-well plate 
and add 10 μl of PCR product. 
 After sealing the plate with an adhesive cover, incubate the plate for 10 
minutes with vigorous shaking. 
 Prepare the Annealing Buffer mixture as follows; PyroMark annealing buffer: 
11.64 μl, sequencing primer: 0.36 μl. 
 Dispense 12 μl of Annealing Buffer mixture into a PyroMark Q96 HS Plate 
(QIAGEN, Valencia, CA).  
7.3.2.2. Strand separation  
 
 Fill the Vacuum Workstation with the corresponding buffers (~180 ml of 70 
% ethanol, Denaturation Solution, Wash Buffer, and Milli-Q grade water). 
 Apply vacuum to the vacuum prep tool. 
 Prime the probes of the vacuum prep tool by immersion in the Milli-Q water 
for approximately 20 seconds. 
 Capture the beads containing the immobilized PCR templates on the filter-
probes by slowly lowering the vacuum prep tool in to the 96-well PCR plate 
from Step #3. 
 Place the vacuum prep tool into 70 % ethanol and let the solution flush 
through the filters for 5 seconds. 
 Place the vacuum prep tool into the Denaturation Solution and flush it through 
the filters for 5 seconds. 
 Place the vacuum prep tool into the Wash Buffer and flush it through the 
filters for 5 seconds. 
 Switch off the vacuum using the switch on the vacuum prep tool handle and 
completely remove it from the vacuum station. 
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 Release the beads in a PyroMark Q96 HS Plate filled with the annealing buffer 
mixture by gently shaking the vacuum prep tool.  
 Seal the PyroMark Q96 HS Plate with an adhesive cover. 
  
7.3.2.3. Primer annealing 
 
 Heat the PyroMark Q96 HS Plate at 80 °C for 2 minutes using the PSQ HS 96 
sample prep thermo plate kit. 
 Remove the plate from the heating block and leave the samples on the bench 
for 10 minutes in order to cool to room temperature. 
 
7.3.2.4. Pyrosequencing reaction  
 
 Load the pyrosequencing reagents into the cartridges. The volumes required 
for each reagent are automatically calculated and described within the 
PyroMark CpG software.  
 After performing the dispensing tip test, run the assay within the PyroMark 
CpG software. Once the run is completed, the data can be extracted (Figure 1). 
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Figure 1: Pyrogram of multiple CpG sites within the LINE-1 sequence.  The Y-axis gives 
intensity (in a.u; arbitrary units), and the X-axis is the nucleotide dispensation order. The 
LINE-1 sequence analyzed in this assay is given at the top of the figure. Methylation at four 
CpG sites (highlighted in gray) is quantified in a single pyrosequencing run. Above the gray 
bars are the percentage methylation levels at each CpG site. 
 
7.4. Notes 
 
 The conventional LINE-1 assay (Yang, Estecio et al. 2004) is based upon the 
L1HS sequence (Table 1). The ‘LINE-1 assay’ referred to throughout this 
chapter is that based upon interrogation of L1HS sequences. 
 Repetitive elements DNA methylation in other species, such as mice, rat and 
monkey, can be measured using bisulfite pyrosequencing. However, the 
repetitive element sequences are different from those in humans, and therefore 
the bisulfite pyrosequencing primers have to be carefully designed for each 
species. These primer sequences are available upon request. 
 DNA methylation analysis using bisulfite pyrosequencing is applicable to a 
wide variety of biological samples, such as DNA isolated from cultured cells, 
whole blood samples and other body fluids (buccal cells, saliva, nasal swab 
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samples, etc.), tumor tissue from different sources, and processed samples 
such as formalin-fixed paraffin embedded tissue samples.  
 The PyroMark CpG software has in-built quality control parameters to assess 
the overall performance of the sequencing run. The software also supports 
analysis, such as methylation frequency, mean methylation values per well, 
and replicates and deviation from expected methylation pattern. One important 
aspect of methylation analysis by pyrosequencing is to assess the overall 
bisulfite conversion efficiency. Since all non-CpG cytosine residues are 
converted to uracil and then to thymine in the subsequent PCR reaction, the 
relative incorporation of thymines and cytosines into the elongated DNA at 
these sites informs upon the efficiency of the bisulfite conversion reaction. 
 Appropriate quality controls are required at each stage of the experiment. 
Quality control samples should be run alongside the samples of interest for the 
bisulfite-conversion of DNA, the PCR reaction, and the pyrosequencing run.  
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8.1. Concluding discussion  
8.1.1. Methods to study environment induced methylation changes 
 
DNA methylation is one the most studied epigenetic modifications. DNA methylation 
is involved in regulation of pathways of cellular haemostasis. Exposure of 
environment agents has the potential to alter the cells DNA methylation machinery. 
Cells with altered methylation patterns can initiate the process of carcinogenesis 
(Brookes and Shi, 2014). It is therefore important to understand the DNA methylation 
changes induced by exposure to environmental agents. In current research, methods 
were developed to quantify the DNA methylation changes induced by exposure to 
environmental stressors.  
 
8.1.1.1. Global DNA methylation and hydroxymethylation 
 
In order to understand the effects of environmental exposure on cellular epigenetics, it 
is required to investigate the distribution of epigenetic modifications in the genome. 
Different methodologies have been employed in order to investigate the tissue 
distribution of cellular epigenetic modifications e.g., global DNA methylation and 
hydroxymethylation. Methods have been developed to determine the DNA 
methylation profiles at the global (% 5mC in the genome) or gene-specific (locus-
specific) level (Zuo et al., 2009). In the current project, methods for both global DNA 
methylation and hydroxymethylation were developed and validated. Methods for 
quantification of global 5mC and 5hmC were developed on LC-MS/MS platform. 
Methods validation was performed in a pilot study where healthy humans were 
requested to participate in the study (chapter 6). Global 5mC and 5hmC levels were 
quantified in blood and saliva DNA of these individuals. The amount of 5mC in the 
genome quantified by our method was described to be similar to the ones reported by 
other studies (Dwi Putra et al., 2014, Thompson et al., 2013). %5mC quantified by the 
current method is in agreement with the previous studies where median 5mC contents 
of 4.1% were observed (Kok et al., 2007). This proved the global 5mC analysis 
developed in-house to be in line with other studies profiling 5mC levels.  
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Global 5hmC quantification recently gained great interest as it represents an 
intermediate pathway of DNA demethylation (Pastor et al., 2013). Little is known 
about the tissue distribution of global 5hmC in different species. In order to 
investigate the 5hmC amount in mice lung tissue, we developed and validated the LC-
MS/MS based method for the 5hmC quantification (chapter 6). In literature, data is 
scant on the tissue distribution of the 5hmC amount for different species. Here, we 
report lower global 5hmC contents compared to the other studies reporting global 
DNA 5hmC (Le et al., 2011).  In essence, in-house developed LC-MS/MS method 
allowed rapid and simultaneous quantification of both 5mC and 5hmC in a single run. 
This method was employed to quantify the global 5mC and 5hmC levels in vitro and 
in humans blood DNA samples exposed to chemicals. The amounts of 5mC and 
5hmC quantified by this method, in vitro and in human blood DNA samples under 
different chemicals-exposure settings are discussed below. 
 
8.1.1.2. Gene specific methylation 
 
For gene specific methylation analysis, different methods and techniques are available 
to investigate the CpG specific methylation marks. For example, methyl-specific 
PCR, methyLight technique, pyrosequencing, microarrays and whole genome 
sequencing based assays for methylation profiling (Plongthongkum et al., 2014) 
These methodologies differ, for example, in terms of sample requirement, batch 
throughput, CpG coverage. In the current study, we used PCR-pyrosequencing to 
investigate methylation status of multiple CpG sites at the promoter regions of genes. 
Bisulfite-treated PCR pyrosequencing is regarded as the “gold-standard technology” 
as it enables mapping methylated sites at single base pair resolution (Tost and Gut, 
2007).  
 
In current research, PCR-pyrosequencing assays were originally developed for human 
LINE-1 and Alu sequences, and were validated in a pilot study where healthy humans 
were recruited to investigate the LINE-1 and Alu methylation status in their blood and 
saliva DNA. The LINE-1 and Alu methylation levels reported in the current research 
are in line with the published methylation values of human LINE-1 and Alu 
sequences (Byun et al., 2013).  However, we observed lower methylation levels for 
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LINE1 and Alu elements in saliva DNA compared to their methylation levels in blood 
DNA. This was expected since saliva comprises mainly the dead cells, which have 
altered methylation patterns as compared to the blood cells where the methylation 
levels are tightly controlled. Further, PCR-pyrosequencing assays were developed for 
nineteen mouse genes to investigate their gene promoter methylation in mice exposed 
to nanomaterial.  Validation of these PCR-pyrosequencing assays were done on 
standard mouse DNA samples (samples obtained by pooling 5 ng of DNA from each 
of randomly selected 10 mouse lung DNA samples). 
 
8.1.2. DNA methylation changes after exposure to chemicals 
 
Research conducted in the current project was aimed at delineating the complex 
interplay between environmental stressors and epigenetics. It is known that epigenetic 
alterations lead to disease process e.g., carcinogenesis, but what is not fully known is 
how environmental exposure leads to epigenetic alterations. Here, we filled this 
knowledge gap by investigating the hypothesis that; exposure to chemicals and 
nanomaterial could induce epigenetic changes in vitro, in animals and in humans.  
 
8.1.2.1. Exposure to organic solvents, hydrocarbons, halocarbons, 
cytostatic agents in vitro 
 
We hypothesized that exposure of organic solvents, halocarbons, polyaromatic 
hydrocarbons, cytostatic agents, to cells will induce global DNA methylation 
alterations in vitro (chapter 2). Different classes of chemicals used in the in vitro 
study are known to induce DNA damage i.e., DNA strand breaks, DNA adducts; 
which might lead to carcinogenesis. However, recently it is proposed that 
carcinogenesis induced by exposure of chemicals, traditionally considered as 
genotoxic, also follows epigenetic pathways (Pogribny et al., 2010). Research 
conducted in the current project corroborated that DNA methylation changes are an 
early event in response to exposure of environmental stressors. As shown in chapter 3, 
global DNA hypomethylation was observed in response to exposure of benzene and 
its metabolite hydroquinone in human cells. However, similar patterns of global DNA 
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hypomethylation were not observed when human cells were exposed to styrene 
metabolite. Noticeably, styrene exposure induced global DNA hypomethylation, 
while its metabolite styrene oxide exposure did not induce global DNA methylation 
changes in cells. This highlighted the subtle differential sensitivity of cellular 
epigenome to chemicals with similar mode of actions. Inside the cells, styrene is 
biotransformed to styrene oxide (Carlson, 2012). It is possible that enzymatic 
activities render cells epigenetically non-responsive to styrene oxide. This showed 
that cells DNA methylation is very dynamic and specific in response to chemical 
exposure.  
 
Similar patterns of global DNA hypomethylation were also observed in human cells 
exposed to halocarbons e.g., carbon tetrachloride, and trichloroethylene.  
Mechanistically, DNA hypomethylation effects of halocarbons could be linked with 
their association with methionine metabolic pathways (Varelamoreiras et al., 1995, 
Tao et al., 1999).  In contrast to above observations, we did not observe DNA 
methylation changes in vitro in response to PAHs such as benzo[a]pyrene, 
cyclophosphamide, benzo[a]fluoranthene, benz[a]anthracene and cytostatic agents 
such as mitomycin C, cyclophosphamide, acrylamide etc. PAHs and cytostatic agents 
are shown to induce DNA damage in cells (Perera et al., 2005, Recio et al., 2010), 
however on the DNA methylation endpoint, these agents are not shown to induce 
global DNA methylation changes in human cells. Although, no global DNA 
methylation changes were observed under the current settings, it is possible these 
chemicals can still induce passive DNA methylation changes by diluting methylated 
cytosine during successive rounds of mitosis.  This could not be confirmed in the 
current settings, since TK6 cells were exposed to these agents for one doubling time. 
It is also possible that exposure to these agents lead to gene specific methylation 
changes. Currently, we are investigating such gene specific methylation changes. In 
essence, these findings showed the induction of global DNA methylation changes as 
an early response of chemical-exposure in cells. 
 
Chemical induced global DNA hypomethylation observed in TK6 cells could poise 
cells to carcinogenesis. Similar to methylation changes observed in TK6 cells, cancer 
cells also frequently exhibit global loss of DNA methylation. In cancer cells, global 
DNA hypomethylation is reported to occur early during carcinogenesis, and this loss 
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of methylation could potentiate the carcinogenesis by activating the oncogenes and 
cell survival (Ehrlich, 2009). This association of global DNA hypomethylation with 
the early stages of carcinogens could be used as cancer biomarker. Tissue specimens 
obtained from suspected individuals could be screened for the global loss of 
methylation in order to calculate the risk of developing cancer. 
 
8.1.2.2. Exposure to organic solvents in humans  
 
DNA methylation alterations induced by organic solvents in vitro were further 
confirmed in human population who had previous exposure of organic solvents. 
Humans chronically exposed to solvents are at risk of developing various diseases 
like cancer and neurobehavioral disorders. In current study, DNA methylation 
patterns associated with exposure to organic solvents were investigated, which might 
be used as markers of solvent exposure to predict the disease susceptibility in 
populations at risk.  Global DNA hypermethylation was observed in humans exposed 
to mixture of solvents e.g., benzene, formaldehyde, chloroform compared to the non-
exposed population. Parameters of organic solvents exposure (i.e., total exposure 
time, cumulative exposure index) were shown to be negatively correlated with global 
DNA methylation in solvent-exposed individuals. Interestingly, as shown in chapter 
4, DNA methylation patterns in CTE patients were comparable to the reference 
populations. Since CTE patients do not have active exposure to solvents, while the 
exposed-group were under current solvent exposure at the time of sampling, this 
could explain the observed effects of DNA hypermethylation in solvent-exposed 
individuals. These results highlighted the dynamic regulation of DNA methylation 
changes, and that the DNA methylation changes could have been reversed in the CTE 
population after the exposure was ceased.  
 
This leads to an important outcome on the “time window” that has to be taken into 
consideration in order to observe the DNA methylation effects in response to 
exposure. DNA methylation effects could be diluted/or reversed outside this time 
window. In previous studies, both sequence specific DNA hypo- and 
hypermethylation response is reported in peripheral blood DNA after exposure with 
low levels of benzene (Bollati et al., 2007). Also in the context of cancer, sequence 
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specific hypermethylation while on global scale of DNA hypomethylation is observed 
which drives epigenetic carcinogenesis (Rountree et al., 2001). These observations 
lead to conclude that apparently contradictory results, induced by solvents exposure 
under different systems, can hold physiological relevance.  
 
Recent in vitro studies also showed that solvent exposure induces DNA methylation 
changes (Liu et al., 2011).  Mechanistically, how exposure to solvents leads to DNA 
methylation alterations is largely unknown. It is suggested that oxidative stress could 
be intermediary pathway leading to solvents induced epigenetic changes (Dreiem et 
al., 2005). Another important observation drawn from this study was gene-
environment interaction that could define individuals’ disease susceptibility on 
exposure to solvents. Gene-environment interaction between GSTP1 and total 
exposure time for global DNA hypomethylation were observed. This is in line with 
the findings that genotypic polymorphism in drug metabolizing enzymes affects 
disease susceptibility (Godderis et al., 2010).  
 
On comparison with in vitro findings, where solvent exposure induced global DNA 
hypomethylation, findings in humans exposed to solvents showed results contrary to 
the in vitro results. Global DNA hypomethylation was observed in cells exposed to 
chemicals in vitro. While global DNA hypermethylation with dose- and time-
dependent hypomethylation was observed in humans exposed to chemicals. On one 
sight, these apparently contradictory findings depict the complexity of translating in 
vitro findings in humans. On other sight, these observations highlight the importance 
of exposure period and exposure dose in studying cells epigenetic response to 
xenobiotic. DNA methylation is considered reversible and dynamic epigenetic 
modification (Ramchandani et al., 1999).  In one study, DNA methylation changes 
were reported to take place as early as 20 minutes following the stimulation of T-
lymphocytes in vitro (Bruniquel and Schwartz, 2003).  On the note of dynamicity of 
DNA methylation marks, short term in vitro exposure of cells to arsenic was shown to 
induce pronounced loss of global DNA methylation. While long term in vitro 
exposure of cells to arsenic was associated with slight hypomethylation of LINE-1 
compared to the greater degree of LINE-1 hypomethylation on short term in vitro 
exposure to arsenic. These observations highlight the importance of time-window in 
studying the epigenetic response to environmental stressors. In this study, chemical 
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exposure in TK6 cells was studied for 24 hours. TK6 cells responded to the chemical 
exposure with global loss of DNA methylation. But, if TK6 cells were exposed to 
even longer time periods (e.g., 48 hours or even longer periods), it could be expected 
that; cells either respond by further demethylating the genome, or cells adaptive 
mechanism stops further demethylation of the genome. In these demethylation 
scenarios, it is difficult to conclude the time-point at which cells physiological 
epigenetic response turns into pathological epigenetic response after exposure to 
environmental stressors. Global loss of methylation could potentially lead cells to 
genome instability i.e., a hallmark of cancer; thus leading towards epigenetic 
carcinogenesis. The time-window to initiate the epigenetic carcinogenesis after cells 
exposure to chemicals could be different for different chemicals.  Hence, it is required 
to characterize the time-window for the cells to initiate pathological epigenetic 
response after exposure to different environmental stressor. Global DNA methylation 
changes observed in vitro and in humans in response to chemical exposure could 
potentially be linked with the initiation of a disease process. Such DNA methylation 
alterations have been described to take place e.g., in cancer, cardiovascular disorders, 
neurological disorders (Brookes and Shi, 2014, Webster et al., 2013, Babenko et al., 
2012). 
 
Another important aspect of DNA methylation patterns observed in CTE patients is 
the phenomenon of reverse causality. It is important to establish if the occurrence of 
epigenetic changes is due to the exposure or is it secondary to the emergence of CTE 
itself; and which lies on the casual pathway linking the two (i.e., linking exposure/or 
disease process to observed epigenetic changes). Without establishing the reverse 
causality, it is challenging to prove if the observed epigenetic changes are linked with 
exposure. In the current study, it is difficult to establish if the observed global 
methylation profiles of CTE patients is under the influence of longer exposure time or 
the observed methylation patterns are due to the CTE itself.  
 
8.1.3. Exposure to nanomaterial  
 
We investigated the epigenetic alterations associated with exposure to nanomaterial. 
Humans have been subject to nanomaterial exposure through various sources, but it 
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has been recent with the large-scale production of engineered nanoparticles that their 
exposure triggered scientific community to investigate adverse health effects 
associated with nanomaterial exposure.  Exposure to nanomaterials has the potential 
to alter the cellular epigenome. However, currently no investigations have been done 
in this direction to assess the epigenetic alterations associated with exposure to 
nanomaterial. Here, we filled this knowledge gap by investigating the hypothesis that; 
cellular exposure to nanomaterial would induce epigenetic changes in animals. In 
order to test the hypothesis, we developed and validated the techniques for the 
quantification of global DNA methylation and hydroxymethylation in the genome, as 
described in the previous section. We developed and validated methods to investigate 
the CpG methylation at promoter regions of genes. Development and validation of the 
CpG specific promoter methylation methods were discussed above. 
 
8.1.3.1. Exposure to gold nanoparticles and carbon nanotubes in 
mice 
 
In the current project, it is shown for the first time that exposure to nanomaterial leads 
to gene promoter methylation alterations in animals (chapter 5). Exposure of gold 
nanoparticles leads to the induction of both hypomethylation and hypermethylation in 
the promoter CpGs in exposed animals. For example, promoter CpGs 
hypermethylation was observed for Atm, Cdk and Gsr genes; while promoter CpGs 
hypomethylation was observed in Gpx gene. Genes with altered promoter methylation 
were shown to take part in divers cellular process e.g., cell cycle process, apoptotic 
process, immune system process, metabolic process and response to stimulus 
pathways. Functionally gold nanoparticles induced promoter hypermethylation in Atm 
and Cdk genes is important. These genes are important regulator of cell cycle, and 
hypermethylation of these genes could affect the normal functions of these genes in 
controlling the cell cycle events.  
 
These findings raised important questions on the biocompatibility of engineered 
nanoparticles. Of particular note were the gold nanoparticles of 60 nm diameter. 
Generally, it is expected that cells with exposure of smaller nanoparticles (such as 5 
nm gold nanoparticles) will manifest higher biological activity compared to the larger 
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nanoparticles. Contrary to it, current findings reported more gene promoter 
methylation perturbations induced by exposure to gold nanoparticles of 60 nm in 
diameter compared to gold nanoparticle of 5 nm diameter. This could partially be 
explained by the physicochemical features of gold nanoparticle used in the current 
research. Gold nanoparticles were citrate coated. Gold nanoparticle of 5 nm diameter 
have higher surface area for the attachment of citrate compared to gold nanoparticles 
of 60 nm and 250 nm diameters.  High contents of citrate on the surface of gold 
nanoparticles of 5 nm diameter could potentially mask the effects of these 
nanoparticles on gene promoter methylation. These 5 nm gold nanoparticles also have 
higher tendency to agglomerate in the biological media compared to the gold 
nanoparticles of 60 and 250 nm diameters, as shown in chapter 5, this could also lead 
to suppressed biological activity.  
  
In nanomaterial-exposed mice with significant promoter methylation changes, no 
significant DNA damage was observed. This observation, that nanomaterial exposure 
can induce epigenetic changes in the genome without DNA damage, implicated 
epigenetics as an early response to exposure; instead of mice adaptive mechanism or 
secondary response to genetic damage. The above findings are preliminary that 
warrant further investigations with different model systems and more types of 
nanomaterial to be included. In contrast to gold nanoparticle, exposure to carbon 
nanotubes (SWCNTs, MECNTs) did not induce major gene promoter methylation 
alterations in mice. Carbon nanotubes exposure affected the Atm gene promoter 
methylation.  This is in contrast to other reports where carbon nanotubes were 
described more toxic and even carcinogenic. Carbon nanotubes exposure was shown 
to induce effects similar to asbestoses exposure (Pacurari et al., 2010). On the global 
DNA methylation and hydroxymethylation endpoints, carbon nanotubes were shown 
to have no effect in mice lung DNA. No other research groups have published 
epigenetic effects of carbon nanotubes in animal models or in humans, and this makes 
it difficult to compare the current findings with others.  
 
Recent epidemiological studies have linked exposure of different metals and 
particular matter in humans to the altered epigenetics patterns, and proposed that cells 
with altered methylation marks could act as pre-neoplastic cells (Weidman et al., 
2007, Libbrecht et al., 2005). In current report, nanomaterial are also shown to have 
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potential to alter the cells epigenetic patterns. The magnitude of these epigenetic 
alterations to render cells to neoplastic phenotype has yet to be investigated. So it is 
important to further characterize nanomaterial induced epigenetic changes, and to 
limit the environmental release of nanomaterial owing to their potential adverse 
biological effects in cells.  
 
8.1.4. Conclusion 
 
 
The major epigenetic mechanisms comprise the DNA methylation, histone PTMs and 
mciroRNAs. DNA methylation changes in response to chemical and nanomaterial 
were investigated in current report. Alterations in histone PTMs and in microRNAs 
were not investigated in this report. It is, however, expected that chemical and 
nanomaterial could also affect the histone PTMs and microRNAs. Number of studies 
has described the alterations in histone PTMs and in mciroRNAs in response to 
environmental stressors. Environmental stressor induced histone PTMs changes are 
suggested to drive carcinogenesis (Martinez et al., 2011, Dik et al., 2012). Regarding 
to microRNAs; exposure to heavy metals i.e., cadmium, arsenic, aluminium leads to 
alterations in the expression levels of microRNAs (miR-146a, miRNA-19a, miR-9 
respectively). Exposure to cigarette smoke is also shown to alter the expression 
profile of microRNAs (Hou et al., 2011). Altered expression levels of microRNAs are 
suggested to drive the process of carcinogenesis. In fact, microRNAs are suggested to 
play role similar to tumour suppressor genes and oncogenes (Garzon et al., 2009). 
Thus, all major epigenetic mechanisms i.e., DNA methylation, histone PTMs and 
mciroRNAs are susceptible to alterations in response to environmental exposure. 
Altered epigenetic patterns in cells can further lead to carcinogenesis and other 
multifactorial diseases.  
 
Concluding the main findings from this research, it can be reported that cells can 
initiate epigenetic changes in response to a variety of environmental stressors. 
Chemicals and nanomaterial represent different categories of environmental stressors. 
This shows that the activation of epigenetic mechanisms is common in response to 
diverse types of environmental stressors. We can report that epigenetic modifications 
can be considered as early makers of xenobiotic stress, which could confer cells 
 
 
156 
neoplastic phenotype. However, the extent and magnitude of epigenetic stress 
required for cells to transform into neoplasm needs to be further investigated. It is also 
important to note that gene promoter methylation at single CpG site can functionally 
act similar to single nucleotide polymorphism (SNP).  In this context, where a single 
SNP or mutation can alter disease susceptibility, methylation at single CpG sites can 
also affect the binding of transcription factors and thus regulates the gene expression. 
Current findings elaborated this phenomenon, where methylation alterations are 
reported at single CpG sites but surrounding CpG sites remained unaffected. These 
findings will further help in delineating cellular signalling mechanisms driving these 
epigenetics alterations. Findings in this report will also enable scientists to build 
strategies of effective biomonitoring for human population at risk, and to develop 
early epigenetic marker of disease susceptibility.  
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9.1. Summary of current research  
9.1.1. Background 
 
Humans are exposed to a variety of environmental stressors during their life time e.g., 
organic solvents, polyaromatic hydrocarbons, halocarbons, cytostatic agents. Due to 
anthropogenic factors, new environmental stressors have been emerged e.g., 
engineered nanoparticle (NPs), and nanotubes. NPs are defined as particles with at 
least one particulate dimension less than 100 nm. Exposure to environmental stressors 
has shown to induce adverse health effects. Recent studies also raised concerns about 
effects in cells in response to nanomaterial exposure. So far, it remains difficult to 
assess the impact of environment on health. Therefore, it is important to get insight in 
the disease mechanisms. 
 
It is proposed that exposure to environmental stressors can lead to epigenetic changes 
similar as observed in diseased cells, e.g. cancer cells.  Epigenetics encompasses 
structural modifications of DNA and histones, and microRNAs which regulate the 
gene expression without affecting the DNA sequence. Methylation of 5
th
-carbon of 
cytosine bases in DNA (5mC) is one of the most studied epigenetic modifications. 
5mC modification can also be demethylated in cells by the actions of different 
enzymes leading to the production of an intermediate modification called DNA 
hydroxylmethylation (5hmC). We hypothesize that exposure to environmental 
stressors could alter the DNA methylation marks globally or in gene specific manner.   
 
9.1.2. Materials & methods 
 
In the current project, global DNA methylation and hydroxymethylation and gene 
promoter methylation changes associated in response to exposure of a range of 
chemicals and nanomaterial (gold NPs (AuNPs) of three size, single-walled carbon 
nanotubes (SWCNTs) and multi-walled carbon nanotubes (MWCNTs)) are 
investigated in the laboratory settings and in humans. Global 5mC and 5hmC was 
quantified by liquid chromatography- mass spectrometry (LC-MS/MS) method, while 
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gene promoter methylation was quantified by bisulfite-PCR pyrosequencing of 17 
genes selected from different pathways commonly affected by exposure to xenobiotic.   
 
9.1.3. Results & discussion 
 
In the laboratory settings, global DNA hypomethylation was observed in TK6 cells in 
response to exposure of benzene (p=0.0295), hydroquinone (p=0.0108), styrene 
(p=0.0115), carbon tetrachloride (p=0.0475) and trichloroethylene (p=0.0294). In 
studying the effects of solvent exposure in humans, DNA hypermethylation (p = 
0.001) was observed in in blood DNA of individuals working with solvents compared 
to the control group. In exposed individuals, GSTP1 genotypic polymorphism was 
found to be significantly associated (p=0.033) with global DNA hypomethylation, 
which describes the potential gene-environment interaction in the aetiology of 
solvent-induced phenotypes.  
 
While studying nanomaterial exposure effects in mice, no global 5mC or 5hmC 
changes were observed in response to AuNPs, SWCNTs, and MWCNTs exposure in 
mice lung DNA samples. In mice lung DNA samples, following promoter 
methylation changes were observed; AuNPs 60nm exposure induced promoter CpGs 
hypermethylation in Atm, Cdk and Gsr genes, while promoter CpGs hypomethylation 
in Gpx gene; changes in promoter methylation of Gsr and Trp53 was also observed 
between low and high dose (i.e., dose effect) of AuNPs 60 nm and AuNPs 250 nm 
respectively; AuNPs size effects on promoter methylation was observed for Trp53 
gene; CNTs exposure affected the promoter methylation of Atm gene. In mice blood 
DNA samples, the only effect occurred was the induction of promoter 
hypermethylation in Pparg gene by exposure of AuNPs 60 nm high dose compared to 
the AuNPs 60 nm low dose. Epigenetically altered genes were involved in DNA 
apoptotic process, immune system process, metabolic process and response to 
stimulus pathways. These finding could implicate the epigenetic pathways in 
carcinogenesis.   
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9.1.4. Conclusion 
 
Concluding the major findings, we can report that cells epigenetic alterations are 
considered as an early event in response to exposure of a verity of environmental 
stressors. We delineated for a wide variety of chemicals i.e., organic solvents, 
hydrocarbons, halocarbons, cytostatic; that their exposure in cells leads to alterations 
in cells global DNA methylation patterns. We also showed that cells exposure to 
nanomaterial alters methylation changes in gene prompter CpGs. Further, it remains 
to be characterized the timing at which cells epigenetic response to environmental 
stressors leads to pathological signalling events which initiate the disease process. 
Future work should also address; the molecular events that are intermediary between 
the exposures of environmental stressors to the observed epigenetic changes; and to 
develop preventative epigenetic screening strategies for human population who are at 
risk of developing environmental exposure induced malignancies.  
 
 
